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The thesis is divided into two sections:  
1. Section one is a general introduction where important results from my research are 
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introduction to manuscripts III and IV. 
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 Abbreviations 
A Adenine hUNG1 Human mitochondrial UNG 
AD Activation Domain hUNG2 Human nuclear UNG 
ANT Adenine Nucleotide Translocator   3-MeA 3-methyladenine  
AP Apurinic/apyrimidinic 3-MeG 3-methylguanine 
ATP Adenosine triphosphate MGMT O6-methylguanine-DNA 
methyltransferase  
BD Binding Domain MMR  Mismatch repair  
BER Base Excision DNA Repair  MNNG N-methyl-N’-nitro-N-
nitrosoguanidine 
C Cysteine MNU Methylnitrosourea 
CAT Catalase MPG N-methylpurine-DNA glycosylase  
Complex I  NADH dehydrogenase or NADH:ubiquinone 
oxidoreductase 
Msh1 Mitochondrial homolog of the E. coli 
MutS  
Complex II  Succinate dehydrogenase mtDNA Mitochondrial DNA 
Complex III  Ubiquinol:cytochome c oxidoreductase nDNA Nuclear DNA 
Complex IV  Cytochrome c oxidase  NER Nucleotide Excision Repair  
Complex V  ATP synthase  NLS Nuclear Localization Signal  
CoQ Coenzyme Q, also called ubiquinone   NPC Nuclear pore complexes 
DNA Deoxyribonuceic acid O2-  Superoxide radical  
E. coli Escherichia coli O4-MeT O4-methylthymine  
FEN1 Flap endonuclease-1, S. cerevisiae rad27 
homolog 
O6-MeG O6-methylguanine 
G Guanine 8-oxoG 7,8-dihydro-8-oxoguanine  
GGR Global genome repair  PCNA Proliferating Cell Nuclear Antigen 
GPx Glutathione peroxidase POL G Polymerase γ 
H2O2   Hydrogen peroxide  Pol ε DNA polymerases (Pol II) 
hAPE1 Human AP endonuclease  Pol δ DNA polymerases (Pol III) 
hEXO1 Human exonuclease 1  rho- Mutations in the mitochondrial 
genome 
hMLH1-
hMLH3 
 
E. coli MutL homolog complex rho0 Lack of mitochondrial genome  
hMLH1-
hPMS1  
  
E. coli MutL homolog complex ROS  Reactive oxygen species  
hMLH1-
hPMS2  
 
E. coli MutL homolog complex S. cerevisiae Saccharomyces cerevisiae 
hMSH2-
hMSH3 
  
E. coli MutS homolog complex, recognizes 
insertion/deletions  
SOD1 Nuclear superoxide dismutase 
hMSH2-
hMSH6  
 
E. coli MutS homolog complex, recognizes 
base:base mispairs and insertion/deletions  
SOD2 Mitochondrial superoxide dismutase
hMYH Glycosylase, Human MutY Homolog   SSB Single-strand binding protein  
HNPCC Hereditary Non-Polyposis Colon Cancer  T Thymine 
hNTH1  Glycosylase, Human Nth homolog TCR Transcription coupled repair  
hOGG1  8-OxoGuanine DNA Glycosylase UNG Uracil-DNA Glycosylase  
HO• Hydroxyl radical  XPG S. cerevisiae Rad2 homolog 
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 Summary 
Increased spontaneous mutation frequency is associated with increased cancer risk. 
However, the relative contribution of spontaneous endogenous mutagenesis to 
carcinogenesis is not known today. Defects in the postreplication DNA mismatch repair 
(MMR) pathway are recognized to increase spontaneous mutations. Mutations in MMR 
genes cause hereditary non-polyposis colon cancer.   
In an effort to identify unidentified genes involved in MMR and tissue-specific MMR-
associated factors, we employed the yeast two-hybrid system, using the human hMSH2 as 
bait and a human fetal liver cDNA library as prey. We demonstrated that hMSH2 interacts 
with a human 5’ → 3’ exonuclease 1 (hEXO1). 
 
Data presented in this thesis also support the conclusion that mitochondrial dysfunction leads 
to spontaneous nuclear DNA damage. We employed the yeast Saccharomyces cerevisiae as 
a model system to investigate a potential link between mitochondrial activity and genomic 
instability. Mitochondrial dysfunction and genetic instability are characteristic features of 
cancer cells. Furthermore, mitochondrial dysfunction is a key feature of aging due to 
accumulation of mutations in mtDNA. Our studies in a yeast model system suggest that 
mitochondria contain some intrinsic properties that control the generation of the mutator 
phenotype associated with cancer cells. We hypothesize that cancer cells by losing their 
mitochondrial function create a mutator phenotype. 
 
Given the importance of maintaining the integrity of the mitochondrial genome we have 
found that it might be valuable to further investigate the molecular processes and 
components responsible for mtDNA repair. It has recently been recognised that base 
excision DNA repair (BER) is operating in the mitochondria, however, knowledge about 
other repair pathways is still very limited. We decided to investigate O6-methylguanine-
DNA methyltransferase (MGMT) because of the fact that its sub-cellular localization has not 
been determined. We determined that it was localized to nucleus but not to mitochondria in 
HeLa and breast epithelial cells. 
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 Sammendrag (Summary in Danish) 
En øget frekvens af spontane mutationer er forbundet med øget risiko for cancer. Hvor stor 
en del af cancinogenese som skyldes spontan endogen mutagenese, er endnu ikke kendt. Fejl 
i det postreplikative DNA mismatch repair (MMR) system har imidlertid vist sig at forøge 
den spontane mutationsfrekvens, da mutationer i MMR-generne kan forårsage hereditær 
non-polypos colon cancer.  
 
For at finde uidentificerede gener, som er involveret i MMR, samt vævsspecifikke MMR-
associerede faktorer, gjorde vi brug af gær two-hybrid systemet. Vi brugte hMSH2 som 
“bait” og et humant føtalt lever cDNA bibliotek som “prey”. Vi viste, at hMSH2 interagerer 
med en human 5’ → 3’ exonuclease 1 (hEXO1). 
 
Endvidere indeholder afhandlingen resultater, som understøtter konklusionen om, at 
mitokondriel dysfunktion fører til spontan nukleær DNA skade. Vi brugte Saccharomyces 
cerevisiae som modelsystem til at undersøge en mulig sammenhæng mellem mitokondriers 
aktivitet og genomisk stabilitet. Mitokondriel dysfunktion og reduceret genetisk stabilitet er 
karakteristiske egenskaber for cancer celler. Yderligere er mitokondriel dysfunktion 
forbundet med aldring på grund af akkumulering af mutationer i mtDNA. Vore studier i et 
gær modelsystem indikerer, at mitokondrier har egenskaber som kan styre udviklingen af 
den mutator fænotype der er forbundet med cancer celler. På baggrund af dette opstiller vi en 
hypotese om, at cancer celler ved at miste deres mitokondrie funktion kan frembringe en 
mutator fænotype.  
 
Givet vigtigheden af at opretholdeholde/reparere det mitokondrielle genom for at forhindre 
mitokondriel dysfunktion, fandt vi det værdifuldt yderligere at undersøge de molekylære 
processer og komponenter ansvarlige for mtDNA reparation. Det er i dag anerkendt at base 
excision DNA repair (BER) virker i mitokondrierne. Viden om andre reparationssystemer i 
mitokondrierne er dog stadig meget begrænset. Vi undersøgte O6-methylguanine- DNA 
methyltransferase (MGMT) subcellulære lokalisation, og fandt at MGMT i bryst epithelial-
celler er lokaliseret til kernen, men ikke til mitokondrierne. 
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1. Analysis of Human DNA Mismatch Repair  
 
1.1 Introduction 
The postreplication DNA mismatch repair (MMR) pathway is responsible for the 
maintenance of DNA fidelity upon replication (Buermeyer et al., 1999; Kolodner & 
Marsischky, 1999; Harfe & Jinks-Robertson, 2000; Jiricny et al., 2000). MMR captures 
errors in the newly synthesized DNA strand that are missed by the polymerase proofreading 
and lowers the mutation frequency by a factor of 100-1000-fold as compared to MMR 
deficient cells (Bhattacharyya et al., 1994; Eshleman et al., 1995). In humans, accumulation 
of mutations is a critical step in carcinogenesis. Loss of a single allele of one of the mismatch 
repair proteins causes Hereditary Non-Polyposis Colon Cancer (HNPCC), a form of cancer 
that accounts for 1-5% of all cases of colon cancer (Lynch & de la Chapelle, 1999; 
Peltomäki, 2001). HNPCC is caused by inherited mutations in MMR genes. Most HNPCC 
families have germline mutations in the hMSH2 (2p22-p21) and hMLH1 (3p21) genes. 
Mutations in the other known MMR genes hMSH6 (2p16), hMSH3 (5q11-q12), hPMSH2 
(7p22), hPMSH1 (2q31), and hMLH3 (14q24) are either rare or non-existent in HNPCC 
families (Peltomäki & Vasen, 1997; Kolodner & Marsischky, 1999; Wood et al., 2001).  
 
Some HNPCC families fail to display mutations in known MMR genes. Therefore, we argue 
that these HNPCC families must harbor mutations in yet unidentified genes that are involved 
in MMR. In an attempt to identify such genes, we employed the yeast two-hybrid system, 
using the human MMR proteins hMSH2 (Rasmussen et al., 2000) or hMLH1 as bait and a 
fetal liver matchmaker cDNA library as prey.  
 
1.2 DNA Mismatch Repair 
 
MMR in Escherichia coli 
Mechanisms and functions of mismatch correction are best understood in Escherichia coli, 
therefore a short introduction to MMR in E. coli is given. MMR is directed by the state of 
adenine methylation of GATC sequences. Since DNA adenine methylation (Dam) occurs 
after replication, an unmethylated newly synthesized strand is temporarily paired with a 
fully methylated parental strand, which provides a strand discrimination signal for MMR in 
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E. coli (Lahue & Modrich, 1989). Initiation of MMR occurs via mismatch recognition and 
binding of a MutS homodimer followed by binding of a MutL homodimer. In E. coli MutL 
serves to couple mismatch recognition with downstream MMR events. Interactions between 
MutL, MutS, and ATP are believed to result in translocation of the MutS-MutL complex 
away from the mispair, leading to the activation of the MutH endonuclease (Allen et al., 
1997; Hall & Matson, 1999). After activation, MutH introduces a nick in the nascent strand 
of the nearest hemi-methylated GATC sequences. MutL helps to load DNA helicase II 
(UvrD) at the nicked GATC site and UvrD unwinds DNA from the nick toward and past the 
mismatch (Hall et al., 1998). Removal of the error-containing DNA strand is facilitated by 
one of four single-stranded, DNA-specific exonucleases (RecJ, ExoI, ExoVII, ExoX) 
depending on the polarity of the reaction (Viswanathan & Lovett, 1998; Burdett et al., 
2001). The resulting single-stranded gap, is stabilized by single-strand binding protein 
(SSB) and filled by DNA polymerase III holoenzyme. The remaining nick is closed by 
DNA ligase and Dam methyltransferase finishes the MMR pathway in E. coli by 
methylating the newly synthesized strand (Rasmussen et al., 1998).  
 
Mismatch recognition - in eukaryotes 
In eukaryotes, mispaired bases in DNA are recognized by the heterodimeric complexes, 
MSH2-MSH6 and MSH2-MSH3 (MutS homologs) (Acharya et al., 1996; Guerrette et al., 
1998, Genschel et al., 1998). Analysis of mismatch binding specificities of the human 
hMSH2-hMSH6 and hMSH2-hMSH3 complexes showed that they were overlapping but 
not identical. The hMSH2-hMSH6 complex recognizes base:base mispairs and 
insertion/deletion mispairs of up to 8 unpaired bases. In comparison, hMSH2-hMSH3 has a 
high affinity for insertion/deletions of 2-8 unpaired bases, weak affinity for single-nucleotid 
insertion/deletion mispairs, and do not bind base:base mispairs (Drummond et al., 1997; 
Genschel et al., 1998). The predominant DNA-binding protein in the hMSH2-hMSH6 
complex appears to be hMSH6 when binding to a mismatched oligonucleotide (Matton et 
al., 2000). Hence, the hMSH2-hMSH6 complex appears to provide the predominant 
mismatch-binding activity in human cells (Genschel et al., 1998; Marra et al., 1998).  The 
hMSH3 protein is believed to compete with hMSH6 for the available hMSH2, as the 
interacting regions of hMSH2 with hMSH3 and hMSH6 are identical (Guerrette et al., 
1998). This prediction is supported by two independent findings: extracts prepared from 
HCT15 cells, which lack hMSH6, contain approximately three-fold higher levels of 
hMSH2-hMSH3 complex compaired to MMR proficient cells (Genschel et al., 1998); and 
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cells overexpressing hMSH3 preferentially form hMSH2-hMSH3 complexes  (Marra et al., 
1998). Thus, hMSH3 interacts with all hMSH2 to form the hMSH2-hMSH3 complex, 
making cells functionally deficient in hMSH2-hMSH6 complex. Consequently, these cells 
lack base:base mispair correction (Drummond et al., 1997; Marra et al., 1998). 
 
Table 1.1 • DNA mismatch repair proteins  
(Kolodner & Marsischky, 1999; Burdett et al., 2001; Wood et al., 2001) 
 
E. coli S. cerevisia H. sapiens 
 
MutS 
 
Msh2-Msh6  
 
hMSH2-hMSH6   
Function 
 
Recognizes single-nucleotide and 
insertion/deletion mispairs. 
 Msh2-Msh3 hMSH2-hMSH3 Recognizes insertion/deletion mispairs. 
MutL Mlh1-Pms1  hMLH1-hPMS2 
 Mlh1-Mlh2 hMLH1-hPMS1 
 Mlh1-Mlh3 hMLH1-hMLH3 
Couples mismatch recognition with downstream 
MMR events in E. coli. The function in 
eukaryotes is unclear. 
 
MutH not identified not identified Endonuclease; nicks hemimethylated GATC 
sequences. 
 
UvrD not identified not identified Helicase;  facilitates DNA unwinding 
RecJ & ExoVII not identified not identified 5’→ 3’single-stranded DNA exonucleases 
ExoI & ExoX not identified not identified 3’→ 5’ single-stranded DNA exonucleases 
not identified Exo1  
 
hEXO1  5’→ 3’ DNA exonucleases that have a 
preference for degrading double-stranded DNA 
 
 
The step after mismatch recognition - in eukaryotes 
Except for the initial mismatch recognition step, relatively little is known about the MMR 
mechanism in humans. However, human MutL homologs have been identified (table 1.1 & 
figure 1.1). The human MutL complexes consist of three different heterodimers: hMLH1-
hPMS2, hMLH1-hPMS1 and hMLH1-hMLH3.  
 
A glutathione-S-transferase (GST) fusion protein assay has shown that the interactions 
between hMLH1 and hPMS2 (Guerrette et al., 1999), hMLH1 and hPMS1 (Kondo et al., 
2001), and hMLH1 and hMSH3 (Lipkin et al., 2000) all are mediated through the same C-
terminal region of hMLH1 (Kondo et al., 2001). This fact could imply that hPMS2, hPMS1 
and hMSH3 are competing for hMLH1.  
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To date, the exact biochemical roles of hMLH1-hPMS1 and hMLH1-hMSH3 complexes 
have not been determined. Only hMLH1-hPMS2 has been shown to be involved in MMR (Li 
& Modrich, 1995; Nicolaides et al., 1995), although, hMLH1 seems to have greater affinity 
for hPMS1 than for hPMS2, when measured in the yeast two-hybrid assay (Räschle et al., 
1999) and hPMS1 has been shown to be mutated in one HNPCC family (Nicolaides et al., 
1994).  
Overproduction of an hMLH3 N-terminal deletion protein is associated with a microsatellite 
instability phenotype (Lipkin et al., 2000). Furthermore, results obtained in S. cerevisiae 
imply that the Mlh1-Mlh3 heterodimer repairs insertion/deletion mispairs, most likely in 
cooperation with the Msh2-Msh3 heterodimer (Flores-Rozas & Kolodner, 1998). These 
results suggest that the hMLH1-hMLH3 complex can substitute for the hMLH1-hPMS2 
complex in the repair of insertion/deletion loops recognized by the hMSH2-hMSH3 complex 
(figure 1.1). 
 
 
G
T
Repair of base-base
mismatches
Insertion/deletion
loop repair
A    A
  A A
hMSH6hMSH2
hMLH1
hPMS2
hMSH3hMSH2
hMLH1
hPMS2
hMSH3hMSH2
hMLH1
hMLH3
?
 
 
Figure 1.1: Protein complexes involved in MMR and their diverse functions. Base:base mispairs are only 
recognized by hMSH2-hMSH6/hMLH1-hPMS2 complexes. Whereas insertion/deletion loops are recognized by 
hMSH2-hMSH6/hMLH1-hPMS2 and hMSH2-hMSH3/hMLH1-hPMS2. Studies in yeast suggest that hMSH2-
hMSH3/ hMLH1-hMLH3 recognize insertion/deletion loops but this has not yet been proven in human, 
therefore the question mark. 
 
As in E. coli, the human MutL homologs have been shown to interact with the mismatch 
recognition complex; hMSH2, hMSH6, hMLH1, and either hPMS2 or hPMS1 (but not both 
together) have been co-precipitated from HeLa nuclear extracts in the absence of added ATP 
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(Matton et al., 2000). The exact function of the MLH heterodimers as well as the signal for 
strand discrimination is not clearly defined in eukaryotes. However, it is known that strand-
specific mismatch repair in human cells can be directed by a single strand nick in the DNA 
helix (Holmes et al., 1990; Thomas et al., 1991).  
It has been demonstrated that PCNA (Proliferating Cell Nuclear Antigen)1 is required for 
initiation of repair as well as for resynthesis in MMR (Umar et al. 1996; Gu et al., 1998).  
Studies (two-hybrid screens) in yeast have shown that Mlh1 interacts with the replication 
accessory factor PCNA, suggesting that Mlh1 heterodimers serve as an interface between 
Msh heterodimers (mismatch recognition) and DNA replication components (Umar et al., 
1996). The involvement of PCNA in MMR initiation has been supported by observations, 
which demonstrated that hMSH2, hMLH1, hPMS2, and PCNA can be co-
immunoprecipitated from HeLa nuclear extracts in the presence of double-stranded circular 
DNA, Mg2+ and ATP. Furthermore, PCNA could not be precipitated from either hMSH2-
defective LoVo or hMLH1-defective H6 cells or if ATP was eliminated from the 
immunoprecitation step suggesting that formation of the complex requires functional hMSH2 
and hMLH1 proteins (Gu et al., 1998). Other research has suggested that PCNA plays an 
important role in steps proceeding mismatch recognition. Bowers et al. (2001) demonstrated 
that following mismatch recognition, PCNA could disrupt ternary complexes in yeast 
composed of Msh2-Msh6, Mlh1-Pms1 and linear mismatched substrate (Bowers et al., 
2001).  
Genetic analyses in yeast also indicate that mutations in PCNA can create mutator 
phenotypes (increase frameshifts in simple sequence repeats) consistent with disrupted 
MMR, possibly as the result of defects in strand discrimination (Johnson et al., 1996; 
Kokoska et al., 1999; Chen et al., 1999). Recent work in yeast has suggested that PCNA-
Msh2-Msh6 interactions play a key role in facilitating specific binding of Msh2-Msh6 to 
mispairs and/or that the specific activity of Msh2-Msh6 is increased by the interaction with 
PCNA (Flores-Rozas et al., 2000). The interaction between PCNA and Msh2-Msh6 seems to 
be mediated by a specific PCNA-binding site present in Msh6 (Flores-Rozas et al., 2000).  
Therefore, PCNA seems to be implicated in steps in all phases of mismatch recognition. 
PCNA interacts with a number of DNA factors, including DNA polymerases (Pol δ, Pol ε), 
                                                          
1 Proliferating cell nuclear antigen (PCNA) is a replication accessory factor encoded by the essential gene POL30 in 
Saccharomyces cerevisiae. It is a homotrimeric ring-shaped protein that serves as an accessory factor for DNA polymerase δ 
(Pol δ) and DNA polymerase ε (Pol ε). DNA-bound PCNA forms a sliding clamp that tethers Pol δ and Pol ε to template 
DNA and thus promotes processive DNA synthesis (Chen et al., 1999).  
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DNA endonucleases (FEN1, XPG), DNA ligases (Ligase 1), and methyltransferases (DNA-
(cytosine-5) methyltransferase), indicating that it may have multiple roles in DNA repair 
(Gary et al., 1999). However, it is still not clear how PCNA is involved in the MMR 
pathway. 
 
Excision 
One of the interacting proteins we found in the two-hybrid screening with hMSH2 as a bait 
was the human exonuclease 1 (hEXO1) (Rasmussen et al., 2000). Therefore, the excision 
step in MMR will be described in greater detail in the next section. 
 
1.3 The Human Exonuclease 1 
The human exonuclease 1 (hEXO1) belongs to a family of nucleases with structure-specific 
nuclease activity that is conserved from phage to human (Lieber, 1997; Ceska & Sayers, 
1998). The strong sequence homologies are limited to two discrete regions, designated to the 
N (N-terminal) and I (internal) regions that comprise the catalytic domain responsible for 
exo- and endonuclease activities. Based on sequence comparisons, positioning of the N-
terminal and internal regions, and their biochemical and biological functions, this nuclease 
family can be divided into three subfamilies (Lee & Wilson III, 1999).  
One subfamily includes human XPG (xeroderma pigmentosum group G) and its S. cerevisiae 
(Rad2) and S. pombe (Rad13) homologs. Another consists of FEN1 (flap endonuclease-1), S. 
cerevisiae (Rad27) and S. pombe (Rad2) homologs. The third subfamily includes human 
exonuclease 1 (hEXO1), S. cerevisiae (Exo1) and S. pombe (Exo1).  
 
The first subfamily – XPG 
The XPG proteins possess both endonuclease and 5’→ 3’ exonuclease activities and are 
known to operate in Nucleotide Excision Repair (NER) (Habraken et al., 1994). Two NER 
subpathways exist; repair of damage that blocks elongating RNA polymerases, transcription 
coupled repair (TCR), and repair of lesions over the entire genome, referred to as global 
genome repair (GGR). In both the TCR and GGR pathways the XPG and ERCC1-XPF 
proteins are responsible for cleaving 3' and 5' respectively of the damaged strand which 
occurs after the damage is detected and a region around the damage site has been opened. 
Cleavages with XPG and ERCC1-XPF result in the removal of 24-32 nucleotides containing 
the lesion. The resulting gap is filled in by the combined action of DNA polymerase δ or ε, 
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PCNA, single-strand binding protein (RPA) and ligase. In mammalian cells, at least 25 
polypeptides are required for the NER process (de Laat et al., 1999; Hoeijmakers, 2001). 
Mutations in the XPG gene have been found to lead to the human disorder xeroderma 
pigmentosum, characterized by a hypersensitivity to sunlight and an increased likelihood of 
developing skin cancer (van Steeg & Kraemer, 1999). 
 
The second subfamily – FEN1 
The FEN1-like proteins exhibit a 5’→ 3’ flap-specific exo/endonuclease that plays an 
important role in multiple DNA metabolic processes. The flap-specific endonuclease activity 
is required for branched DNA structures produced by DNA polymerase strand displacement 
during lagging strand DNA synthesis, or as intermediates during DNA recombination 
(Harrington & Lieber, 1994a, 1994b). The 5’nuclease function of FEN1 is responsible for the 
excision of Okazaki fragments, (FEN1 excises the final 5’-terminal ribonucleotide at the 
RNA-DNA junction) (Bambara et al., 1997) and for long-patch base excision repair (Kim et 
al., 1998).  
In S. cerevisiae, a deletion of the FEN1 homolog Rad27 results in sensitivity to the alkylating 
agent methylmethane sulfonate, modest sensitivity to ultraviolet light, increased spontaneous 
chromosome instability, and temperature sensitivity (Johnson et al., 1995; Reagan et al., 
1995; Vallen & Cross, 1995). These phenotypes are consistent with participation of FEN1 in 
both DNA replication and repair. 
 
The third subfamily – EXO1 
The human exonuclease 1 (hEXO1) gene consists of 14 exons, and is transcribed to yield a 3-
kb mRNA. The hEXO1 gene is located on chromosome 1 (1q42-43) (Schmutte et al., 1998; 
Tishkoff et al., 1998; Wilson III et al., 1998). 
There exist two forms of exonuclease 1, hEXO1a/HEX1 and hEXO1b (Schmutte et al., 1998; 
Tishkoff et al., 1998; Wilson III et al., 1998). The hEXO1a/HEX1 protein is 803 amino acids 
long, whereas the hEXO1b protein is 846 amino acids. This difference in length arises from 
alternatively spliced RNA transcripts involving only C-terminal content outside of the 
nuclease domain (Schmutte et al., 1998; Tishkoff et al., 1998).  
The ratio between hEXO1a/HEX1 and hEXO1b ESTs, found during database searches, was 
1:6, which suggests that hEXO1b is the more abundant species (Tishkoff et al., 1998). The 
DNA sequences of the hEXO1 two-hybrid clones we isolated showed homology to the C-
terminal region of hEXO1b (Rasmussen et al., 2000). 
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It should be noted that hEXO1 will be used as nomenclature for human exonuclease 1 when 
hEXO1a/HEX1 and hEXO1b are not compared.   
 
Interactions with hEXO1  
The S. cerevisiae and human exonucleases 1 (Exo1 & hEXO1) interact with mismatch repair 
protein Msh2/hMSH2 as demonstrated by the two-hybrid system and immuno-
coprecipitation, suggesting that hEXO1 may play a role in MMR (Tishkoff et al., 1997; 
Schmutte et al., 1998; Tishkoff et al., 1998; Rasmussen et al., 2000). The interaction is 
mediated through C-terminal domains for both the S. cerevisiae and human exonucleases 1 
(Tishkoff et al., 1997; Rasmussen et al., 2000). We have shown that hMSH2 interacts with 
both forms of human exonuclease 1, suggesting that the interacting domain is located 
between exons 8 and 13 (∼amino acids 384-870) (Rasmussen et al., 2000). Recently, 
Schmutte et al. (2001) suggested that the carboxy-terminal amino acids 603-846 in hEXO1 
are the specific interacting region with hMSH2 (Schmutte et al., 2001). 
 
Like hMSH2, the hMLH1 protein interacts with hEXO1 through the C-terminal domain of 
the hEXO1, as demonstrated by the two-hybrid system and via in vitro pull-down assay 
(Jäger et al., 2001; Schmutte et al., 2001). Two other MMR proteins, hMSH6 and hPMS2, 
have been shown not to interact with hEXO1 in the two-hybrid system (Rasmussen et al., 
2000; Jäger et al., 2001). However, the N-terminal (amino acids 129-390) of hEXO1 seems 
to interact with the N-terminal of hMSH3 (Schmutte et al., 2001). This result indicates that 
hEXO1 and hMSH3 proteins interact with same region of hMSH2. The interacting region of 
hMSH2 with hEXO1 are amino acids 261-671 of hMSH2 (261-669aa are essential for 
interaction and 261-600aa stabilize the interaction) and the interaction region between 
hMSH2 and hMSH3 are amino acids 378-625 of hMSH2. (Schmutte et al., 2001).  
 
Expression/localization of hEXO1 
We have shown that hMSH2 and hEXO1 are co-expressed at high levels in fetal liver, adult 
testis and thymus. hEXO1 transcripts are expressed in the fetal tissue of liver, spleen and 
kidney but not in adult liver, spleen, and kidney tissue, suggesting a role for hEXO1 in 
development of these tissues. Northern Blot analysis revealed that hEXO1 is highly expressed 
in several liver cancer cell lines as well as in colon and pancreas adenocarcinomas but not in 
the corresponding non-neoplastic tissue (Rasmussen et al., 2000).  
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Sub-cellular localization of hEXO1 was restricted to the nucleus of murine NIH3T3 cells 
transfected with YFP-hEXO1b plasmids (Jäger et al., 2001), indicating that hEXO1 has no 
function in the mitochondria. 
 
Mutator gene 
Disruption of EXO1 increased the mutation rate in S. cerevisiae cells, indicating a role for 
EXO1 in DNA repair (Tishkoff et al., 1997; Tran et al., 1999). However, S. cerevisiae exo1 
mutants show a moderately lower mutator phenotype than that caused by mutations in MSH2 
(Tishkoff et al., 1997; Tran et al., 1999). This suggests that there are additional exonucleases 
involved in MMR in S. cerevisiae. 
FEN1 may be another exonuclease involved in MMR. It has been observed that rad27 and 
exo1 mutations are lethal in combination with one another, unlike the corresponding single 
mutants  (Tishkoff et al., 1997; Gary et al., 1999). Overexpressions of Exo1 or hEXO1 
proteins suppress both the temperature sensitive and the spontaneous mutator phenotype of 
rad27 mutants. (Tishkoff et al., 1997; Qiu et al., 1999). 
hEXO1 remains unverified as a colon cancer predisposition gene. However, Wu et al. (2001) 
have detected germline hEXO1 variants in HNPCC families. All hEXO1 variants were 
identified in families in which no germline hMSH2, hMLH1, and hMSH6 mutations had been 
found. One hEXO1 variant found in a family with HNPCC resulted in a truncated protein that 
was 106 amino acids shorter than the wild-type gene product detected (Wu et al., 2001). 
Because hEXO1 interacts with hMSH2 through its C-terminal, the shorter gene product could 
have functional consequences for MMR. 
 
DNA exonuclease activity 
All of the Exo1 homologous (S. cerevisiae, S. pombe, and human) posses a 5’→ 3’ double-
stranded DNA exonuclease activity (Szankasi & Smith, 1995; Tishkoff et al., 1997; Qiu et 
al., 1999). The hEXO1 and Exo1 proteins act both on single-stranded DNA (ssDNA) and 
double-stranded DNA (dsDNA) substrate but have prefererence for dsDNA. The human 
hEXO1 does not discriminate between RNA and DNA substrates in vitro (Qiu et al., 1999). 
This suggests that the lethality of the exo1rad27 double mutants are caused by inability to 
remove primer RNAs during lagging strand DNA synthesis. As mentioned earlier, the 
function of removing RNA primers of the lagging DNA strand is known to be performed by 
the FEN1/Rad27 nuclease in eukaryotes (Bambara et al., 1997). However, the efficiency of 
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hEXO1 to remove RNAs indicates that it may also be involved in removal of RNA primers 
during lagging strand DNA synthesis. 
A detailed analysis of the nuclease domain (HEX1-N2) of hEXO1 showed that HEX1-N2 has 
5’flap and pseudo flap-like structure-specific endonuclease activities analogous to FEN1 (Lee 
& Wilson, 1999). However, neither HEX1-N2 nor FEN1 were active on 3’-flap structures 
(Lee & Wilson, 1999). An analysis revealed that HEX1-N2 degrades blunt duplex substrate 
at a rate roughly 7-fold faster than ssDNA, but the analysis did not show specific 
endonuclease activity at 10-base pair bubble-like structures, G:T mismatches, or U:G 
mismatches (Lee & Wilson, 1999). 
 
Both hEXO1 and FEN1 appear to be directed by their C-terminal domains. As mentioned 
earlier hEXO1 associates with hMSH2 and hMLH1 through a C-terminal interaction, a 
physical association that may direct hEXO1 to sites of mispaired nucleotides. The C-terminus 
of FEN1 has been identified as the PCNA binding sequence (Gary et al., 1997; Warbrick et 
al., 1997). PCNA stimulates FEN1 nuclease activity and PCNA stabilizes FEN1 on a DNA 
substrate (Tom et al., 2000). These properties suggest that FEN1 and PCNA interact during 
the course of DNA replication, DNA repair, or both.  
Gomes & Burgers (2000) have found that protein-protein contacts between FEN1 and PCNA 
differ depending on whether the proteins are in complex with DNA or not (Gomes & 
Burgers, 2000). In the absence of DNA, FEN1 interacts with PCNA mainly through the 
InterDomain Connector Loop (IDCL). However, when PCNA encircles the DNA, the C-
terminal domain of PCNA rather than its IDCL is important for binding FEN1 (Gomes & 
Burgers, 2000). This interesting bimodal interaction between PCNA and FEN1 may represent 
a model for several other proteins with the PCNA-binding motif (Q1XX[ILM]4XXF7[FY]8). 
The PCNA-binding motif has been identified in a large number of proteins involved in DNA 
metabolic processes, such as DNA methylation (MCMT, cytosine-5-methyltransferase), NER 
(XPG endonuclease), base excision repair (hMYH glycosylase), MMR (hMSH3 and hMSH6) 
and cell cycle control (p21) (Warbrick, 1998; Tsurimoto, 1999; Boldogh et al., 2001; 
Kleczkowska et al., 2001). 
 
3' → 5' exonuclease 
Strand-specific mismatch repair in HeLa cell extracts can be directed by a single strand nick 
in a heteroduplex and the mismatch correction is independent of whether the nick occurs 3' or 
5' to the mispair (Fang & Modrich, 1993). This suggests that the human MMR possesses a 
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bidirectional capability. Polymerase δ and ε are responsible for lagging and leading DNA 
strand replication. The 3' → 5' proofreading exonuclease activity of both polymerase δ and ε 
has been proposed to be functionally redundant with Exo1 in S. cerevisiae (Tran et al., 1999). 
Yeast strains harboring inactivation of exo1 and the 3' → 5' proofreading exonuclease 
function of polymerase ε led to an increase in the mutation rate of up to 55-fold over that 
found for either single mutant (Tran et al., 1999). Furthermore, yeast strains with mutation in 
the 3' → 5' proofreading exonuclease of DNA polymerase δ in combination with a deletion of 
exo1 or msh2 are lethal. These findings indicate that 5' → 3' activity of Exo1 and the 3' → 5' 
exonuclease activity of DNA polymerase δ participate in a bi-directional MMR (Tran et al., 
1999). 
 
1.4 Methods  
We employed the yeast two-hybrid system in order to identify new MMR proteins. The yeast 
two-hybrid system is a genetic assay designed to detect protein-protein interactions in vivo 
and has been used with great success to identify new partners in multi-protein complexes 
(Fields and Song, 1989; Chien et al., 1991).  
 
Principles of the two-hybrid system 
The yeast two-hybrid system relies on the structure of particular transcription factors that 
have two physically separable domains. One domain (the Binding Domain) interacts with the 
DNA at an upstream activation site. The second domain (the Activation Domain) binds to the 
basal transcription apparatus and activates transcription. The MATCHMAKER GAL4 two-
hybrid system (CLONTECH) utilizes the yeast GAL4 transcriptional activator which is 
required for expression of genes encoding proteins involved in galactose metabolism. In the 
two-hybrid system, the two GAL4 domains are separately fused to proteins, and the 
recombinant hybrid proteins are expressed in yeast. If the two hybrid proteins interact, the 
two GAL4 domains (BD and AD) will be in close proximity and will be able to activate 
transcription of reporter genes (e.i. HIS and lacZ) (Bai & Elledge, 1997).  
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Figure 1.2. The principle of the two-hybrid system. The bait is cloned into the DNA-BD vector where it is 
expressed as a fusion to amino acids 1–147 of the yeast GAL4 protein. A second gene or cDNA library is 
cloned into the AD vector, where it is expressed as a fusion to amino acids 768–881 of the yeast GAL4 protein. 
When the fusion proteins interact, the DNA-BD and AD domains are brought into close proximity and can 
activate transcription of reporter genes. The DNA-BD target the transcription factor to a specific promotor 
sequence UAS (upstream activation sequence) whereas the DNA-AD domain facilitate assembly of the 
transcription complex allowing the initiation of transcription (Bai & Elledge, 1997).  
 
 
The BD-plasmids GAL4-hMSH2 (pLJR105) or GAL4-hMLH1 (pACJ14) were transformed 
into S. cerevisiae strain Y190 as described in Rasmussen et al. (2000). The human fetal liver 
matchmaker cDNA library (CLONTECH, #HL4029AH) was sequentially transformed into 
Y190/pLJR105 or Y190/pACJ14.  
 
 
Table 1.2 • Summary of Two-hybrid screening  
 
Number of independent clones in human fetal liver cDNA library 
 
3.5x106 * 
Average insert size 1.5 kb 
Amount of library plasmids used 40 µg 
Cotransformation efficiency 2.2x104 - 8.2x104 cfu/µg 
Clones screened 8.8x105 - 3.2x106
Positive colonies 20 - 40 
*Libraries with at least 1x106 independent clones are representative of the genomic DNA or mRNA population 
complexity (protocol #PT3061-1; www.clontech.com). 
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Interactors were selected on synthetic dextrose minimal medium (SD) lacking tryptophan (to 
maintain the GAL4 binding domain plasmids), leucine (to maintain the GAL4 activation 
domain plasmids), and histidine (to identify peptides capable of assembling a functional 
GAL4 transcription factor), and supplemented with 30 mM 3-amino-1, 2, 4-triazole (3-AT). 
The plates were incubated at 30oC for 7-10 days and approximately 700 positive clones 
(minimum size ∼ 1 mm) for each screen were picked from SD/-TRP/-LEU/-HIS + 3-AT 
plates and screened for β-galactosidase activity to verify positive interactions (for more 
method details see Rasmussen et al., 2000). The total number of positive interactions after β-
galactosidase screening was therefore only ∼ 30 positive clones per screen (table 1.2). 
 
 
1.5 Results & Discussion 
Library screenings with BD-hMSH2 and BD-hMLH1 were done twice for each MMR 
protein. The results presented in table 1.3A and 1.3B are a summary of four independent 
screens. A hMSH2-hMSH6 binding domain vector was also constructed by inserting the 
hMSH2 coding sequence into the SalI site of the pBridge binding domain vector 
(CLONTECH). The human hMSH6 coding sequence was inserted into the NotI site. The 
hMSH6 protein was in this way conditionally expressed from the PMet25 promoter. Because 
hMSH2 binds to a mismatch DNA sequence in complex with hMSH6, one could expect 
hMSH6 to work as a bridge protein that stabilizes a weak interaction between hMSH2 and 
another MMR protein, or as a modifier of hMSH2 or another MMR protein. However, a 
library screen using this construct gave no positive interactions. 
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Table 1.3A • Result of yeast two-hybrid screen  
 
 
• hMSH2 as bait 
 
  
Number of clones 
Human exonuclease 1 (hEXO1)  7 
Human G/T mismatch binding protein (hMSH6)            2 
   
Human alpha1-antichymotrypsin  8 
Human alpha-1-microglobin  1 
Human alphaglobin  1 
Human Alu RNA binding protein  1 
Human colony stimulating factor 1 (CSF-1, FMS)  1 
Human complement component 3 (C3)  1 
Human cofilin (F-actin depolymerizing protein)  1 
Human ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5)  1 
Human fibrinogen  4 
Human gammaglobin  5 
Human glycine amidotransferase  1 
Human haptoglobin   1 
Human hemoglobin alpha (HBA1)  2 
Human hemoglobin gamma G (HBG2)  5 
Human homeobox protein HOX-B6 (Hox-2.2)  1 
Human HU-K4   1 
Human importin alpha homolog  1 
Human mitochondrial COX1 (cytochrome C oxidase subunit I)  1 
Human mitochondrial COX3 (cytochrome C oxidase subunit III)  1 
Human mRNA for long-chain acyl-CoA synthetase   1 
Human non-muscle myosin alkali light chain isoform     1 
Human selenoprotein P (SEPP1)  1 
Human serum albumin (ALB)  3 
Human sodium phosphate transporter (NPT3)  1 
Human translation elongation factor 1 alpha1 (EEF1A1)  1 
ribosomal protein L13a  2 
rRNA from: Homo sapiens mitochondrion"16S ribosomal RNA"  2 
Unknown human cDNAs  18 
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Table 1.3B  • Result of yeast two-hybrid screen  
 
 
• hMLH1 as bait 
 
  
Number of clones 
Human homolog of mutL (hPMS1)  3 
   
Human 14-3-3 gamma (YWHAG)  1 
Human alpha-1-antichymotrypsin  10 
Human alpha-2-HS-glycoprotein (AHSG)  1 
Human EIF4A1 (translation factor 4AI)  1 
Human fibrinogen beta (FGB)  1 
Human fibrinogen gamma  2 
Human H19   1 
Human haptoglobin (HP)  1 
Human hemoglobin gamma G (HBG2)  5 
Human homeobox protein HOX-B6 (Hox-2.2)  3 
Human H-protein (glycine cleavage system)  1 
Human karyopherin alpha2  (importin alpha, Rch1, hSRP1)  1 
Human ornithine decarboxylase antizyme  1 
Human peroxiredoxin 2 NKEFB (natural killer cell enhacing factor)  1 
Human poly(A)-binding protein-like 1 (PABPL1)  1 
Human RAB22A (Ras oncogene family)  1 
Human ribosomal protein L27a (RPL27A)  1 
Human ribosomal protein S11 (RPS11)  1 
Human serum albumin  1 
KIAA0860  1 
KIAA1018  2 
Unknown human cDNAs  8 
 
 
Two-hybrid screening with hMSH2 as a bait  
Our screens identified 77 clones as interactors. Sequence analysis showed that the majority of 
the clones contained unidentified human cDNAs and extracellular proteins such as 
gammaglobin, fibrinogen and α-antichymotrypsin. Furthermore, we isolated two clones 
containing hMSH6, which is known to form a complex with hMSH2 and seven clones 
containing hEXO1 (Rasmussen et al., 2000). When full-length hEXO1 was fused to GAL4 
activation domain in pACT2, we were unable to detect protein-protein interaction with any of 
our MMR (BD) constructs in the two-hybrid system. However, when full-length hEXO1 was 
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fused to the GAL4 binding domain in pAS2, we could detect interactions with MMR (AD) 
proteins in the two-hybrid assay. This could explain why we failed to isolate any full-length 
cDNAs of hEXO1 in our two-hybrid screen (Rasmussen et al., 2000).  
Three clones containing COX1, COX3 and 16S ribosomal RNA were shown to form a 
complex with hMSH2. However, these interactions are probably artifacts as COX1 and 
COX3 are subunits of cytochrome c oxidase (Complex III) of the electron transport chain. It 
has not yet been determined if MMR is active in human mitochondria. In yeast a MutS 
homolog (Msh1) of the MMR pathway has been identified in mitochondria (Reenan & 
Kolodner, 1992). Our two-hybrid screenings with hMSH2 and hMLH1 did not indicate the 
presence of mitochondria specific MMR proteins, although we can not exclude that they can 
be found among the unidentified human cDNAs. 
 
Two-hybrid screening with hMLH1 as a bait 
The screening with hMLH1 was performed as described previously for hMSH2 (Rasmussen 
et al., 2000). The GAL4 DNA-BD was fused to full-length hMLH1 and verified by 
sequencing. Again the sequence analysis of the hMLH1 interactors showed that the majority 
of the clones contained unidentified human cDNAs and proteins such as fibrinogen and α-
antichymotrypsin (table 1.3B). Furthermore, we isolated three clones containing hPMS1, 
which is known to form a complex with hMLH1. To find hPMS1 as the interacting partner 
with hMLH1 at first surprised us, as hPMS2 has been shown to be approximately 10-fold 
more abundant in HeLa nuclear extract than hPMS1 (Räschle et al., 1999). However, the 
same authors demonstrated that the affinity of hMLH1 for hPMS1, measured in the yeast 
two-hybrid system, was greater than for hPMS2 (Räschle et al., 1999). Therefore, a greater 
affinity for hPMS1 could explain why we only isolated this gene in our two-hybrid screen. 
Given that hPMS2 might compete with hPMS1 for the available hMLH1, we decided to 
determine the relative amounts of hPMS1 in human tissues. We used a human RNA master 
blot (figure 1.3) and a human multiple tissue RNA master blot (figure 1.4) from CLONTECH 
to characterize the expression pattern of hPMS1 (as described in Rasmussen et al., 2000). We 
found that hPMS1 is predominantly expressed in fetal liver and adult liver, but also in 
pancreas, kidney, testis and appendix (figure 1.3). The hMLH1-hPMS1 complex could 
therefore predominate in fetal liver and account for why we isolate hPMS1 and not hPMS2 
when using the two-hybrid screen. It is tempting to speculate that hPMS1 is tissue specific 
and that the hMLH1-hPMS1 complex plays an important role in DNA repair in liver. 
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Figure 1.3. Expression profile of hPMS1. The RNA master blot (CLONTECH #7770-1) 
was hybridized with hPMS1 or β-actin control probes. 
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Figure 1.4. Hybridization of multiple tissue Northern blot with hPMS1 probe. Each lane contains following 
human tissues. Lane 1: brain. Lane 2: heart. Lane 3: skeletal muscle. Lane 4: colon. Lane 5: thymus. Lane 6: 
spleen. Lane 7: kidney. Lane 8: liver. Lane 9: small intestine. Lane 10: placenta. Lane 11: lung. Lane 12: 
peripheral blood leukocyte (CLONTECH #7780-1). 
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Importin α 
In the hMSH2 and the hMLH1 two-hybrid screens we found interaction with an importin α 
homolog and importin-α, respectively. Importin-α is also known as importin 58/Srp1/Rch1/ 
Kap60/karyopherin α (Jans et al., 1998).  
 
All passive and active transport into and out of the nucleus occurs through the nuclear pore 
complexes (NPCs) present in the nuclear envelope. Molecules smaller than approximately 60 
kDa may passively diffuse through the NPCs into the nucleus, but import of larger molecules 
requires specific transport signals (Görlich, 1998). Targeting of many proteins to the nucleus 
is determined by the presence of a Nuclear Localization Signal (NLS), a short sequence 
containing one or two clusters of basic amino acid residues. (Köhler et al., 1999). An NLS-
bearing protein, often termed the "cargo", is delivered to the nucleus by association with a 
heterodimer, formed by importin α and importin β (also called karyopherin- α and -β). 
Importin α recognizes the NLS, while importin β is responsible for docking to the NPC and 
translocation through the pore (Görlich, 1998; Jans et al., 1998; 2000). Translocation into the 
nucleus is terminated at the nuclear side of the NPC by disassembly of the trimeric NLS-
protein/importin α/β complex. Association of importin β with the protein Ran, a Ras-related 
GTPase may trigger the dissociation (Jans et al., 2000). 
Higher eukaryotes possess more than one form of importin-α (at least 6 forms for humans) 
(Köhler et al., 1999). The larger number of distinct importin α isoforms in higher mammals 
implies that there is specialization in their cellular role, and that different isoforms could bind 
unique target proteins. Consistent with this is the fact that neither any single human importin-
α nor any triple combinations of three analyzed importin-α homologues were able to 
complement a S. cerevisiae SRP1 mutant (S. cerevisiae has only one gene for importin-α) 
(Nachury et al., 1998).  
The hMSH2 human mismatch repair protein has a weak nuclear signal (Boulikas, 1997). A 
protein processing a single weak NLS is more likely to be retained in the cytoplasm after a 
mutation at the NLS peptide than a protein with two or more NLSs (Boulikas, 1997). 
Mutations at the weak NLS of the hMSH2 gene, or dysfunction of translocation proteins like 
importin-α may result in cytoplasmic retention that again could lead to dysfunction of the 
MMR pathway. Hampered translocation of the MMR proteins could thus be a possible 
explanation why so many HNPCC families fail to display mutations in the known MMR 
genes. We hope to do more research regarding translocation of MMR proteins in the future. 
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Potential NLSs for MMR proteins are listed in table 1.4 by using the PSORT software 
programs (Nakai et al., 1992; http://psort.nibb.ac.jp/). 
 
Table 1.4 • Prediction of nuclear localization signal (NLS) 
 
MMR protein Potential NLSs Reference 
 
hMSH2 
 
EKHEGKHQKLL at 422 
 
(Boulikas et al., 1997) 
 
hMSH3 
 
RRKP at    3 
RRKK at   76 
RKKR at   77 
KKRP at   78 
KKRK at  704 
KRKR at 1091 
PVKKKVK at   87 
PLIKKRK at  701 
RRKKRPLENDGPVKKKV at   76 
RKKRPLENDGPVKKKVK at   77 
KKRPLENDGPVKKKVKK at   78 
KRPLENDGPVKKKVKKV at   79 
 
 
(PSORT; Nakai et al., 1992) 
hMSH6 KKRR at  246 
RKRK at  298 
KRKR at  299 
HRRR at  382 
RRRP at  383 
RKRKRMVTGNGSLKRKS at  298 
KRKRMVTGNGSLKRKSS at  299 
RKRMVTGNGSLKRKSSR at  300 
KRMVTGNGSLKRKSSRK at  301 
 
(PSORT; Nakai et al., 1992) 
hMLH1 PRKR at  469 
RKRH at  470 
KRHR at  471 
PRRR at  496 
PRKRHRE at  469 
PRRRIIN at  496 
 
(PSORT; Nakai et al., 1992) 
hPMS1 RPRK at  869 
KRAIEQESQMSLKDGRK  at  636 
 
(PSORT; Nakai et al., 1992) 
hPMS2 PNTKRFK  at  574 
 
(PSORT; Nakai et al., 1992) 
hEXO1 KRPR at  418 
KRKH at  775 
PIKRKLI at  290 
 
(PSORT; Nakai et al., 1992) 
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2. Repair of Mitochondrial DNA 
2.1 Introduction 
Within all mammalian cells there are two distinct genomes, one located in the nucleus 
(nDNA) and the other in the mitochondria (mtDNA). Although each human somatic cell has 
several hundred to thousand mitochondria (and 1-10 mtDNA copies per mitochondrion) the 
amount of the mtDNA is only roughly 1% of the total DNA in the cell due to the small size 
of mtDNA compared to nDNA (Bestwick, 1982; Wallace et al., 1998). The mammalian 
mtDNA retains only 22 tRNAs, 12S rRNA and 16S rRNA genes necessary for the 
mitochondrial protein synthesis as well as 13 polypeptide genes (Anderson et al., 1981). All 
13 polypeptides are part of the 87 structural polypeptide subunits, all of which are 
components of the respiratory chain. The respiratory chain is composed of five multisubunit 
enzymes whose components are encoded by both the nuclear and mitochondrial genomes 
(Wallace, 1999). 
 
Unlike nDNA mammalian mtDNA contains very few noncoding sequences, no introns and it 
is unprotected by histones. Therefore, damage to mtDNA can be expected to have greater 
impact on cell function than damage to nuclear DNA, as the probability of damaging coding 
sequences in mtDNA is much higher. Thus, it has been reported that the rate of point 
mutations is higher in mtDNA compared to nDNA in human tissues (Khrapko et al., 1997). 
In addition mtDNA point mutations and mtDNA rearrangement mutations (deletions and 
insertions) have now been recognized to play a critical role in numerous human disorders 
which prove the importance of maintaining the integrity of the mitochondrial genome (Kang, 
1998; Kogelnik et al., 19982; Pulkes & Hanna, 2001; Wallace, 1999). 
For this reason DNA repair in mitochondria could be expected to be very efficient. 
However, early investigations of removal of UV-induced pyrimidine dimers in mtDNA led 
to the conclusion that mitochondria accumulate DNA damage because these organelles are 
deficient in repair activity (Clayton et al., 1974; Prakash et al., 1975). This finding, in 
combination with very limited interest in this research area, led to the belief that rather than 
repairing damage in mtDNA, cells simply destroyed the injured genomes and replaced 
them by replicating existing, undamaged mtDNA  
                                                          
2Variations in the human mitochondrial genomes are updated on http://www.gen.emory.edu/mitomap.html 
(Kogelnik et al., 1998). 
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(LeDoux et al., 1999). It has later been confirmed that UV-induced pyrimidine dimers are 
not repaired in mitochondria (LeDoux et al., 1992; Pascucci et al., 1997), which suggest 
absence of nucleotide excision repair. However, recent evidence showed that mitochondria 
are indeed able to repair their genomes (Croteau et al., 1999; Marcelino & Thilly, 1999). 
Unfortunately the knowledge about the repair mechanisms operating in the mitochondria is 
still limited. 
 
To gain a better understanding of the molecular processes and components responsible for 
DNA repair in the human mitochondrion we have investigated the sub-cellular localization 
of O6-methylguanine-DNA methyltransferase (MGMT) (Rasmussen et al., II).  
 
2.2 Base Excision Repair 
Several observations support that mitochondria have Base Excision DNA Repair (BER) 
pathways that are responsible for the removal of simple lesions in DNA (Croteau et al., 
1999; Marcelino & Thilly, 1999).  Removal of a damaged base by the BER pathway is 
initiated by DNA glycosylase that cleave the N-glycosylic bond between the base and the 
deoxyribose-phosphate backbone (Lindahl & Wood, 1999). The resulting abasic site is 
cleaved 5’ by an apurinic/apyrimidinic (AP) endonuclease that generates a 3’OH group, 
which can be extended by a DNA polymerase, but not ligated before a 5’ terminal 
deoxyribose-phosphate residue is removed. The removal of the abasic sugar residues is done 
by a lyase. Finally, the gap is filled by DNA polymerase and the ends rejoined by DNA 
ligase (Lindahl, 2000). Several distinct DNA glycosylases have been identified both in 
nuclei and mitochondria in human cells (table 2.1). 
 
Repair of uracil 
Uracil-DNA Glycosylase (UNG or UDG) removes uracil bases in DNA. An uracil base in 
DNA can occur as a result of either misincorporation of dUTP instead of dTTP into a newly 
synthesized DNA, or deamination of cytosine to uracil (Slupphaug et al., 1995). 
Deamination of cytosine to uracil, unless repaired before the next round of replication, will 
result in a GC → AT transition mutation (Slupphaug et al., 1995). Studies have 
demonstrated the presence of both nuclear- and mitochondrial-associated UNG (Anderson & 
Friedberg, 1980; Slupphaug et al., 1993; Otterlei et al., 1998). The human mitochondrial 
(hUNG1) and nuclear (hUNG2) forms have identical catalytic domains, but very different N-
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terminal sequences. The two forms are both generated from the hUNG gene using two 
promoters, and making use of an exon specific for the N-terminal end of the nuclear form, 
and alternative splicing (Nilsen et al., 1997; Otterlei et al., 1998).  
 
Repair of oxidative damage 
Both purine and pyrimidine residues in DNA are sensitive to reactive oxygen species (ROS) 
(Croteau & Bohr, 1997). The most common purine lesion is 8-hydroxyguanine also called 
7,8-dihydro-8-oxoguanine (8-oxoG) (Steenken & Jovanovic, 1997; Burrows & Muller, 
1998). 8-oxoG is a highly mutagenic base derivative, which base-pairs with adenine as well 
as cytosine, causing G → T transversion mutations (Cheng et al., 1992). The mitochondrial 
respiratory chain produces superoxide (Wallace, 1999) which can be converted to hydroxyl 
radicals via hydrogen peroxide (Imlay & Linn, 1988). The hydroxyl radical is the main 
species of active oxygen that attacks the guanine base (Kasai et al., 1984). Because mtDNA 
is subjected to a relatively high amount of oxidative damage and because the strand 
containing 28 of the 37 mitochondrial genes is rich in guanine (Bianchi et al., 2001), it 
seems that mitochondria would need efficient DNA repair mechanisms to remove oxidative 
damage from its DNA. 
 
Removal of 8-oxoguanine 
An early study revealed that 8-oxoG can pair with all four normal bases (Kuchino et al., 
1987) but it was later shown that 8-oxoG perferentially pairs with C or A during in vitro 
DNA synthesis (Shibutani et al., 1991). In E. coli two DNA glycosylases, encoded by mutM  
(Fpg) and mutY genes, function to prevent mutagenesis by removing 8-oxoG paired with 
cytosine and adenine (Bailly et al., 1989; Tchou et al., 1991; Michaels et al., 1992).  
The human MutM homolog, hOGG1 (8-OxoGuanine DNA Glycosylase) excise 8-oxoG 
preferentially when it is paired with C, followed by 8-oxoG:T and 8-oxoG:G, but it has no 
detectable 8-oxoG:A-specific strand cleavage (Hazra et al., 1998). The glycosylase activity 
of hOGG1 is accompanied with apurinic/apyrimidinic (AP) lyase that cleaves the AP site via 
β-elimination (Hazra et al., 1998). 
Human OGG1 localizes both to the nucleus and mitochondria (Takao et al., 1998; Nishioka 
et al., 1999). Seven alternatively spliced forms of hOGG1 mRNAs have been identified 
(Nishioka et al., 1999). All these splice forms of hOGG1 contain a putative mitochondrial 
targeting signal (MTS) at the common N-terminal region. A nuclear localization signal 
(NLS) was only found in the C-terminal end of hOGG1-1a (Nishioka et al., 1999). Human 
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OGG1-1a, which has been found to have a weak MTS, localized predominantly to the 
nucleus. When the NLS is deleted, the protein is targeted to mitochondria (Nishioka et al., 
1999). When a strong MTS is fused upstream to the hOGG1-1a gene it is selectively targeted 
to the mitochondria (Dobson et al., 2000).  
Interestingly, results from mice liver have revealed that mitochondrial 8-oxoG glycosylase 
activity increased with age. In contrast no age-associated changes were found for nuclear 8-
oxoG glycosylase activity or mtUDG activity (de Souza-Pinto et al., 2001). This result 
suggests that the mitochondrial OGG1 glycosylase is up-regulated during the aging process. 
 
Removal of adenine paired with 8-oxoguanine 
The Human MutY Homolog, hMYH has been shown to excise adenine mispaired with 
guanine and 8-oxoG as well as 2-hydroxyadenine paired with 8-oxoG in double-stranded 
oligonucleotides (Ohtsubo et al., 2000). This glycosylase has been detected in nucleus and 
mitochondria (Takao et al., 1998; 1999; Ohtsubo et al., 2000; Boldogh et al., 2001). 
Boldogh et al. (2001) found that the levels of hMYH in the nucleus was increased 3- to 4-
fold during progression of the cell cycle and reached maximum levels in S phase, suggesting 
a cell cycle-dependent regulation of expression and/or subcellular targeting. However, there 
was no evidence that the cytoplasmic or mitochondrial levels of hMYH decreased as nuclear 
levels increased (Boldogh et al., 2001).  
It has been suggested that 8-oxoG:C is more efficiently repaired in mitochondria than 8-
oxo:A. Miyako et al. (2000) detected inefficient cleavage of human mtDNA by the E. coli 8-
oxoG:C specific MutM protein but could report that human mtDNA was cleaved by the 8-
oxoG:A specific MutY protein, suggesting that 8-oxoG accumulates as an 8-oxoG:A pair but 
not as an 8-oxoG:C pair. 
 
Removal of oxidized pyrimidines 
Oxidized pyrimidines, such as thymine glycol, 5-hydroxycytosine and 5,6-dihydrouracil 
(DHU), are excised by the hNTH1 glycosylase (a homolog of E. coli endonuclease III, Nth) 
(Ikeda et al., 1998; Takao et al., 1998; Lindahl & Wood, 1999). Thymine glycol is only 
slightly mutagenic but it can block progression of both DNA and RNA polymerases 
(Stierum et al., 1999). The DHU DNA lesion derives from cytosine by deamination. Its 
opposite base should be guanine, but DHU is also able to mispair with adenine during DNA 
replication. hNTH1 cleaves A or G opposite DHU with the same rate (Ikeda et al., 1998). 
The human NTH1 has, similar to hOGG1, combined glycosylase and AP lyase activity and 
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this enzyme is located to both nucleus and mitochondria (Tomkinson et al., 1990; Takao et 
al., 1998; Mol et al., 1999). 
 
Removal of 3-methyladenine 
The N-methylpurine-DNA glycosylase, MPG (MDG, AAG, APNG) gene is coding for a 
human glycosylase, which removes 3-methyladenine (3-MeA) as well as 3-methylguanine 
(3-MeG), 7-methylguanine (7-MeG), N6-ethenoadenine, hydroxanthine, guanine, and 8-
oxoG (Pendlebury et al., 1994; Wyatt et al., 1999; Bouziane et al., 2000). The MPG activity 
has so far only been reported from nuclear extracts.  
 
 
Table 2.1 • Enzymes identified in repair of mitochondrial DNA in human cells 
 
Gene 
 
 
Full Name 
 
Substrates/Activity 
DNA glycosylases: major altered base 
released 
 
AP lyase 
activity 
 
Base excision repair (BER) 
 
hUNG1 Uracil-DNA glycosylase U no 
hOGG1 8-oxoguanine DNA glycosylase 1 8-oxoG opposite C yes 
hMYH MutY homolog (E.coli) A opposite 8-oxoG or G no 
hNTH1 Endonuclease three homolog 1(E.coli) T-glycol yes 
 
Other BER factors 
 
hMTH1 MutT homolog (E.coli) Hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP  
hLIG3 DNA Ligase III Ligation  
hPOLG 
 
Polymerase-gamma Replication/repair polymerase   
 
 
Other BER factors 
In cells, the deoxyribonucleotide pools are also subjected to oxidative damage. dGTP can be 
converted to 8-oxo-dGTP and incorporated into nascent DNA strands opposite adenine. The 
MutT enzyme in E. coli hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP, and thereby prevents 
misincorporation of the damaged base into DNA (Maki & Sekiguchi, 1992). The human 
MutT homolog, hMTH1 (for mutT homologue) is present in the cytoplasm as well as in the 
mitochondrial matrix (Kang et al., 1995; Nakabeppu, 2001). The hMTH1 gene produces by 
alternative transcription inititation and splicing, seven different mRNAs. One of these 
mRNA’s is imported into mitochondria when fused to green fluorescent protein, GFP 
(Nakabeppu, 2001). The human MTH1 protein has wide substrate specificity as it has been 
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reported to hydrolyze 8-oxo-dGTP, 8-oxoG, 8-oxo-dATP and 2-OH-dATP (Nakabeppu, 
2001).  
 
A major human AP endonuclease, hAPE1 (alternative titles; human apurinic endonuclease 1 
(HAP1), apurinic/apyrimidinic exonuclease (APEX), apurinic/apyrimidinic endonuclease/ 
redox effector factor (APE/REF-1)) plays a central role in BER (Evans et al. 2000). It 
initiates repair by hydrolyzing AP sites in DNA produced either spontaneously or after 
removal of bases in DNA by DNA glycosylases (i.e. UNG). Alternatively, it can act as a 3'-
phosphoesterase after the AP lyase reaction of DNA glycosylases/AP lyases (i.e. hOGG1) 
(Izumi et al., 2000). Takao et al. (1998) examined the subcellular localization of hAPE1 and 
found that it was only localized to the nucleus (Takao et al., 1998). Furthermore, Prieto-
Alamo & Laval (1999) found no increased hAPE1 activity in the mitochondrial fraction of 
Chinese hamster ovary (CHO-9) cells transfected with a plasmid expressing the human 
APE1 compared to a 4.5 fold activity increase in nuclear fractions. However, the APE1 
homolog in S. cerevisiae, the Apn1 enzyme has been shown to localize in both nucleus and 
mitochondria. The Pir1 (a cell wall protein) is required for the localization of Apn1 to 
mitochondria (Vongsamphanh et al., 2001). Results of two different studies have also shown 
that APE1 is present in mitochondria of rat thyroid FRTL-5 cells and rat pleural mesothelial 
cells (Fung et al., 1998; Tell et al., 2001). However, the contribution of the mitochondrial 
AP lyase activity, to repair of abasic sites, and the processing of 3'-unsaturated sugar-
phosphate generated by e.i. hOGG1 AP lyase activity, still remain to be established in 
human mitochondria. 
 
Human mitochondrial DNA is replicated by polymerase γ. Polymerase γ (POLG) is a 
heterodimer composed of a 140-kD catalytic subunit (POLG1) and a smaller accessory 
subunit (POLG2) (Schmitt & Clayton, 1993). Because polymerase γ is the only known DNA 
polymerase in human mitochondria, it is expected to participate in DNA replication and 
repair in this organelle (Longley et al., 1998). The human polymerase γ has been shown to 
posess both 3'→5' exonuclease proofreading activity and lyase activity (Schmitt & Clayton, 
1993; Longley et al., 1998). The human polymerase γ fills single nucleotide gaps and 
produces a substrate that can be ligated after action of uracil-DNA glycosylase and AP-
endonuclease (Longley et al., 1998). 
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A mitochondrial DNA ligase has been identified. The human DNA ligase III gene encodes 
both a nuclear and a mitochondrial protein and DNA ligase III plays an essential role in the 
maintenance of mtDNA in mammalian cells (Lakshmipathy & Campbell, 1999; 2001).  
 
Mismatch repair 
The DNA mismatch repair (MMR) removes errors in the newly synthesized DNA strand that 
are missed by the polymerase proofreading (see Analysis of human DNA Mismatch Repair). 
It is not yet known if there is an active post-replication MMR system in human mitochondria 
but it has been indicated that hMSH6 is not involved in repair of mismatches in the mtDNA. 
Human hMSH6 deficient lymphoblastoid cells have a higher spontaneous mutation rate in 
the nuclear genome but a similar spontaneous mutation rate in mitochondrial DNA when 
compared to a parental mismatch repair proficient cell line (Marcelino et al., 1998; 
Marcelino & Thilly, 1999).  
In yeast, a component of the MMR pathway (Msh1) has been identified in mitochondria 
(Reenan & Kolodner, 1992). The Msh1 protein is a homolog of the E. coli MutS mismatch 
binding protein (Reenan & Kolodner, 1992). Inactivation of the MSH1 gene resulted in large 
scale mtDNA rearrangements suggesting that Msh1 is involved in repair of mtDNA (Reenan 
& Kolodner, 1992).  
 
Direct repair 
We have investigated the sub-cellular localization of O6-methylguanine-DNA methyl-
transferase (MGMT) in human mitochondria (Rasmussen et al., II). Therefore, the MGMT 
protein will be described in greater detail in the next section. 
 
2.3 Direct Repair: O6-Methylguanine-DNA Methyltransferase 
O6-methylguanine (O6-MeG) is generated endogenously by reactive cellular catabolites and 
S-adenosylmethionine, which normally acts as a methyl donor in the synthesis of 5-
methylcytosine but occasionally causes methylation at other sites (Rossman & Goncharova, 
1998; Lindahl & Wood, 1999). 
Alkylating agents produce various kinds of alkylated purine and pyrimidine bases in DNA, 
3-methyladenine (3-MeA), O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT), 
among other adducts (Lindahl & Sedgwick, 1988). 3-MeA has been shown to block DNA 
replication (Larson et al., 1985) and is excised by 3-methyladenine glycosylase (MPG). O6-
 34
Repair of Mitochondrial DNA 
MeG and O4-MeT DNA lesions are mutagenic and carcinogenic (Loveless, 1969; Swann, 
1990). However, O4-MeT is formed less frequently than O6-MeG. The proportion of 
alkylation at each site is ~ 0.1 % for O4-MeT and 3-6% for O6-MeG of total alkylation after 
reaction with Dimethylnitrosamine (DMN), Methylnitrosourea (MNU) or 1,2-
Dimethylhydrazine (SDMH) (Singer & Dosanjh, 1990).  
During DNA replication, O6-MeG can pair with thymine leading to G:C → A:T transition 
mutations while O4-MeT can pair with guanine, generating A:T → G:C transition mutations 
(Singer & Dosanjh, 1990; Dosanjh et al., 1991; 1993, Altshuler et al., 1996). Both 
prokaryotic and eukaryotic DNA alkyltransferases remove methyl groups from the O6 
position of the guanine. cDNAs coding for the repair protein from E. coli (ada, Sedgwick, 
1983; ogt, Potter et al., 1987), S. cerevisiae (MGT1, Xiao et al., 1991), mouse (Shiota et al., 
1992), rat (Rahden-Staron & Laval, 1991) and human (MGMT, Tano et al., 1990; Rydberg 
et al., 1990; Hayakawa et al., 1990) have all been cloned and characterized. Furthermore, 
DNA methyltransferase has been identified in 28 different species (Pegg, 2000). Although 
the amino acid sequences of these proteins are homologous, there are only 8 absolutely 
invariant residues in these sequences (Gly109, Asn137, Pro144, Cys145, His146, Arg147, Lys165, 
and Glu172, numbered according to the human MGMT sequence) (Xu-Welliver et al., 2000).  
 
MGMT function 
Human O6-MethylGuanine-DNA MethylTransferase (MGMT, also known as AGT) repairs 
O6-alkylguanine (O6-MeG, O6-ethylguanine & O6-butylguanine) in double-stranded DNA in 
a single step. MGMT removes alkyl groups from the O6 position of guanine to a cysteine 
acceptor residue in MGMT without removing the damaged base (Pegg, 2000). The cysteine 
residue is located at position Cys145 in MGMT in a highly conserved sequence -PCHR- 
(Pegg, 2000). It has been shown that mutation of the cysteine acceptor site leads to a 
complete loss of MGMT activity (Harris et al., 1992; Crone & Pegg, 1993; Hazra et al., 
1997; Edara et al., 1999). Once bound to the cysteine acceptor site, the alkyl group 
permanently inactivates MGMT. Therefore, the number of O6-alkylG that can be repaired is 
equal to the number of active MGMT molecules – MGMT is “suicidal” in the repair of O6-
alkylG residues in DNA (Pegg, 1990; 2000). Even though MGMT is not specific for methyl 
groups, the rate of the reaction decreases as the size of the adduct increases (Pegg & Byers, 
1992). 
Mutational analysis of the MGMT protein showed that deletion of 7 amino acids from the N 
terminus (codons 1-7) or 28 amino acids from the C terminus (codons 180-207) result in 
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specific activity comparable to that found for the full-length MGMT (Hazra et al., 1997). 
Mutant MGMT with deletion of codon 1-10 or 1-19 were shown to be active in protecting 
cells from a methylating agent N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) suggesting 
that they are able to repair methylated DNA in vivo (Crone et al., 1996). However, the 
mutant MGMT proteins were less effective compared to the wild-type MGMT and highly 
unstable with half-lives of 48-90 min compared to a half-live of > 720 min for wild-type 
MGMT. Interestingly, we found that deletion of codons 2 to 18 resulted in a complete 
absence of MGMT in nucleus and accumulation in cytoplasm (Rasmussen et al., II). This 
suggests that deletion of the first 18 codons interfere with stability and translocation to 
nucleus. However, our results indicate that this mutant MGMT protein provide the same 
level of protection to killing by MNNG as MGMT wild-type (Rasmussen et al., II). It has 
been found by site-directed mutagenesis that the fully conserved residues Asn137, His146, 
Arg147 and Glu172 are critical for maintaining the MGMT stability. Proteins with mutations in 
these residues were highly unstable with half-lives of 15-60 min (Crone et al., 1996). 
Furthermore, the residues Arg128 and Tyr114 seemed to be involved in DNA binding and 
catalytic activity (Kanugula et al., 1995; Goodtzova et al., 1998).  
 
Repair of O4-methylthymine 
Although E. coli Ogt has been shown to repair O4-MeT it is still not fully established if the 
human MGMT can repair O4-MeT (Sassanfar et al., 1991). The rate constants for MGMT 
acting on O6-MeG is much higher than O4-MeT (O6-MeG  = 1x109 M-1min-1 and O4-MeT = 
1.8x105 M-1min-1 (Zak et al., 1994). Repair of O6-MeG by MGMT in vivo is 1000-5000-fold 
greater than for O4-MeT (Samson et al., 1997; Encell & Loeb, 2000). However, one study 
has shown that human MGMT expressed in E. coli suppresses MNNG-induced A:T → G:C 
mutations indicating that MGMT repairs O4-MeT DNA lesions (Kooistra et al., 1999). Other 
studies showed that expression of MGMT in a methyltransferase-deficient E. coli strain 
(lacking Ade and Ogt) failed to suppress A:T → G:C mutations, but actually increased O4-
MeT mutations (Samson et al., 1997, Edara et al., 1999). Samson et al. (1997) suggested 
that MGMT binds to O4-MeT lesions but repairs it so slowly that it interferes with the repair 
of this lesion by NER and consequently increases the frequency of A:T → G:C mutations. 
The mammalian NER pathway has been shown to repair both O6-MeG and O4-MeT lesions 
(Bronstein et al., 1991; 1992, Huang et al., 1994, Kein et al., 1994). However, the ability to 
serve as substrates for NER increases with the size of adduct and is poor for methyl groups 
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(Pegg & Byers, 1992). It is still unknown whether NER is the predominant pathway for 
removal of O4-MeT lesions in human cells or serves as a back-up repair system for removing 
O6-MeG lesions in cells with limited MGMT activity.  
 
The methylation tolerant phenotype 
Even though MGMT is widely expressed, the intracellular MGMT levels vary between 
different tissues and also between different individuals. The liver and spleen have the highest 
MGMT activities and the nervous system and mammary gland the lowest (Myrnes et al., 
1983; Yarosh et al., 1985; Pegg & Byers, 1992; Karran & Bignami, 1994).  Most tumor cells 
express high level of MGMT, while about 15-20% of human tumor cell lines are deficient in 
MGMT expression (Sklar et al., 1981; Tsujimura et al., 1987; Yu et al., 1999). Cells lacking 
MGMT activity (Mex- or Mer- cells) are more sensitive to mutagenesis and killing by 
alkylating agents (Karran & Bignami, 1994).  
Alkylating agents were among the first cytotoxic drugs used in the treatment of cancer and 
are still used clinically against a number of tumors (Kleibl & Margison, 1998). A class of 
anti-tumor alkylating agents as the chloroethylnitrosourea (CENU) is clinically used to treat 
a number of tumors, including brain neoplasms, malignant melanoma, advanced lymphomas, 
and gastrointestinal carcinomas (Kreklau et al., 1999). However, certain tumors are resistant 
to alkylating chemotherapeutic agents and this resistance are known to be correlated with the 
level of MGMT in the tumors (Pegg & Byers, 1992). Another mechanism of cellular 
resistance to methylating agents is an ability to ignore the presence of O6-MeG lesions in 
DNA. This tolerance of DNA damage is due to the loss of MMR, even if MGMT is not 
expressed or expressed at low levels (Carethers et al., 1996; Karran & Hampson, 1996; 
Hampson et al., 1997; Umar et al., 1997; Dosch et al., 1998; Kawate et al., 1998, Humbert 
et al., 1999).  
There is increasing evidence that tumor cells could acquire resistance to methylating drugs 
by loss of MMR activity. A lack of MMR results in poor ability of the cell to detect DNA 
damage and activate apoptosis, thus increasing the mutation rate throughout the genome 
(Fink et al., 1998). This implies that genotoxic and cytotoxic effects of O6-MeG are 
mediated by MMR. In vitro studies have demonstrated that the mammalian hMSH2-hMSH6 
complex can recognize O6-MeG: T and O6-MeG: C (Duckett et al., 1996; Ceccotti et al., 
1996; Mu et al., 1997; Christmann & Kaina, 2000). Although, the mechanisms of MMR-
mediated response to base damage are not known, two models have been proposed as 
explanations.  
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1. In one model, the MMR system recognizes the mismatched bases opposite the damaged 
base but since there is no perfect complementary match for O6-MeG, the polymerase will 
again fail to find an ideal partner and incorporate thymine or cytosine opposite O6-MeG 
on the newly synthesized strand. The repeated attempts to repair the mismatch will result 
in a methylated template strand that is single-stranded for much of the time and a newly 
synthesized strand that contains persisting DNA termini. The killing effect of the lesion 
is expected to come during the following cycle of DNA replication, when the replication 
fork arrives at a discontinuity and thus generates a double-strand break that will then 
trigger apoptosis (Galloway et al., 1995; Karran & Hampson, 1996;  Kaina et al., 1997). 
2. In the second model, MMR proteins function as the sensors of DNA damage, and 
generate a signal capable of activating apoptosis (Modrich, 1997; Fink et al., 1998).  
The p53 protein functions as a transcription factor that regulates the expression of several 
genes involved in cell cycle control, DNA damage repair, and apoptosis. Therefore, p53 is 
the classic signal transduction molecule thought to respond to DNA breaks and gaps (Nelson 
& Kastan, 1994; Huang et al., 1996; Vogelstein et al., 2000). However, MNNG induced 
apoptosis seems to be p53-independent (Hickman & Samson, 1999). Moreover, Christmann 
& Kaina (2000) have shown that after exposure of cells to MNNG, hMSH2, hMSH6 and 
hPMS2 proteins are translocated from the cytoplasm into the nucleus, leading to an increased 
nuclear MMR protein level immediately after exposure. This translocation was independent 
of the p53 status of the cells and was first observed at high dosage level of the mutagen in 
cells expressing MGMT (>25 µM MNNG; 750 fmol/mg protein MGMT; Christmann & 
Kaina, 2000). In order to explore a possible link between p53 and MGMT we expressed the 
MGMT-GFP fusion protein in cell lines with different p53 status. One cell line was wild 
type for p53, one expressed very low levels of the p53 protein, and one cell line was 
completely deficient for p53 activity. We found no difference in subcellular localization of 
MGMT suggesting that MGMT translocation is independent of the p53 status. In all three 
cell lines the MGMT-GFP fusion protein was exclusively present in the nucleus (Rasmussen 
et al. II). 
 
Treatment of human cells with MNNG concentrations that increased the mutation rate of 
nuclear genes showed no induction of mitochondrial mutations (Mita et al., 1988). 
Marcelino et al. (1998) observed that to induce MNNG mutations above a very high 
spontaneous background in mtDNA, one needed to treat MNNG-resistant (MT1) cells with 
an amount of MNNG (4 µM) that would kill all normal parental cells. Therefore, they 
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concluded that it is unlikely that in vivo mutations are induced in mtDNA by exogenous 
mutagens in normal human cells (Khrapko et al., 1997; Marcelino et al., 1998).  
 
Mitochondrial MGMT activity 
Two groups have reported mitochondrial MGMT activity in rat liver (Myers et al., 1988; 
Satoh et al., 1988). The kinetics of removal of O6-MeG was similar in nuclear and 
mitochondrial DNA (Myers et al., 1988). Furthermore, they found very slow removal of O6-
butyl-2'-deoxyguanine in mtDNA but fast removal in nDNA which is consistent with the 
absence of NER in mitochondria (Myers et al., 1988). Satoh et al. (1988) reported the 
removal of O6-ethyl-2'-deoxyguanosine (O6-EtG) from mtDNA and nDNA in rat liver 
following exposure to N-ethyl-N-nitrosourea in vivo. Longer alkyl groups including ethyl- is 
known to be repaired by MGMT and NER (Pegg, 2000), indicating, that O6-EtG is removed 
by an alkyltransferase mechanism in the mitochondria. Additionally, N-methyl-N-nitrosourea 
(MNU) induced mutations were repaired in mitochondria from Chinese hamster ovary 
(CHO) cells (LeDoux et al., 1992).  
These results obtained in rodents suggest that an alkyltransferase mechanism is operating 
within the mitochondrion in mammalian species. However, extrapolation of results obtained 
with rodents to human cells may not be straightforward. Even MGMTs from mammalian 
species have different substrate specificity. For eksample rat MGMT repairs O6-EtG much 
better than human MGMT (Liem et al., 1994). Mitochondrial MGMT activity has not yet 
been reported from human cells and the intracellular localization seems ambiguous. 
 
MGMTs intracellular localization  
Most immunostaining data have shown that MGMT is a nuclear protein (Ayi et al., 1992, 
Lim & Li, 1996; Belanich et al., 1996). However, there are reports on cytosolic appearance 
indicating that MGMT could be present in nucleus, cytoplasm and mitochondria (Ayi et al., 
1992; Ishibashi et al., 1994a,b; Belanich et al., 1996).  To access the actual localization of 
the MGMT protein we studied exogenous MGMT-GFP expressed as fusion protein in a 
human breast epithelial cell line (MCF12A) and detected the subcellular localization by 
fluorescence microscopy. We found that MGMT localized mainly in the nucleus. We also 
observed a weak cytoplasmic staining but no mitochondrial localization. Our results 
therefore suggest that MGMT is not present in mitochondria of human cells (Rasmussen et 
al., II). In order to test whether nuclear MGMT was recruited to mitochondria upon DNA 
damage of mtDNA by alkylating agents we treated cells expressing MGMT-GFP with 
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MNNG. The MGMT-GFP fusion protein was detected in nucleus but not in mitochondria 
indicating that nuclear MGMT is not recruited to mitochondria after DNA damage by 
MNNG (Rasmussen et al., II). This suggests that the alkyltransferase mechanism which 
seems to be operate within the mitochondrion in mammalian species is not MGMT in human 
breast epithelial cells. 
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3.  Mitochondrial Dysfunction versus Genetic Stability of 
the Nuclear DNA 
 
3.1 Introduction 
Mitochondrial diseases are severely debilitating and characteristically complex in nature.  
They can affect any organ in the body at any age. Usually the mitochondrial diseases are 
inherited through the mother but they can also be sporadic or induced by the environment.  
Mitochondrial dysfunction is found in diseases as diverse as cancer, infertility, diabetes, 
heart diseases, blindness, deafness, kidney disease, liver disease, stroke, and migraine.  
Mitochondrial dysfunction is also involved in aging and neurodegenerative diseases such as 
Parkinson and Alzheimer dementia (Wallace, 1999; DiMauro & Schon, 2001).  To date, 
there is no cure for mitochondrial diseases. 
 
We used Saccharomyces cerevisiae as a model system to explore the role of mitochondrial 
dysfunction on genetic stability of the nuclear DNA (Rasmussen et al., III) as well as the role 
of mitochondrial activity in oxidative DNA damage and repair of the nuclear genome 
(Rasmussen et al., IV) 
 
3.2 Mitochondrial Biology and Genetics 
The mitochondria are surrounded by a double membrane, a smooth outer membrane, and a 
"highly folded" inner membrane (termed cristae). Depending on source and conformational 
state, cristae can vary from simple tubular structures to more complex lamellar structures 
that are connected to the inner boundary membrane (Frey & Mannella, 2000; Perkins & 
Frey, 2000). The inner membrane of the mitochondrion contains the proteins and enzymes of 
the electron transport chain (Complexes I-IV) and Complex V that are responsible for 
phosphorylation of ADP to ATP (adenosine diphosphate to adenosine trisphosphate). The 
inner compartment is called the matrix, which contains the many enzymes of Krebs cycle 
(the citric acid cycle), the pathway of fatty acid oxidation, and the mitochondrial DNA 
(Scheffler, 1999). 
 
In mammalians, electron transfer from NADH donated to Complex I (NADH dehydrogenase 
or NADH:ubiquinone oxidoreductase) or electrons from succinate (donated to Complex II, 
succinate dehydrogenase) are transfered to coenzyme Q, also called ubiquinone or CoQ. 
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Regardless of whether CoQ receives its electrons from Complex I or II, it shuttles them to 
Complex III (ubiquinol:cytochome c oxidoreductase). From Complex III the electrons move 
through cytochrome c and Complex IV (cytochrome c oxidase or COX), which passes the 
electrons directly to oxygen to form water. As electrons transverse complex I, III, and IV, 
protons (H+) are moved from the mitochondrial matrix across the inner membrane into the 
inter-membrane space. This creates an electrochemical proton gradient (∆Ψ) that is positive 
and acidic on the outside and negative and alkaline on the mitochondrial matrix side. The 
proton gradient across the inner-membrane is used to drive the condensation of ADP and Pi 
(inorganic phosphate) to generate ATP by allowing the protons to flow back through 
Complex V (ATP synthase or F1F0ATPase). Under normal circumstances, the inner 
membrane is impermeable to protons, leaving Complex V as the only route whereby protons 
can return to the matrix (figure 3.1). The ATP is exchanged for ADP across the 
mitochondrial inner membrane by the Adenine Nucleotide Translocator, ANT (Wallace, 
1999; Saraste, 1999). In fungi, Complex I is very similar to its counterpart in other 
eukaryotes except for S. cerevisiae, Saccharomyces carlsbergii and Kluyveromyces lactis 
which do not contain Complex I.  
 
The mammalian Complex I is a NADH dehydrogenase involved in the oxidation of intra-
mitochondrial NADH produced by the citric acid cycle, and its NADH-binding site faces the 
mitochondrial matrix. S. cerevisiae has three NADH dehydrogenases; Nde1 and Nde2 which 
both face the intermembrane space (referred to as external) and Ndi1 an internal NADH 
dehydrogenase like the mammalian Complex I (Joseph-Horne et al., 2001). Ndi1 is believed 
to be attached to the inner membranes on the matrix side (de Vries & Grivell, 1988; de Vries 
et al., 1992). It has been shown that when Ndi1 was expressed in a Complex I-deficient 
Chinese hamster cell, it restored the capacity for respiration and oxidative phosphorylation in 
these cells (Seo et al., 1998). Furthermore Ndi1 was incorporated into mitochondria in 
human embryonic kidney cells where Complex I was still present. Overexpression of Ndi1 in 
cells led to decreased coupling of NADH oxidation to ATP synthesis (ADP/Oxygen 
consumption ratio down from 2.4 to 1.8), while succinate oxidation was unchanged. These 
results suggest that the Ndi1 protein from S. cerevisiae complements the mammalian 
Complex I consisting of 43 peptides (Wallace, 1999). However, Ndi1 does not translocate 
protons, but only feeds electrons to the electron transport chain (Joseph-Horne et al., 2001). 
Apart from the lack of Complex I in S. cerevisiae the electron transport and proton transfer 
proceed via the same complexes as in mammalians (figure 3.1) 
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3.3 Reactive Oxygen Species 
Mitochondria generate more than 80% of cellular energy in the form of ATP and are 
therefore regarded as the "powerhouse" of the cell (Kang et al., 1998). However, 
mitochondrial respiration is also the major endogenous source of Reactive Oxygen Species 
(ROS), including superoxide radical (O2-), hydrogen peroxide (H2O2) and the hydroxyl 
radical (HO•) (Cadenas & Davies, 2000). Under normal physiological conditions, in vitro 
evidence indicates that electrons "leak" from the electron transport chain, converting about 
1-2% of oxygen molecules into O2-, a more reactive form of oxygen (Boveris & Chance 
1973; Boveris, 1977; Papa, 1996; Loft & Poulsen, 1996). Research in ROS production from 
mitochondria indicate that Complex I (Robinson, 1998) and Complex III (Turrens et al., 
1985; Nohl & Jordan 1986) play a major role in production of superoxides however O2- may 
also arise from Complex II (Ishii et al., 1998) in mammalian cells. Under normal metabolic 
conditions, Complex III seems to be the main site of O2- production (Finkel, 2001). 
 
Superoxide itself can attack enzymes containing the catalytically iron-sulfur [4Fe-4S] 
tetranuclear cluster, such as Complex I, Complex II and the Krebs cycle enzyme aconitase, 
resulting in release of iron and decreased mitochondrial ATP production (Flint et al., 1993; 
Gardner, 1995, Melov et al., 1999; Cadenas & Davies, 2000). Hence, mitochondria are 
particularly sensitive to oxidative stress. As we are using S. cerevisiae as model system it 
should be noted that the Ndi1 is a polypeptide enzyme with no iron-sulfur cluster and 
therefore not attacked by O2- (de Vries & Grivell, 1988).  
ROS is reduced by intracellular antioxidant enzymes including superoxide dismutase, 
glutathione peroxidase and catalase. Superoxide is simultaneously reduced and oxidized 
(dismutated) to form hydrogen peroxide and oxygen by superoxide dismutase (SOD). 
Eukaryotes, including S. cerevisiae, hold a manganese containing superoxide dismutase 
(MnSOD, product of the SOD2 gene) in the matrix of the mitochondria, and a copper-and 
zinc containing form (CuZnSOD, product of the SOD1 gene) in the nuclear and cytoplasmic 
matrixes. Further, mammalians have an extracellular CuZn superoxide dismutase (SOD3) 
(Crapo et al., 1992; Lindenau et al., 2000; Srinivasan et al., 2000). 
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Figure 3.1. Mitochondrial respiratory chain and reactions involved in removal of ROS in mitochondria 
The respiratory enzyme complexes involved in oxidative phosphorylation are NADH-dehydrogenase 
(Complex I in mammalian and Ndi1 in S. cerevisiae); succinate dehydrogenase (Complex II); 
ubiquinol:cytochrome c oxidoreductase (Complex III); cytochrome c oxidase (Complex IV); ATP synthase 
(Complex V) in both mammalian and S. cerevisiae. Complex I and II in mammalian cells and Complex II in 
S. cerevisiae contains 4Fe-4S centers. When the respiratory chain is inhibited, the electrons accumulate in the 
early stages of the respiratory chain (Complex I and coenzyme Q), were they can be donated to molecular 
oxygen to give superoxide.  Superoxide (O2-) is converted to hydrogen peroxide (H2O2) by mitochondrial 
superoxide dismutase (SOD2). H2O2 is converted to water (H2O) by glutathione peroxide (GPx1 in 
mammalian). Ferrous ions (Fe2+), released e.i. during O2- attack of enzymes with 4Fe-4S centers, can 
participate in a Fenton reaction and convert H2O2 into hydroxyl radical (HO•) (Wallace, 1999; Joseph-Horne 
et al., 2001). GSH (reduced glutathione); GR (glutathione reductase); GSSG (oxidized glutathione). 
 
Hydrogen peroxide produced by SOD2 in the mitochondria is reduced to water (H2O) by 
glutathione peroxidase (GPx), in a reaction that converts reduced glutathione (GSH) to 
oxidized glutathione (GSSG) (figure 3.1). Five GPx isoenzymes have been found in 
mammalian cells. GPx1, which are located in the mitochondria and cytosol and Gpx4 (or 
PHGPx, a phospholipid hydroperoxide) are found in most tissues. Cytosolic Gpx2 and 
extracellular Gpx3 are poorly detected in most tissues except for the gastrointestinal tract 
and kidney, respectively (de Haan et al., 1998). Hydrogen peroxide can also be reduced to 
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H2O by catalase (CAT), located primarily in peroxisomes (especially in liver) and in 
cytoplasm (erythrocyte) (Bai & Cederbaum, 2001). Catalase has only been found in 
mitochondria of rat heart (Radi et al., 1991). In the presence of transition metal ions (Fe2+, 
Cu+) hydrogen peroxide can be converted by the Fenton reaction to the highly damaging 
hydroxyl radical, which can cause degradation of most biological macromolecules, e.g. 
peroxidation of lipids, oxidation of sugars and of protein thiols, DNA base damage, and 
strand breakage of nucleic acids (Bai et al., 1999). 
 
3.4 Effects of Mitochondrial ROS Production 
Inhibition of mitochondrial oxidative phosphorylation 
Inhibition of mitochondrial oxidative phosphorylation in mice not only reduces energy 
production, but also increases mitochondrial ROS production. Mitochondria from normal 
mice have an increased H2O2 production after antimycin A inhibition (Esposito et al., 
1999). Antimycin A is not a direct producer of H2O2 but an inhibitor of Complex III. Thus, 
the inhibition results in a substantial increase in superoxide production (Raha et al., 2000) 
which is converted into H2O2 by SOD2. 
Also, mitochondria from adenine nucleotide translocator Ant1 (-/-) mice were shown to 
have the same high level of H2O2 as normal mitochondria treated with antimycin A. This 
suggests that the absence of ANT1 blocks the exchange of ADP and ATP across the 
mitochondrial inner membrane, thus inhibiting oxidative phosphorylation which is 
resulting in increased oxidative stress. Furthermore, tissues with high oxidative stress 
(skeletal muscle and heart) were showed to increase the level of ROS detoxification 
enzymes, SOD2 and GPx protein in Ant1 (-/-) mice. Although the antioxidant activities 
were increased, a very high level of mtDNA rearrangement was observed in the Ant1 (-/-) 
mice heart but not in skeletal muscle. It was suggested that the different levels of mtDNA 
rearrangement in the two tissues were a result of lower induction of SOD2 in the heart than 
in skeletal muscle (Esposito et al., 1999). 
 
Cytosolic superoxide dismutase (sod1) mutants 
By analyzing null SOD1 and SOD2 mutations in different species it has been suggested 
that ROS could be involved in limiting life span. Yeast cells deficient in the SOD1 gene are 
viable but grow poorly in oxygen and the mutation frequencies are increased in nDNA in 
sod1∆ mutant cells compared to the wild type parental strain (Gralla & Valentine, 1991; 
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Longo et al., 1997, Rasmussen et al., IV). It has been shown that SOD1 activity in motor-
neurons is an important factor in ageing and lifespan of Drosophila (Parkes et al., 1998). 
Sod1 null mutants of Drosophila have a very short lifespan (the adult lifespan is shortened 
by 85-95%). Overexpression of human SOD1 in motor neurons of a wild type Drosophila 
extended the adult life span by up to 40% (Parkes et al., 1998). 
 
Mutations in the SOD1 gene are also linked to Familial Amyotrophic Lateral Sclerosis 
(FALS) a disorder resulting from degeneration and death of motor neurons. 15-20% of 
FALS patients have been found to harbour mutations in SOD1. Transgenic mice that 
express a mutant SOD1 allele develop a motor neuron degeneration that parallels most 
aspects of ALS (Gurney et al., 1994; Bruijn et al., 1997). Whereas, knockout mice 
deficient in the entire SOD1 gene live to adulthood and show no overt motor defect 
(Reaume et al., 1996). This result demonstrates that the loss of SOD1 function is not, by 
itself, sufficient to kill motor neurons in vivo. It has been suggested that FALS is a 
consequence of reduction in SOD1 dismutation activity leading to oxidative damage (loss-
of-function) or a gain-of-function as the mutant SOD1 protein seems to increase the ability 
to generate hydroxyl radicals (Yim et al., 1996; Bogdanov et al., 1998; Liu et al., 1999). 
The results obtained with SOD1-/- knockout mice suggest that FALS SOD1 acquires or 
enhances toxic property. 
 
Mitochondrial superoxide dismutase (sod2) mutants 
Yeast sod2∆ mutants have a less dramatic phenotype than sod1∆ mutants when grown in 
glucose media although sod2∆ mutants are oxygen-sensitive and grow poorly in carbon 
sources that require respiration for their metabolism (Liu et al., 1992; Longo et al., 1996). 
In contrast to sod2∆ mutants  in yeast, an acute toxicity of mitochondrial O2- has been 
found in SOD2-/- mice. While mice, deficient in cytosolic SOD1 activity were viable 
(Reaume et al., 1996), inactivation of the mitochondrial SOD2 was lethal early in life. Two 
models of SOD2 knockout mice have been reported. SOD2tm1Cje mutant mice in which 
exon 3 has been deleted (Li et al., 1995) and SOD2m1BCM mutants which are missing exon 
1 and 2 (Lebovitz et al., 1996). The homozygous SOD2 tm1Cje mutant mice die within the 
first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in liver and 
skeletal muscle, and metabolic acidosis (Li et al., 1995). The homozygous SOD2m1BCM 
mutant mice survived up to 18 days and showed motor disturbance, central nervous system 
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injury, and extensive mitochondrial injury within cells with requirements of high levels of 
oxidative metabolism, including cardiac myocytes, neurons, hepatocytes, and 
hematopoietic cells (Lebovitz et al., 1996).  
In the SOD2 tm1Cje (-/-) mutant mice, the mitochondria's O2- toxicity was shown to result in 
dramatic reductions in the activities of mitochondrial enzymes containing iron-sulfur 
centers, including the Krebs cycle enzyme aconitase and respiratory chain enzymes of 
Complex I and II. Hence, the dilated cardiomyopathy observed in SOD2 (-/-) mice (Li et 
al., 1995) was caused by blocking of the Krebs cycle and respiratory chain giving energy 
starvation in the heart (Melov et al., 1999). The increased mitochondrial oxidative stress of 
the SOD2 (-/-) mice also resulted in high levels of oxidative damage to DNA. However, it 
was not determined whether it was nDNA, mtDNA damage or both (Melov et al., 1999). 
Measurement of the lipid peroxidation levels in heterozygous SOD2 tm1Cje (+/-) mutants and 
SOD2 (+/+) control mice revealed that young SOD2 (+/-) and control animals had the same 
levels of lipid peroxidation in the liver mitochondria. However, lipid peroxidation peaked 
for SOD2 (+/-) at middle age and declined in old SOD2 (+/-) animals, whereas lipid 
peroxidation of SOD2 (+/+) mice first peaked at old age (Kokoszka et al., 2001). Apoptosis 
seemed to be able to explain the loss of mitochondrial lipid peroxidation from middle-age 
to old age in SOD2 (+/-) mice. TUNEL staining showed that old SOD2 (+/-) mouse livers 
had three times more apoptotic hepatocytes than old SOD2 (+/-) mouse livers. It was 
therefore suggested that cells with a high number of damaged mitochondria was destructed 
by apoptosis (Kokoszka et al., 2001). 
 
It has also been demonstrated that Caenorhabditis elegans life span was increased 54% by 
treatment with SOD/catalase mimetics. In addition, treatment with these compounds could 
restore a mev-1 mutant life span to normal. The mev-1 gene, encodes the cytochrome b 
subunit of succinate dehydrogenase (Complex II) and the mutant increases mitochondrial 
ROS production which shortens the worms life span by 37% (Melov et al., 2000). 
 
The just mentioned models showed that ROS generation by mitochondria can be damaging 
to mitochondria themself but also to the length of life span of the animal. High ROS 
production can increase the percentage of mutant mtDNA, which decreases the 
mitochondrial energetic capacity and increases ROS production as well as the propensity for 
apoptosis. The tissues most sensitive to mitochondrial dysfunction are brain, heart, skeletal 
muscle, endocrine system and kidney (Wallace, 1999). 
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ROS generates a variety of DNA lesions including modified bases, abasic sites, and single 
strand breaks. If left unrepaired, these damages may contribute to a number of degenerative 
processes, including aging and cancer. Association to cancer has been established because 
one of the major base lesions formed upon oxidative attack to DNA, 7,8-dihydro-8-
oxoguanine (8-oxoG), was present at higher level in both lung and breast tumor tissue 
compared to normal tissue (Malins et al., 1991; Olinski et al., 1992). However, an important 
question is whether ROS generated in mitochondria contributes to induce mutations in 
nDNA? 
 
 
3.5 Mitochondrial Dysfunction Contributes to nDNA Mutations 
Hydroxyl radicals are extremely unstable with an estimated half-live of only 10-9 seconds 
(Pryor, 1986) whereas H2O2 is freely diffusible and relatively long-lived and may therefore 
efflux out of the mitochondria, and into the cytoplasm (Finkel & Holbrook, 2000; Bai & 
Cederbaum, 2001). Diffusion of H2O2 across the mitochondrial membrane has been 
suggested by Bai et al. (1999). They showed that catalase overexpressed in the 
mitochondria of HepG2 cells protected the cells from cytotoxicity of H2O2. Similarly, 
overexpression of cytosolic catalase protected HepG2 cells from cytotoxicity of antimycin 
A. Bai et al. (1999) showed that H2O2 diffuses into the mitochondria and that damage to 
the mitochondria could be an important factor contributing to H2O2 toxicity.  Similarly, 
cytosolic catalase protected the cells against antimycin A induced H2O2 toxicity, 
suggesting that mitochondrial produced H2O2 diffused into the cytosol.  
 
We used the yeast S. cerevisiae as a model system to investigate a potential link between 
mitochondrial activity and genomic instability. We generated strains that were either 
impaired in mitochondrial activity due to mutations in the mitochondrial genome (rho-) or 
strains absolutely deficient in mitochondrial activity due to lack of mitochondrial genome 
(rho0). We assayed these strains for spontaneous mutations and found that spontaneous 
mutation frequencies, measured as nuclear mutational events, were significantly higher in 
both rho- and rho0 strains compared to the wild type strains (Rasmussen et al., III) 
 
To investigate whether the increased spontaneous mutation frequencies observed in the rho0 
and rho- strains were a result of defective respiratory function in these cells, we measured the 
effect of disrupting the respiratory chain function in S. cerevisiae using various 
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mitochondrial inhibitors. We demonstrated that all drugs caused an increase in nuclear 
spontaneous mutation frequencies but that antimycin A had the most profound impact. This 
indicates that mitochondrial ROS production can cause nuclear mutations. Further, our 
results show that mitochondrial function and more specifically complex III activity is critical 
for maintaining genomic integrity (Rasmussen et al., III). The results correspond with in 
vitro studies indicating that Complex III may be responsible for more than 80% of ROS 
produced in S. cerevisiae (Chance et al., 1979). However, not all types of inhibition of the 
respiratory chain result in mutations in nDNA. We observed that mutations in COQ3 and 
COX6 did not affect spontaneous mutation frequencies and we therefore concluded that 
inhibition of these specific gene products is not involved in mitochondrial-mediated 
mutagenesis (figure 3.2).  
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Figure 3.2. Mutation frequencies in S. cerevisiae Hansen BY4741 wild type, coq3∆, and cox6∆ (Research 
Genetics, Inc., Huntsville, AL). The COQ3 gene encodes an O-methyltransferase required for two steps in the 
biosynthetic pathway of ubiquinone (coenzyme Q) - coq3 mutants do not synthesize coenzyme Q (Jonassen & 
Clarke, 2000). The cox6 gene encodes subunit VI of Complex IV. S. cerevisiae cytochrome c oxidase is 
composed of nine different subunits.  The three largest (cox1, cox2, and cox3) are encoded by mitochondrial 
genes the other six are encoded by nuclear genes (de Vries and Marres, 1987; Foury et al., 1998). Strains 
deficient in cox6 activity show residual cytochrome c activity corresponding to 7% of the activity found in wild 
type mitochondria (de Vries and Marres, 1987).  
 
 
It has been demonstrated that respiration plays a role in ROS production as well as for 
viability in SOD deficient yeast strains. S. cerevisiae deficient in Sod2 activity failed to 
grow normally in hyperoxia (doubling time 10.8 h.). In contrast, sod2 null mutants with 
complete absence of electron transport (rho0) grew normally in hyperoxia (doubling time 
2.8h.). In addition, the viability was partially restored by mutations (cox6) which disrupt 
the electron transport chain (doubling time 5.6 h.). Lack of respiration (coq3 mutant) also 
prevents viability loss of sod1 null mutants and sod1sod2 double null mutants (Guidot et 
al., 1993; Longo et al., 1996). 
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We examined S. cerevisiae sod mutant strains and found that deficient sod activity increases 
nuclear spontaneous mutation frequencies and that this mutator phenotype is suppressed by 
inactivation of mitochondrial activity (sod1∆ rho0 or sod2∆ rho0).  These data indicate that 
mitochondrial dysfunction either decreases oxidative damage to nuclear DNA by preventing 
formation of ROS and/or increase repair of oxidative DNA damage (Rasmussen et al. IV). 
Measurement of intra-cellular levels of O2- and H2O2 in strains deficient in mitochondrial 
activity (rho0 and rho-) showed lower levels of both O2- and H2O2 in rho0 and rho- cells 
(Rasmussen et al. III). These results showed that inactivation of mitochondrial function 
decreases intracellular levels of ROS and suggest decreasing mutagenesis caused by ROS. 
Furthermore, gene expression analysis showed that mitochondrial dysfunction did not 
increase repair gene expression in sod1rho0 cells compared to sod1 cells (Rasmussen et al. 
IV). Gene expression analysis also revealed that genes involved in detoxification are 
repressed in rho0 compared to wild type cells (Table 3.1).  
 
Table 3.1 • Expression of genes involved in detoxification in rho0 and rho+ cells 
 
 
Probe Set 
Name 
 
ORF 
 
Gene name 
 
Abs Call
 
Fold Change 
in rho0
 
Descriptions 
Genes repressed in rho0    
7907_at YPL163C SVS1 P 2.4 Serine and threonine rich protein. 
7432_at YBL064C  P 2.7 Homolog to thiol-specific antioxidant 
10634_at YKL062W MSN4 P 2.8 zinc finger protein 
4074_at YIR038C GTT1 P 2.9 Glutathione transferase 
8410_at YOR163W DDP1 P 3.1 Strong similarity to S.pombe SPAC13G6.14 protein 
4924_at YGR088W CTT1 P 5.9 Cytoplasmic catalase T 
10581_at YKL026C GPX1 A 5.3 Strong similarity to glutathione peroxidase 
Genes induced in rho0    
8723_at YOL158C ENB1 P 2.2 Similarity to subtelomeric encoded proteins 
4483_s_at YHR053C CUP1-1 P 2.5 Copper-binding metallothionein 
8400_at YOR153W PDR5 P 3.5 Multidrug resistance transporter 
7109_at YBR244W GPX2 P 7.9 Probable glutathione peroxidase (EC 1.11.1.9) 
The Abs Call = the Absolute Call; The transcript is present (P) or absent (A) for rho0. When the transcript is 
absent, is the fold change an approximation and calculated using the noise level. 
 
We used DNA microarray hybridization to analyse the expression of genes known to be 
involved in detoxification of ROS in rho0 and wild type cells (table 3.1).  We found that the 
cytoplasmic catalase (CTT1), glutathione transferase (GTT1), and glutathione peroxidase 
(GPX1) genes were repressed in rho0 cells.  In contrast, glutathione peroxidase (GPX2) was 
induced.  It has previously been shown that several oxidative agents such as H2O2 and O2- 
generating agents (Inoue et al., 1999) induce the expression of the GPX2 gene.  Our gene 
expression analysis showed that the expression of the transcription factor Msn4 encoded by 
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the MSN4 gene was repressed in rho0 cells.  Msn4 and Msn2 proteins regulate the expression 
of gene products that are induced by stress conditions through the stress response element 
(STRE) promoter sequence (Gasch et al., 2000; Causton et al., 2001).  Msn4 and Msn2 
proteins have been shown to bind upstream of the STRE element (Görner et al., 1998).  A 
known target for this transcription factor is the CTT1 gene (Gasch et al., 2000).  Our results 
indicate that rho0 cells experience stress although the nature of this stress is unknown at this 
time. 
 
These data indicate that absence of mitochondrial respiration is an important factor for the 
viability as well as for suppression of nuclear spontaneous mutations in sod1rho0 mutant 
cells. Our results suggest that rho0 cells have a lower production of ROS which results in 
lower nuclear spontaneous mutation frequency even when Sod1 or Sod2 are absent. 
 
Since the level of ROS is lower in rho0 cells one would expect that rho0 cells had lower 
spontaneous mutation frequencies than wild type but this is not the case. Interestingly we 
show that rho0 cells had (2.6 fold) statistically significant higher spontaneous mutation 
frequencies than wild type. Gene expression analysis showed that REV1 expression is 
upregulated in rho0 strains. The REV1 gene encodes a deoxycytidyl transferase activity 
involved in error-prone translesion DNA synthesis (TLS) that inserts dCMP opposite an 
abasic site or a strand break in the template, thereby producing a terminus that can be 
extended by polymerase zeta (Pol ξ). Polymerase ξ is composed of two subunits encoded by 
REV3 and REV7. TLS is mutagenic because Rev1 preferentially inserts cytosine opposite an 
abasic site in yeast (Lawrence and Hinkle, 1996; Nelson et al., 1996; Lawrence and Maher, 
2001). We examined rev1rho0, rev3rho0 and rev7rho0 strains to determine if inactivation of 
TLS could eliminate the mutator phenotype observed in rho0 cells. Our results show that 
mitochondrial-mediated mutator phenotype depend on functional Rev1, Rev3 and Rev7 
proteins and that the mutator phenotype of rho0 cells is suppressed by preventing 
Rev1/Rev3/Rev7-dependent translesion synthesis (Rasmussen et al., III).  
It has been shown that 3-methyladenine DNA glycosylase encoded by MAG1 in S. 
cerevisiae, which removes a variety of alkylated bases and generates abasic sites, increases 
spontaneous mutation frequency by 600-fold when overexpressed in S. cerevisiae. This 
mutator phenotype is also dependent on the Rev1/Rev3/Rev7 TLS bypass pathway (Glassner 
et al., 1998). 
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Our genetic evidence therefore suggests that mitochondrial dysfunction contributes to 
spontaneous DNA damage, which is fixed in the genome as mutation by error-prone 
Rev1/Rev3/Rev7 TLS pathway, which results in cell survival but genetic instability. 
 
Interestingly, one of the profound features of cancer cells is their defective mitochondrial 
function. A role for mitochondria in tumorigenesis was hypothesized when it was found that 
most tumors up-regulate glycolysis and therefore seems to be more dependent upon 
glycolysis for energy production, than mitochondrial oxidative phosphorylation (Warburg, 
1956).  
 
Furthermore, cancer cell lines (bladder, head, neck, colorectal and pancreatic) and lung 
primary tumors have been observed to have high frequency of homoplasmic mutations of 
mtDNA. The mitochondrial mutations are present in each of the hundreds of mitochondrial 
genomes in the tumor cell and in virtually all of the cells of the tumor (Polyak et al., 1998; 
Fliss et al., 2000; Jones et al., 2001). Homoplasmic mutations of mtDNA indicate that a 
single cell with a mutant mitochondrial genome has acquired a selective growth advantage 
during tumor evolution, allowing it to become the predominant cell type in the tumor cell 
population. Homoplasmy also indicates that each mutant mitochondrial genome has a 
replicative advantage in the particular mitochondria in which it occurred, and that this 
mitochondrion has selectively proliferated over other mitochondria in the same cell (Polyak 
et al., 1998; Jones et al., 2001). 
 
Our studies using S. cerevisiae with depleted mitochondria suggest that cancer cells by 
losing their mitochondrial function create a mutator phenotype (Rasmussen et al., II). Figure 
3.3 provides a model for how mitochondrial dysfunction generates a mutator phenotype in 
two different ways: 
1. Inhibition of the respiratory chain increases mitochondrial ROS production. 
Mitochondrial reactive oxygen species damage the mtDNA and the nDNA if 
mitochondrial H2O2 diffuses to the nucleus and is converted to HO• which can cause 
DNA damage. 
2. Mitochondrial dysfunction leads to nuclear DNA damage. The DNA damage activates 
the Rev1/Rev3/Rev7 error-prone translesion DNA synthesis pathway that contributes to 
cell survival, but at the expense of higher spontaneous mutation frequency. 
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Nuclear Mutations
Increased levels of DNA damage?
(Imbalanced repair of DNA damage?)
Increased levels of DNA damage?
(Reactive oxygen species (ROS))
Suppressor gene inactivation Oncogene activation
Uncontrolled proliferation
Tumor
Mitochondrial dysfunction
1 2
Figure 3.3. Mitochondrial dysfunction creates a mutator phenotype. Our results suggest that mitochondrial 
dysfunction can create a mutator phenotype in at least two ways. 1) Mitochondrial dysfunction caused by 
inhibition of the respiratory chain increases mitochondrial ROS production and if the ROS level is higher than 
the endogenous antioxidant capacity, ROS might difusse as H2O2 to the nucleus. In nucleus H2O2 can be 
converted to HO• which causes DNA damage. If the DNA damage is left unrepaired mutations in nDNA will 
occur and may lead to mutations that enhances cancer risk. 2) Mitochondrial dysfunction leads to nuclear DNA 
damage. The nature of this spontaneous nuclear DNA damage is unknown at this time, but might be caused by 
imbalanced repair as seen when Mag1 is overexpressed (Glassner et al., 1998). However, the DNA damage 
activates the Rev1/Rev3/Rev7 TLS pathway, which contributes to cell survival, but at the expense of higher 
spontaneous mutation frequency, which may lead to enhanced cancer risk. 
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Abstract
 .Mutations in DNA mismatch repair MMR genes have been shown to segregate with Hereditary Nonpolyposis
 .Colorectal Cancer HNPCC . However, because many HNPCC families fail to display mutations in known MMR genes, we
argued that changes in other components of the MMR pathway may be responsible. The increasing number of proteins
reported to interact in the MMR pathway suggests that larger complexes are formed, the composition of which may differ
among cell types and tissues. In an attempt to identify tissue-specific MMR-associated factors, we employed the yeast
two-hybrid system, using the human hMSH2 as bait and a human fetal liver library as prey. We demonstrate that hMSH2
X X  .interacts with a human 5 –3 exonuclease 1 hEXO1rHEX1 and that this interaction is mediated through their C-terminal
domains. The hMSH6 protein does not interact with hEXO1 in the two-hybrid system. Dot-blot analysis of multiple tissue
RNA revealed that hMSH2 and hEXO1 are coexpressed at high levels in fetal liver as well as in adult testis and thymus.
Northern blot analysis also revealed that hEXO1rHEX1 is highly expressed in several liver cancer cell lines as well as in
colon and pancreas adenocarcinomas, but not in the corresponding non-neoplastic tissue. q 2000 Elsevier Science B.V. All
rights reserved.
Keywords: Mismatch repair; hMSH2; hEXO1; Two-hybrid; Cancer
) Corresponding author. Tel.: q45-46-74-27-28; fax: q45-46-
74-30-11.
 .E-mail address: ljr@virgil.ruc.dk L.J. Rasmussen .
1. Introduction
Changes in the efficiency of DNA repair and
recombination activities can be associated with pre-
w xdisposition to cancer 1 . The finding that Hereditary
0921-8777r00r$ - see front matter q 2000 Elsevier Science B.V. All rights reserved.
 .PII: S0921-8777 00 00012-4
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 .Nonpolyposis Colorectal Cancer HNPCC families
frequently harbor mutations in DNA mismatch repair
 .MMR genes has generated widespread interest in
w xthis research area 2–4 . At the time of writing,
germline mutations in at least four genes, hMSH2,
hMLH1, hPMS1 and hPMS2, all homologs of bacte-
rial components involved in MMR, have been found
in HNPCC patients. Although no biochemical role
has to date been proposed for hPMS1, the other three
w xproteins have been shown to participate in MMR 3 .
In addition, MMR proteins might play important
roles in other pathways of DNA metabolism such as
DNA recombination and cell cycle checkpoint sig-
w xnaling 4 .
The development of an assay to study MMR in
cell-free extracts of bacteria has led to a detailed
understanding of the mechanism underlying the re-
pair process and, on the basis of these in vitro
w xstudies, a model for MMR has been proposed 5 ,
w xreviewed in Refs. 4,6 . Based on homology between
eukaryotic and prokaryotic MMR proteins, it has
been hypothesized that the mechanism underlying
human MMR is similar. Subsequently, it has been
shown that eukaryotic MMR proteins interact with
polypeptides involved in DNA replication, DNA re-
combination, and DNA nucleotide excision repair
 . w xNER 7–17 . A number of these genes have been
inactivated giving rise to complex phenotypes, such
as defects in MMR and recombination or in NER
w xand recombination 18–20 . These findings suggest
that DNA repair proteins are components of larger
protein complexes, and that at least some of these
proteins function in several distinct processes. The
increasing number of polypeptides reported to inter-
act with proteins in the MMR pathway suggests that
these complexes are composed of a larger number of
subunits, and also that the composition of such com-
plexes differs among cell types and tissues.
In the present communication, we have employed
the yeast two-hybrid system in an attempt to identify
proteins that interact with the human MMR protein
hMSH2 in vivo, using hMSH2 as bait. We chose a
human fetal liver cDNA library as prey since we
expected MMR-associated proteins to be highly ex-
pressed in an organ containing rapidly proliferating
cells. We report that hMSH2 interacts with the gene
products of both hMSH6 and hEXO1rHEX1. We
were unable to detect binding between hMSH6 and
hEXO1 in the two-hybrid assay. Our results suggest
that the interaction between hMSH2 and hEXO1 is
mediated via the C-terminal domains of these pro-
teins. Expression analysis showed that high levels of
this exonuclease are indeed coexpressed with hMSH2
in fetal liver as well as in adult testis and thymus.
Coexpression, although at lower levels, is also found
in colon, small intestine, bone marrow, placenta,
fetal kidney, fetal spleen and fetal thymus. Further
expression analysis revealed high levels of hEXO1
transcripts in liver cancer cell lines and in colon and
pancreas adenocarcinomas, but not in the corre-
sponding non-neoplastic tissue.
2. Material and methods
2.1. Human cell lines
The cell lines HepG2 human hepatocellular car-
.  .cinoma , SK-Hep1 human liver adenocarcinoma ,
 .Huh-7 human hepatocellular carcinoma , Chang
 .  .human liver , and WRL68 human liver embryo
were purchased from European Collection of Cell
 .Cultures Wiltshire, UK . All cell lines were main-
tained as monolayer cultures in DMEM Gibco, Life
. Technologies supplemented with 10% FBS Gibco,
.Life Technologies .
2.2. Plasmids
Plasmid pLJR105 was constructed by inserting
the human hMSH2 coding sequence into the NcoI
site of the pAS2 binding domain vector CLON-
.TECH . The hMSH2 gene was obtained on a 2.9-kbp
w xfragment from pCite-1-hMSH2 21 kindly provided
by Dr. Josef Jiricny Institute of Medical Radiobiol-
.ogy of the University of Zurich, Switzerland . The
hMSH2 bait was sequenced to confirm that the
hMSH2 protein was in frame with the GAL4 binding
domain. Plasmid pLJR112 contains a C-terminal
truncation of the hMSH2 gene and was constructed
by deleting a 1-kb fragment between the BlpI bp
.  .1796 in hMSH2 and Sal I located in the vector
sites in pLJR105. This truncation eliminates the C-
terminal 374 amino acids of the hMSH2 protein and
includes elimination of the conserved region. The
 .  .HEX1 C-terminal and HEX1 N-terminal plasmids
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were constructed by inserting either a 1182- or a
1355-bp fragment into the NcoI and BamHI sites of
 .the pACT2 activation domain vector CLONTECH .
The fragments were amplified by PCR using primers
containing additional NcoI or BamHI sites. Primer
pairs 5X-GGCACCATGGGGATACAGGGAT-3X, 5X-
CGGGATCCTCACTTCAATTGTGGGGCATCT-3X
and 5 X-G G C A C C A T G G C C T G C C C A T T -
CAAGAAGT-3X, 5X-CGGGATCCTCAGAATTTTT-
TAAATCCAA-3X were used for amplification of the
N-terminal and C-terminal parts of the
hEXO1arHEX1 protein, respectively.
2.3. Two-hybrid techniques
 .The GAL4-hMSH2 pLJR105 bait plasmid was
transformed into S. cere˝isiae strain Y190 MATa ,
ura3-52, his3-200, lys2-801, ade2-101, trp1-901,
leu 2 -3 , 1 1 2 , g a l4 D , g a l8 0 D , cyh r 2 ,
LYS2::GAL1 -HIS3 -HIS3, URA3::GAL1 -UAS TATA UAS
w xGAL1 -lacZ 22 . The resulting strain was subse-TATA
quently transformed with a human fetal liver match-
 .maker cDNA library CLONTECH, aHL4029AH
and hMSH2 interactors were selected on synthetic
 . w xdextrose minimal medium SD 23 lacking trypto-
 . phan to maintain pLJR105 , leucine to maintain the
. GAL4 activation domain plasmids , and histidine to
identify peptides capable of assembling a functional
.GAL4 transcription factor and supplemented with
 . 25 mM 3-amino-1, 2, 4-triazole 3-AT SD-HIS-
.TRP-LEUq25 mM 3-AT . 3-AT is a competitive
inhibitor of the S. cere˝isiae His3 protein and is
used to lower the background growth of the reporter
strain due to leaky expression of the HIS3 gene. The
plates were incubated at 308C for 7–10 days and a
total of 53 positive clones, Y1–Y53, were screened
for b-galactosidase activity on SD-TRP-LEUq60
mgrml 5-bromo-4-chloro-3-indolyl-b-D-galactoside
 .X-gal plates to verify positive interactions. These
clones were rescued for the GAL4 binding domain
 .plasmid pLJR105 by repeated growth on SD-LEU
plates. The rescued clones were tested for lack of
lacZ expression on SD-LEUqX-gal plates to elimi-
nate false positive clones.
2.4. DNA sequencing
DNA sequencing was performed directly on yeast
colonies grown on SD-HIS-TRP-LEU plates by
touching the colony with a sterile pipette tip. The
pipette tip was rinsed in incubation buffer 1.2 M
sorbitol; 100 mM sodium phosphate, pH 7.4; 2.5
.mgrml zymolase and incubated at 378C for 5 min.
Sequence inserts were amplified by PCR using the
MATCHMAKER AD LD-Insert Screening Am-
 .plimer Set CLONTECH . The PCR amplified frag-
ments were purified using a Qiaquick PCR purifica-
 .tion kit Qiagen and sequenced. Database searches
were performed using the BLAST algorithm
.http:rrwww.ncbi.nlm.nih.govrBLASTr .
2.5. Northern blot analysis
Human RNA Master Blot containing 100–500 ng
 .q  .poly A RNArdot Human RNA Master Blot was
purchased from CLONTECH. For detection of tran-
 .scripts in human cells aliquots 20 mg of total RNA
 TM .RNAqueous , Ambion were run on 1%
agaroser0.2 M formaldehyde gels and immobilized
onto nylon membranes. All probes were labeled by
random primer extension Rediprime DNA labeling
. wsystem, Amersham Pharmacia Biotech and a-
32 x  .P dCTP Amersham Pharmacia Biotech using a
PCR product as template. For the detection of exonu-
clease homologs, the blots were probed with either a
914-bp fragment containing the N-terminal region of
 .hEXO1arHEX1 N-terminal probe or a 946-bp frag-
ment containing the C-terminal region of
 .hEXO1arHEX1 C-terminal probe . These probes
were generated by PCR primers 5X-GGTGCCA-
CATGCGATCTCTGAG-3X and 5X-TCCAATCC-
X  .CACGCAGTGATGAC-3 HEX1 N-terminal probe
and 5X-GAGTGTAAGCACTCCACCTAGG-3X and
X X 5 -CCCGGCTTGTTCTCGGCATTAT-3 HEX1 C-
.terminal probe . For the detection of hMSH2, the
blots were probed with a 1054-bp fragment contain-
ing the N-terminal region, which shows limited ho-
mology to other known MutS homologs. This probe
was generated by PCR primers 5X-GTGCGCTTCTT-
TCAGGGCATGC-3X and 5X-TTATTCAGCAAGG-
X  .CAGCCAGAG-3 hMSH2 probe . All membranes
were hybridized with 1=106 cpmrml of 32 P-labeled
probes. The Human RNA Master Blot was prehy-
bridized for 30 min at 658C and hybridized overnight
at 658C in ExpressHybw solution according to the
 .manufacturer CLONTECH . All other membranes
were prehybridized for 30 min at 688C and hy-
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bridized for 90 min at 688C in QuikHybw Hybridiza-
 .tion Solution Stratagene . Blots were washed twice
at room temperature for 15 min and once at 608C
 .with wash solution 1= SSC, 0.1% SDS . Images
were obtained using autoradiography. GAPDH and
b-actin probes provided by the manufacturer
 .CLONTECH were prepared as described above
and used to correct for differences in loading.
2.6. b-galactosidase assays
b-galactosidase specific activity was assayed on
three separate transformants of each strain. In brief,
colonies were inoculated into 5 ml of SD-LEU-TRP
medium and grown overnight at 308C with vigorous
shaking. The next day, 2 ml of overnight cultures
were inoculated into 2 ml of YPD medium and the
cultures grown for 3–5 h at 308C with vigorous
shaking. Samples were prepared and assayed for
b-galactosidase activity essentially as described
by CLONTECH Protocol a PT1020-1,
.www.clontech.com .
3. Results
3.1. Identification of hMSH2-interacting protein
partners
To define the mechanism of human MMR and to
identify missing components of this complex pro-
cess, we set up a two-hybrid screen in S. cere˝isiae,
using as bait GAL4 fused to the entire open reading
frame of human hMSH2 and as prey GAL4 activa-
tion-tagged human fetal liver matchmaker cDNA
 .library. Our initial screen identified 53 Y1–Y53
clones as interactors. Sequence analysis showed that
the majority of the clones contained either yet
unidentified human cDNAs or proteins such as g-
globulin, fibrinogen, albumin, haptoglobin, repeat
regions, ferritin, and a-chymotrypsin but that Y5,
Y10, Y47 and Y50 contained a carboxyl-terminal
region of the human homologue of S. cere˝isiae
w x exonuclease EXO1, termed hEXO1b 10, 11 Fig.
.1 . We also isolated two clones containing hMSH6,
w xwhich is known to form a complex with hMSH2 4 ,
confirming to us that hMSH2 is able to form a
complex with human MMR proteins in yeast.
The DNA sequences of the hEXO1 clones we
 .isolated Y5, Y10, Y47 and Y50 showed a perfect
match to the 3X-end of hEXO1b, which is dissimilar
 .to the hEXO1arHEX1 sequence Fig. 1 . Further-
more, we observed several DNA sequence polymor-
phisms in the hEXO1 clones that could reflect hu-
 .man population variation Fig. 1 . The C to T base
 .pair change bp 2488 in Y5, Y10 and Y47 causes a
 .  .proline P to leucine L codon change, whereas the
 .  .G to A bp 1279 in Y50 causes an arginine R to
 .histidine H codon change. The Y50 clone contains
 .also an A to G base pair change bp 1983 , which
 .  .results in a lysine K to glutamic acid E codon
change. Furthermore, Y50 contains a deletion of
 .CAG bp 1486 resulting in a deletion of an alanine
 .A residue. All the clones we isolated appear to
interact equally well with hMSH2 in the two-hybrid
assay, indicating that these amino acid residues are
not crucial for hMSH2-hEXO1 interaction. The Y5,
Y10 and Y47 clones contained an additional 127-bp
 .sequence Fig. 1 , which corresponds to 59171–
59048 bp of the genomic DNA sequence Genbank
.AC004783 . This sequence is located upstream of
 . w xthe first exon Exon 1 in hEXO1arHEX1 12 . For
simplicity, we have named this 127-bp DNA se-
quence for Exon 0. We do not think that Y5, Y10
and Y47 represent true splice variants of hEXO1b
since we were only able to detect transcripts corre-
sponding to full-length hEXO1 using Northern blot
 .analysis data not shown .
3.2. Interaction domains of hMSH2 and hEXO1
It has been shown that purified full-length
hEXO1b interacts with hMSH2, in vitro, in an im-
w xmunoprecipitation assay 10 . We used two-hybrid
analysis to characterize the interaction between
hMSH2 and hEXO1 in vivo and to define the re-
gion of association. We fused the full-length
hEXO1arHEX1 and hEXO1b cDNAs to the GAL4
activation domain in pACT2 and tested for interac-
tion with our GAL4–hMSH2 binding domain plas-
 .mid pLJR105 . We were unable to detect protein–
protein interactions with any of our full-length ex-
onuclease 1 constructs in the two-hybrid assay Fig.
.2A . However, when we switched the inserts around
and instead fused hMSH2 to the GAL4 activation
dom ain in pA C T2, and hEXO 1b and
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w x  .Fig. 1. Exonuclease 1 gene structures. The full-length hEXO1arHEX1 and hEXO1b 10–12 coding regions comprise 13 exons II–XIV .
 X .The shorter variants named Y5, Y10, Y47 and Y50 comprise eight exons VII –XIV . These clones contain only a part of exon VII that we
refer to as exon VIIX. Solid lines represent exon sequences containing the N and I regions thought to be required for exonuclease activity.
Shaded boxes in hEXO1arHEX1 and hEXO1b represent the predicted coding regions. DGA to stop indicates the two base pairs deletion of
GA that causes a frameshift in hEXO1arHEX1 compared with hEXO1b. The Y5, Y10 and Y47 clones contain an additional 127-bp DNA
 .  .sequence exon 0 corresponding to 59171–59048 bp of the genomic DNA sequence Genbank AC004783 .
hEXO1arHEX1 to the GAL4 binding domain in
pAS2, we could detect an interaction in the two-hy-
 .brid assay Fig. 2A, Table 1 . One reason for this
discrepancy could be that the GAL4 activation do-
.main -hEXO1 fusion proteins are structurally differ-
ent from the native proteins and therefore unable to
 .interact with the GAL4 binding domain –hMSH2
fusion protein. This would also explain why we
failed to isolate any full-length cDNAs of hEXO1b
or hEXO1arHEX1 in our initial two-hybrid screen.
W e constructed truncated peptides of
hEXO1arHEX1 such that the protein was divided
into two regions containing either the 451 amino
acids N-terminal or the 388 amino acids C-terminal
 .part of full-length hEXO1arHEX1 Fig. 1 . We also
constructed a C-terminal truncation of hMSH2 to
delete the conserved region of the protein that is
necessary for interaction with hMSH3 and hMSH6
w x24 . We did not observe any interaction between
hMSH2 and the N-terminal region of hEXO1 in the
 .two-hybrid test Fig. 2B . Neither did we observe
interaction between the hMSH2 N-terminal region
and any of the exonuclease clones we isolated in the
 .two-hybrid screen data not shown . However, we
cannot rule out that the N-terminal region of hEXO1
makes contact to hMSH2 in the native protein. Inter-
estingly, we did observe an interaction between
 .hMSH2 and Y5 hEXO1b C-terminal , as well as
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Fig. 2. Interaction of hMSH2 with hEXO1arHEX1 and hEXO1b
 .  .Y5 . A Strains containing various plasmids were streaked in
 .horizontal rows on either SD-LEU-TRPqX-gal upper panel or
 .  .SD-LEU-TRP-HISq45 mM 3-AT lower panel plates. B Strains
containing various plasmids were streaked on SD-LEU-TRPqX-
gal plate. The plasmids contained in each strain tested are indi-
cated at the top of each column and at the left of each row. No
 .insert: pAS2, SNF4: pACT2 containing SNF4 control , and SNF1:
 .pAS2 containing SNF1 control . BD: binding domain. AD: acti-
vation domain.
Table 1
Specific b-galactosidase activity assay for protein interactions in
the two-hybrid assay
Specific b-galactosidase
aactivity
 .  .Y5 AD qhMSH2 BD 6.3
 .  .Y5 AD qhMSH2-N BD 0
 .  .HEX1-N AD qhMSH2 BD 0
 .  .HEX1-N AD qhMSH2-N BD 0
 .  .HEX1-C AD qhMSH2 BD 0.3
 .  .HEX1-C AD qhMSH2-N BD 0
 .  .hMSH2 AD qHEX1 BD 17.7
 .  .hMSH2 AD qhEXO1b BD 12.8
 .  .SNF4 AD qSNF1 BD 3.1
 .  .pACT2 AD qpAS2 BD 0
aSpecific b-galactosidase activity was determined as described
in Materials and methods.
between hMSH2 and hEXO1arHEX1 C-terminal
.  . region Fig. 2B, Table 1 . Our Y5 hEXO1b C-
.terminal clone did not contain the full-length
hEXO1b cDNA, but instead contained an insert en-
coding the carboxyl half of hEXO1b protein begin-
ning at amino acid 302. These data argue that the
carboxyl-terminal region of hMSH2 contacts the car-
boxyl-terminal domains of both hEXO1arHEX1 and
hEXO1b. Thus, the hMSH2-interacting region is out-
 .side the N and I regions Fig. 1 thought to be
w xrequired for exonuclease activity 12,25,26 . Our re-
sults complement the finding that S. cere˝isiae
yMSH2 interacts with the carboxyl-terminal region
w xof yEXO1 outside the N and I regions 16 .
hEXO1arHEX1 differs from hEXO1b by two nu-
 .cleotides 2616-AG-2617 at the boundary of exon
 .14 Fig. 1 . This frame-shift results in the truncation
of the hEXO1arHEX1 polypeptide by 43 amino
acids. We show that hMSH2 interacts with both
forms of human exonuclease 1, suggesting that the
interacting domain is located between exons 8 and
 .13 Fig. 1 . Interestingly, from data shown in Fig. 2
it appears that hMSH6 does not interact with hEXO1
in our two-hybrid assay.
3.3. Expression of exonuclease and hMSH2 in hu-
man tissues
We used a human RNA master blot to character-
ize the expression pattern of hEXO1 and to look for
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tissues predominately expressing the C-terminal tran-
script of hEXO1. One of the DNA probes contained
only the C-terminal region of hEXO1arHEX1 and
should detect all hEXO1 splice variants identified to
Fig. 3. Expression profiles of human exonuclease 1 and hMSH2. The RNA master blot was hybridized with hMSH2, hEXO1arHEX1
N-terminal, hEXO1arHEX1 C-terminal or b-actin control probes.
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date. The second probe contained the N-terminal
region of hEXO1arHEX1, which would be specific
for full-length hEXO1arHEX1 and hEXO1b mR-
NAs, but would not detect the C-terminal transcripts
 .Fig. 1 . We reasoned that by comparing the expres-
sion patterns obtained with these two probes, we
would be able to identify tissues that express only
C-terminal fragment. Since we did not observe any
differences in expression results, it would appear that
no tissue preferentially expresses the C-terminal part
 .of hEXO1 Fig. 3 . We do not know whether the
C-terminal part of hEXO1 is naturally present and
has a specific function in the cell or whether its
occurrence is a result of inefficient DNA synthesis
during the construction of the matchmaker cDNA
library, but presume the latter to be true based on the
fact that shorter transcripts were not observed. Both
probes detected transcripts prominently expressed in
fetal liver, adult testis and thymus, but we also
observed significant expression in adult colon, small
intestine, bone marrow, placenta, fetal kidney, fetal
 .spleen and fetal thymus Fig. 3 . Interestingly, we
did not detect any expression of hEXO1 mRNA in
adult liver, spleen, and kidney, indicating a specific
role for hEXO1 in the development of these tissues.
Since hMSH2 interacts with exonuclease 1 Fig.
.2 , we compared the expression patterns of hMSH2
with that of hEXO1 to identify tissues where the
exonuclease could play a role in DNA repair andror
recombination. We found that hMSH2 is expressed
 .in all tissues investigated Fig. 3 . Fig. 3 shows that
hMSH2 and hEXO1 are coexpressed at higher levels
in fetal liver, adult testis, thymus, and at lower levels
in bone marrow, placenta, fetal spleen, fetal kidney
and fetal thymus.
3.4. Expression of exonuclease and hMSH2 in hu-
man li˝er cancer cell lines
We have shown that hEXO1 is expressed in the
 .fetal liver but not in the adult liver Fig. 3 . We thus
examined the expression of the hMSH2 and hEXO1
 .genes in various human liver cell lines Fig. 4 :
 .HepG2 human hepatocellular carcinoma , SK-Hep1
 . human liver adenocarcinoma , Huh-7 human hep-
.  .atocellular carcinoma , Chang human liver , and
 .WRL68 human liver embryo . As expected, both
hEXO1 and hMSH2 were highly expressed in the
Fig. 4. Expression of human exonuclease 1 and hMSH2 in liver
cancer cell lines. Membranes containing total RNA isolated from
human adult liver, fetal liver, and various liver cell lines were
probed with hMSH2, hEXO1a r HEX1 N-terminal domain,
hEXO1arHEX1 C-terminal domain and GAPDH control probes.
The lower panel of the figure shows the 28S ribosomal RNA band
of the ethidium bromide stained gel. The human liver cell lines are
described in Materials and methods.
 .fetal liver but not in the adult liver Fig. 4 . One
reason for failing to detect any hMSH2 expression in
the adult liver in this experiment could be that the
 .qblot shown in Fig. 3 contains poly A mRNA while
the blot in Fig. 4 contains total RNA. However,
since hMSH2 is preferentially expressed in prolifer-
w xating cells 27–29 , high transcript levels in the
normally quiescent adult liver would be unexpected.
When the hEXO1 probes were used, we could only
detect a single transcript of approximately 3 kb,
which corresponds to full-length hEXO1 Fig. 4 and
.data not shown . This result suggests that hEXO1
mRNA is unlikely spliced to any of the shorter forms
identified in the two-hybrid screens and that the
C-terminal clones likely do not exist. A 3-kb tran-
script was detected using the hMSH2 probe, which
corresponds to the full-length hMSH2 cDNA. Inter-
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estingly, we find that both hEXO1 and hMSH2 are
highly expressed in the liver cancer cell lines HepG2,
SK-Hep1 and Huh7 as well as in the fetal-like Chang
and WRL68 cells.
3.5. Expression of exonuclease and hMSH2 in tumor
tissue
Our results revealed that hEXO1 is expressed
preferentially in tissue containing proliferating cell
populations as well as in cell lines established from
 .human liver tumors Figs. 3 and 4 . This led us to
investigate the expression of hEXO1 in human tu-
mors from colon and pancreas. Interestingly, we
found that hEXO1 expression is indeed upregulated
in samples isolated from colon and pancreas adeno-
 .carcinomas compared to normal tissue Fig. 5 . These
results support the idea of hEXO1 being preferen-
tially expressed in proliferating cells. Interestingly,
Fig. 5. Expression of human exonuclease 1 and hMSH2 in colon
and pancreas adenocarcinomas. Membranes containing total RNA
isolated from human adenocarcinomas and corresponding non-
neoplastic tissue were probed with hMSH2, hEXO1arHEX1
C-terminal domain and GAPDH control probes. The lower panel
of the figure shows the 28S ribosomal RNA band of the ethidium
bromide stained gel. Colorectal and pancreatic adenocarcinoma
and normal colon and pancreatic tissue were collected during
surgery and immediately frozen in liquid nitrogen. All tumors
were verified by histological examination. Normal tissues from
colon and pancreas were also examined histologically and found
to be free of tumor cells. The local ethics committee approved the
use of tumor and normal tissue.
we found that hMSH2 expression is upregulated in
the colon tumors but not in the pancreas tumors Fig.
.5 . These results may imply a defect in MMR activ-
ity in the pancreas tumors due to the low levels of
hMSH2 protein.
4. Discussion
Eukaryotic proteins are often components of larger
complexes. It is therefore easy to imagine that the
disruption of a particular protein–protein interaction
might affect several different cellular processes. In
addition, many eukaryotic genes show tissue-specific
expression and it is conceivable that the composition
of protein complexes varies among different cell
types and tissues. In agreement with this model, it
has been shown that mice carrying disruptions of
specific MMR genes display a variety of phenotypes
ranging from tissue-specific tumorigenesis to sterility
w x20,30–35 . This is consistent with the evidence that
implicates MMR proteins in processes other than
postreplicative MMR. Homologous and homeolo-
gous recombination, transcription coupled repair or
cell cycle control following DNA damage are exam-
w xples of such pathways 2,4,6 . It is possible, even
likely, that MMR proteins will interact with different
partners in each of these alternative pathways. Identi-
fication of these partners will help elucidate the
mechanisms of these complex processes.
In an attempt to identify tissue-specific MMR-as-
sociated factors, we employed the yeast two-hybrid
system, using the human hMSH2 as bait and a
human fetal liver library as prey. We demonstrate
that hMSH2 interacts with hEXO1 through their
C-terminal domains. Another MutS homolog hMSH6
does not interact with hEXO1 in the two-hybrid
system. It has previously been shown that the human
exonuclease 1 is expressed in a wide variety of
w xtissues 11 . Our comparative expression analysis
revealed that hMSH2 and hEXO1 are coexpressed in
the fetal liver, adult testis and thymus as well as in
colon, small intestine, and in the fetal tissues of
kidney and spleen but not in the corresponding adult
tissues. hEXO1rHEX1 is highly expressed in sev-
eral liver cancer cell lines as well as in colon and
pancreas adenocarcinomas, but not in the corre-
sponding non-neoplastic tissue.
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4.1. Interaction between hMSH2 and human exonu-
clease 1
The human MMR protein hMSH2 forms het-
erodimers with hMSH3 or with hMSH6, which func-
tion in the substrate recognition step during MMR.
In the subsequent step, these bound heterodimers
interact with the hMLH1rhPMS2 complex. Al-
though the following events of the MMR process are
not clear, it is anticipated based on the bacterial
model that the four-protein complex will recruit DNA
helicase and exonuclease activities, which mediate
the displacement and the degradation of the mis-
match-containing strand, respectively. The position
of the strand break and the initiation site of the
exonucleolytic process with respect to the mismatch
would determine the nature of the exonuclease. Thus,
repair of mismatches with upstream-positioned
strand-discrimination nicks will require a 5X–3X ex-
w xonuclease such as EXO1 16 . Conversely, MMR
involving downstream nicks would require 3X–5X ex-
onucleases to mediate the degradation process. In the
present study, we show that hMSH2 interacts with
the human 5X–3X exonuclease hEXO1. We are cur-
rently investigating whether the hMSH2rhEXO1
complex functions in MMR or other pathways such
as recombination, where hEXO1 has already been
w xshown to play a role 11,16 .
4.2. Comparati˝e expression analysis of hEXO1
Tumorigenesis in HNPCC patients is primarily
restricted to the proximal colon and endometrium.
We found that the hMSH2 and hEXO1 genes are
coexpressed, although at low levels, in colon and
small intestine. Due to the likely redundancy be-
tween exonucleases in the MMR process, it would
appear unlikely to anticipate that mutations in the
hEXO1 gene will segregate with HNPCC. Human
population studies monitoring the association of
hEXO1 gene defects with cancer or the construction
of a mEXO1 knockout mouse should clarify if this
exonuclease plays any role in carcinogenesis. Our
expression profiles of hMSH2 and hEXO1 also re-
vealed that these genes are coexpressed in human
testis and bone marrow, suggesting a role in meiosis
and hematopoiesis likely due to their function in
w xrecombination 36 . Along these lines, we have also
shown that both hEXO1 and hMSH2 are highly
expressed in the fetal liver; a site of hematopoiesis
during fetal development. However, in addition to
supporting hematopoiesis during embryonic develop-
ment, the fetal liver is also characterized by rapid
division of fetal hepatocytes. We have shown that
hEXO1 and hMSH2 are not expressed in normal
adult liver where cell turnover is normally very slow.
However, both genes are highly expressed in the
liver cancer cell lines HepG2, SK-Hep1 and Huh7 as
well as in the fetal-like Chang and WRL68 cells.
Furthermore, we showed that hEXO1 is highly ex-
pressed in colon and pancreas adenocarcinomas but
not in the corresponding non-neoplastic tissues. These
results suggest a role for hEXO1 in cellular pro-
w xcesses other than meiosis and hematopoiesis 36 .
Such processes could be MMR, recombinational re-
pair or replication, which are expected to be active in
proliferating cells such as fetal hepatocytes and can-
cer cells. Current studies are examining for potential
associations of hEXO1 with factors from these cellu-
lar activities. The fact that hEXO1 is specifically
expressed in liver cancer cells as well as in colon
and pancreas adenocarcinomas could make the ex-
pression of this gene a useful marker to diagnose
these cancers.
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Abstract 
 
DNA repair is essential for maintaining the integrity of the genetic material.  A number of 
DNA repair mechanisms have been well characterized for the nuclear DNA.  However, 
little is known about DNA repair in mitochondria.  Mutations in mitochondrial DNA 
(mtDNA) are involved in the pathogenesis of a variety of diseases including cancer, heart 
disease, diabetes, and a number of degenerative diseases.  Furthermore, accumulation of 
mutations in mtDNA is a common feature of aging cells.  Human mtDNA is extremely rich 
in guanine, therefore, repair of modified guanine is important for proper mitochondrial 
function. Certain intracellular or exogenous DNA damaging agents are known to frequently 
modify guanine to O6-MeG in DNA.  Generation of O6-MeG is mutagenic because it can 
mispair with thymine resulting in G:C → A:T transition mutations. The DNA repair protein 
O6-Methylguanine-DNA Methyltransferase (MGMT) removes methyl groups from the O6 
position of guanine (O6-MeG) in the nuclear DNA.  In order to gain understanding of the 
role of MGMT in mitochondria, we investigated (1) whether MGMT contains 
mitochondrial localization signals and is transported to mitochondria, (2) whether MGMT, 
when expressed in mitochondria can repair O6-MeG DNA lesions in this organelle, and (3) 
whether MGMT when expressed in mitochondria can protect cells from apoptosis induced 
by the DNA damaging agents which modify guanine in mtDNA. 
 
 
 69
Manuscript II 
Introduction 
 
Mammalian cells contain two distinct genomes: a nuclear (nDNA) and a mitochondrial 
(mtDNA).  Despite each human somatic cell contains 100 to 1000 mitochondria, that each 
contains 1 to 10 mitochondrial genomes, the amount of the mtDNA is only estimated to 
account for 1% of total DNA in the cell (Wallace et al., 1998; Bestwick, 1982). 
In contrast to nDNA the mammalian mitochondrial genome contains few noncoding 
sequences, no introns and it is not protected by histones. Thus, damage to mtDNA is 
expected to have great impact on the function of this organelle. Accordingly, it has been 
reported that the rate of point mutations is elevated in mtDNA compared to nDNA 
(Khrapko et al., 1997). Point mutations in and genomic rearrangements of mtDNA have 
been recognized to play a critical role in numerous human disorders underscoring the 
importance of maintaining the integrity of the mitochondrial genome (Pulkes and Hanna, 
2001; Wallace, 1999; Kogelnik et al., 19983). 
Given the importance of maintaining the mitochondrial genome intact for 
organelle activity, efficient DNA repair systems in mitochondria would be expected. Even 
so, early investigations showed that UV-induced pyrimidine dimers are not removed from 
mtDNA, a result that led to the conclusion that mitochondria are deficient in DNA repair 
(Clayton et al., 1974; Prakash et al., 1975). These findings encouraged the model that 
rather than repairing DNA damage in mtDNA, cells simply eliminate damaged genomes 
and replace them by replicating existing undamaged mitochondrial genomes (LeDoux et 
al., 1999). It was later confirmed that UV-induced pyrimidine dimers are not repaired in 
mitochondria (LeDoux et al., 1992; Pascucci et al., 1997) suggesting that mitochondria do 
not have a functional nucleotide excision repair (NER) pathway. However, recent 
research has shown that at least base excision repair (BER) activities are operational in 
mitochondria showing that this organelle does indeed repair damaged mtDNA (Croteu et 
al., 1999; Sawyer et al., 1999). But the knowledge about the mechanisms underlying 
DNA repair in the mitochondria is still limited. 
DNA repair alkyltransferases, responsible for removing methyl groups from the O6 
position of guanine, have been identified in both prokaryotic and eukaryotic organisms. The 
genes coding for these DNA repair alkyltransferases have been cloned from Escherichia 
coli (ada, Sedgwick, 1983; ogt, Potter et al., 1987), Saccharomyces cerevisiae (MGT1, 
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Xiao et al., 1991), mouse (MGMT, Shiota et al., 1992), rat (MGMT, Rahden-Staron and 
Laval, 1991) and human (MGMT, Tano et al., 1990; Rydberg et al., 1990; Hayakawa et al., 
1990).  To date most research has focused on the role of DNA repair alkyltransferases in 
repair of nDNA but mitochondrial MGMT activity has been reported in rat liver (Myers et 
al., 1988; Satoh et al., 1988). 
A mitochondrial DNA repair alkyltransferase has been partially purified from rat 
liver mitochondria and it was shown that this protein is similar in size to the 23 kDa DNA 
repair protein found in nuclei (Myers et al., 1988). DNA damage caused by the methylating 
agent N-methyl-N-nitrosourea (MNU) is repaired in mitochondria from Chinese Hamster 
Ovary (CHO) cells (LeDoux et al., 1992) suggesting that an alkyltransferase repair 
mechanism is active in mammalian mitochondria. However, mitochondrial MGMT activity 
has not been identified in human cells and the intracellular localization seems ambiguous. 
To gain a better understanding of the molecular processes and components 
responsible for DNA repair of methylation damage in the human mitochondrion we have 
investigated the localization of human MGMT. We found that full-length MGMT localized 
to the nucleus when expressed as a GFP fusion protein. This nuclear localization was 
independent of p53 status and we did not observe any MGMT protein in mitochondria in 
cells treated with MNNG. Our results suggest that the N-terminal region (codons 2-18) is 
required for directing the MGMT protein to nucleus. Expression of the MGMT protein 
lacking codons 2-18 in the mitochondria protected the cells from the cytotoxic effect of 
MNNG but had no effect on survival of cells treated with the oxidizing agent Menadione. 
                                                                                                                                                                                 
3Variations in the human mitochondrial genomes are updated on http://www.gen.emory.edu/mitomap.html 
(Kogelnik et al., 1998). 
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Materials & Methods 
 
Cell Cultures 
Human MCF12A (breast, mammary gland, normal, non-tumorigenic epithelial) cells were 
obtained from ATCC. MCF12A cells were maintained in DMEM/F12 growth medium 
(Gibco/Life Technologies) supplemented with 10% Horse Serum (Gibco/Life 
Technologies), 1% Penicillin-Streptomycin (Gibco/Life Technologies), 100 ng/ml Cholera 
Toxin (Sigma), 500 ng/ml Hydrocortisone (Sigma), 10 µg/ml Insulin (Sigma), and 20 ng/ml 
EGF (Epidermal Growth Factor, PeproTech) at 37oC in a humidified 95% air-5% CO2 
atmosphere. HCT116 p53-/- (colorectal carcinoma) human cells were obtained from Dr. 
Bert Vogelstein (Johns Hopkins University) and maintained in McCoy's 5A medium 
(Gibco/Life Technologies) supplemented with 10% fetal bovine serum (Gibco/Life 
Technologies), 1% Penicillin-Streptomycin (Gibco/Life Technologies) at 37oC in a 
humidified 95% air-5% CO2 atmosphere. HeLa (HSL2, cervical carcinoma) cells were 
maintained as previously described (Singh et al., 1999) in DMEM (Gibco/Life 
Technologies) supplemented with 10% FBS (Gibco/Life Technologies), 1% Penicillin-
Streptomycin (Gibco/Life Technologies) and 4 ng/ml uridine (Gibco/Life Technologies) at 
37oC in a humidified 95% air-5% CO2 atmosphere. 
 
Construction of plasmids 
A DNA sequence of MGMT lacking the terminal 23 amino acids (codon 185 to 207) was 
cloned into the Eco47III and SacI sites of pEGFP-N2 (Clontech). Oligonucleotides were 
used to PCR amplify a MGMT fragment (∆MGMT) lacking codons 2 to 18 and 185 to 207. 
The 5' primer: 5'GAAGATCTATGCTGGAG CTGTCTGGTT3' contains a BglII site and 
the 3' primer, 5'TTGAGCTC CCTCCCAAGCCTG3' contains a SacI site. The ∆MGMT 
fragment was cloned into the BglII and SacI sites of the pEGFP-N2 vector. The pShooter 
vectors pEF/myc/mito and pEF/myc/mito/GFP (control) (Invitrogen) containing the 
mitochondrial targeting sequence (MSVLTPLLLRGLTGSARRLPVPRAKIHSL) are 
designed to express and target a recombinant protein to the mitochondria in mammalian 
cells. Plasmid pEF/myc/mito-MGMT plasmid was constructed by inserting the complete 
coding sequence of human MGMT into the XhoI and NotI sites of pEF/myc/mito. The 
fragment containing full-length MGMT was amplified by PCR using the primers: (5' 
primer) 5'CCGCTCGAGATGGACAAGGATTGTGA3' containing a XhoI site and (3' 
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primer) 5'AAGCGGCCGCTCAGTTTCGGCCAGCA3' containing a NotI site. The DNA 
sequences of all constructs were confirmed by DNA sequencing. 
 
Transfection 
Cell cultures were transfected using either Lipofectamine2000 or Lipofectin 
(Gibco/LifeTechnologies) according to manufacturer’s guidelines. For fluorescence 
microscopy exponentially growing cells were counted and diluted, and 3 x 105 cells were 
seeded in 2 ml culture medium in glass bottom dishes (BioSoft International, Amsterdam, 
The Netherlands) one day prior to treatment. On the day of treatment cells were transfected 
with 3.5 µg DNA of each construct and incubated at 37oC in a humidified 95% air-5% CO2 
atmosphere for 24 hours before they were assayed for MGMT-GFP expression. 
Alternatively, exponentially growing cells were counted and diluted, and 7 x 104 cells were 
seeded in 2 ml culture medium without serum in tissue culture dishes containing coverslips 
one day prior to treatment. On the day of treatment cells were transfected with 2 µg DNA 
and incubated at 37oC in a humidified 95% air-10% CO2 atmosphere for 48 hours before 
they were assayed. In these experiments the growth medium was changed every 18 hours. 
 
MitoTracker staining 
For detection of mitochondria, MitoTracker Red (CMXros, Molecular Probes, Eugene, OR) 
was added to the growth medium of the transfected cells. Cells grown in glass bottom 
dishes were stained with 500 nM of MitoTracker Red for 20 min at 37oC in a humidified 
95% air-5% CO2 atmosphere. Cells grown on coverslips were stained with 50 nM of 
MitoTracker Red for 30 min in a humidified 95% air-5% CO2 atmosphere before fixation 
with 3.7% formaldehyde in Hank's balanced salt solution. Cells were treated with 20 µM 
MNNG (N-methyl-N’-nitro-N-nitrosoguanidine) (Sigma) for 2 or 3 hours. After 1 hour and 
45 min of MNNG treatment the growth medium was changed to medium containing both 
MNNG and MitoTracker Red and incubated further. The cells were visualized using a LSM 
510 confocal laser scanning microscope (Zeiss) or a Zeiss-Axiovert 135 TY Inverted 
microscope equipped with PXL camera (SENSYS Phptometrics). 
 
Cell proliferation assay 
The Cell Titer 96TN AQueous nonradioactive cell proliferation assay kit (Promega) was 
used to assay cell survival. Exponentially growing cells were counted, diluted, and seeded 
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in 100 µl of culture medium in 96-well microtiter plates at a cell density of 1 x 104 cell/well 
one day prior to treatment. On the day of treatment cells were transfected with 0.32 µg 
DNA/well in 125 µl growth medium Cells were transfected with either pEF/myc/mito/GFP 
(control), pEF/myc/mito-MGMT, pEGFPN2 (control), MGMT-GFP or ∆MGMT-GFP. 
Cells were incubated for 2-3 days at 37oC in a humidified 95% air-5% CO2 atmosphere 
before treatment with 0, 13.6, 54.4, 108.8, and 217.6 µM MNNG or 100, 400 or 1000 µM 
Menadione (Sigma). Cells were incubated for 3 days and on the third day cell survival was 
evaluated by the cell proliferation assay according to manufacturer’s guidelines. The data 
represent an average of two experiments where each data point represents an average of ten 
independent measurements. 
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Results 
 
The human MGMT protein localizes to nucleus 
DNA repair alkyltransferases have been identified in both nuclear and cytoplasmic fractions 
of eukaryotic cells (Ayi et al., 1992; Lee et al., 1992; Brent et al., 1993; Ishibashi et al., 
1994a,b; Lim and Li, 1996). Cytoplasmic appearance of MGMT indicates that this repair 
protein could be present in mitochondria. To access the actual localization of the MGMT 
protein we studied exogenous MGMT-GFP expressed as fusion protein in human breast 
cell line MCF12A and detected the subcellular localization by fluorescence microscopy. 
We found that MGMT protein is mainly localized in the nucleus (Figure 2), which is 
supported by most of the immunostaining analysis reported (Ayi et al., 1992, Lim and Li, 
1996; Belanich et al., 1996). However, we observed no mitochondrial localization 
concluded from the results of Mito Tracker Red staining of the cells (Figure 2). We did not 
observe any difference in subcellular localization of MGMT when we compared fixed cells 
(Figure 2B) with viable cells (Figure 2C). Our control experiment expressing the GFP alone 
showed the expected diffuse localization (Figure 2A). These results reveal that the human 
MGMT, when expressed as a GFP fusion protein, localizes in the nucleus. The results 
presented in Figure 2 also show that the codons 184 to 207 of the C-terminal part of 
MGMT is not required for proper nuclear localization of the protein as these were deleted 
in our construct. 
We deleted codons 2 to 18 of MGMT in order to investigate the importance of this region 
in subcellular localization of MGMT. The ∆MGMT-GFP construct, lacking codons 2 to 18 
of the N-terminal region and codons 184 to 207 of the C-terminal region of MGMT, was 
exogenously expressed in MCF12A cells. Interestingly, we found that deletion of codons 2 
to 18 resulted in weak nucleus staining and an accumulation of ∆MGMT in cytoplasm 
(Figure 2D). We observed weak fluorescence with several fluorescence forming dots within 
the cytosol. However, the granular dots was not identical with the mitochondrial Mito 
Tracker Red staining, although we can not exclude that any cytoplasmic ∆MGMT protein is 
located in mitochondria because of the uniform weak fluorescence around the granular dots 
(Figure 2D). Our data suggest the N-terminal domain or more specifically codons 2 to 18 
are essential for proper nuclear localization of MGMT. 
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The localization of MGMT is independent of p53 status 
The p53 protein has been detected inside the mitochondria but the majority of 
mitochondrial-associated p53 is found on the surface of this organelle (Sansome et al., 
2001). Furthermore, the p53 protein has been shown to reduce transcription of the MGMT 
gene in human fibroblasts (Harris et al. 1996). Both p53 and MGMT play roles in DNA 
damage recognition and repair. The p53 protein is believed to detect DNA damage and 
activate one or more cell cycle checkpoints that allow repair of damaged DNA. In contrast, 
there has been no evidence so far that MGMT is involved in activation of cell cycle 
checkpoints but a role in repair of DNA damage is well established. Previous studies by 
Balanich et al. (1996) have shown that MGMT in HT29 colon cancer cells were localized 
to nucleus and cytoplasm (cell lines defective in p53, Gayet et al., 2001), indicating that 
MGMT could be present in nucleus, cytoplasm and mitochondria in p53 defective cells. In 
order to explore a possible link between p53 and MGMT we expressed the MGMT-GFP 
fusion protein in two cell lines differing in p53 status. One cell line is completely deficient 
in p53 activity (HCT116 p53-/-) and the other expresses very low levels of the p53 protein 
(HeLa HSL2). We found no difference in subcellular localization of MGMT (Figure 3) 
suggesting that MGMT translocation is independent of the p53 status. In both cell lines the 
MGMT-GFP fusion protein was exclusively present in the nucleus. 
 
Alkylating agents have no effect on the localization of MGMT 
It has been shown that mtDNA is damaged by alkylating agents and that O6Me-G DNA 
lesions are repaired in mitochondria (Satoh et al., 1988; LeDoux et al., 1992). However, 
our data suggest that MGMT locates to the nucleus and no MGMT protein is detected in 
mitochondria of untreated cells (Figure 2). In order to test if nuclear MGMT is recruited to 
mitochondria upon DNA damage of mtDNA by alkylating agents we treated cells 
expressing MGMT-GFP with MNNG. MCF12A cells were treated with 20 µM MNNG for 
3 hours and cells were analyzed by fluorescence microscopy. The MGMT-GFP fusion 
protein was detected in nucleus but not in mitochondria (Figure 4) indicating that nuclear 
MGMT is not recruited to mitochondria after DNA damage by MNNG. 
 
 
Effect of MGMT expression in protecting cells from alkylating agents  
Research from other groups has shown that O6-Me-G and O6-Et-G lesions are repaired in 
mitochondria (Satoh et al., 1988; LeDoux et al., 1992). Our data suggest that MGMT does 
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not play a role in repair of O6Me-G DNA lesions in mitochondria. We constructed a set of 
plasmids in order to (1) investigate the cytotoxic effect of alkylation damage in cells 
expressing MGMT in mitochondria and (2) investigate the role of the cytoplasmic ∆MGMT 
protein in protecting cells after alkylation damage. MCF12A cells were transfected with the 
pEF/myc/mito-MGMT construct, which directs the fusion protein to mitochondria, as well 
as the pEF/myc/∆MGMT-GFP and pEF/myc/MGMT-GFP constructs. Surprisingly, 
expression of mito-MGMT increased sensitivity to killing by MNNG whereas expression 
of ∆MGMT-GFP provided the same level of protection to killing by MNNG as MGMT-
GFP (Figure 5). We also treated cells with Menadione, which introduce oxidative damage 
to DNA. These lesions are not repaired by MGMT serving as a control for the effects on 
cell survival observed after transfection with the plasmids and MNNG treatment are 
specific for alkylation damage. We did not observe any difference in cell survival after 
treatment with Menadione (Figure 6). Our results indicate that the presence of MGMT in 
mitochondria increases sensitivity to MNNG. Conversely the cytoplasmic ∆MGMT protein 
protects cells from killing by MNNG at high doses. 
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Discussion 
 
MGMT is a small protein of 207 amino acids and a molecular weight of 21.7 kDa 
(Hayakawa et al., 1990; Rydberg et al., 1990). It has been proposed that small non-nuclear 
proteins, with a molecular weight less than 40-60 kDa can passively equilibrate between the 
cytosol and the nucleus (Weis, 1998). The small size of the MGMT protein and its DNA 
binding property may allow apparent mobilization to nuclear DNA by passive diffusion and 
DNA binding. However, when bacterial methyltransferase (ada; 39 kDa) is expressed in 
mammalian cells it fails to accumulate in the nucleus of NIH-3T3 cells (Dumenco et al., 
1989). Therefore, it seems unlikely that the “diffusion” model of the entry into the nucleus 
for this protein operates. It has been suggested that the sequence -KLLKVVK- (codons 
101-107) shares some homology to the nuclear location signal PKKKRKV (Ayi et al., 
1992; Weis, 1998). However, mutants of this basic –KLLKVVK- region of MGMT were 
DNA binding and repair deficient but entirely nuclear (Lim and Li, 1996). MGMT 
expressed as β-gal fusion protein, which is too large (130 kDa) for the passive diffusion 
into the nucleus, was shown to be present in the nucleus (Lim and Li, 1996). We show that 
a MGMT-GFP fusion protein localizes to the nucleus suggesting that MGMT can target the 
GFP into the nucleus. We also show that the MGMT protein does not localize to 
mitochondria when fused to GFP.  
Comparison of the structures and sequences of bacterial (Ada) with the human 
MGMT proteins reveals that the similarity between these proteins is highest in the C-
terminal region (MGMT amino acids 92 to 174 and Ada amino acids 94 to 175)(Wibley et 
al., 2000). A divergent N-terminal region could therefore explain nuclear-targeting 
differences between Ada and MGMT. It has been suggested that the residues Glu45 to 
Gly55 form a "hydrophobic handle" that may serve to anchor MGMT to other proteins 
(Wibley et al., 2000). The conformation of residues Glu45 to Gly55 is stabilized by the first 
β-strand (residues Lys8 to Ser14) in MGMT. We showed that a deletion of the first 18 
amino acids is sufficient to keep MGMT in the cytoplasm. Mutant proteins of MGMT 
carrying deletions of either codons 1 to 10 or 1 to 19 were active in protecting cells from  
killing by MNNG (Crone et al., 1996). These results suggest that these mutant proteins are 
active in repair of alkylation DNA damage in vivo. However, it was shown that the mutant 
MGMT proteins were less effective in repair compared to wild type MGMT as well as 
highly unstable with half-lives of 48-90 min compared to a half-live of > 720 min for the 
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wild type MGMT. We found that the ∆MGMT-GFP construct lacking codons 2 to 18 of the 
N-terminus resulted in weak fluorescence from nuclear and several bright granular dots in 
the cytosol, indicating degradation in lysosome and therefore a shorter half-live than 
MGMT-GFP. Interestingly, it has been shown that both N- and C-terminal deletions of the 
MGMT protein (deletion of codons: 1-30; 1-60; 1-90; 1-120; 1-150; 1-180, 165-180; 59-
207 or 31-207) affect the nuclear localization of MGMT (Lim and Li, 1996). In summary 
these observations indicate that the structure of MGMT is of great importance for 
subcellular localization. 
We re-evaluated possible targeting signal for nucleus and mitochondria by using the 
PredictNLS, MitoProt and PSORT software programs4. PredictNLS finds experimentally 
known nuclear localization signals in a given protein. MitoProt calculates the N-terminal 
protein region that can support a Mitochondrial Targeting Sequence (MTS) and the 
cleavage site (Claros and Vincens, 1996) and PSORT finds both MTS and NLS sequences 
(Nakai et al., 1992). Neither of these programs identified any nuclear localization signal or 
Mitochondrial Targeting Sequence (MTS) in the MGMT protein (data not shown). 
The majority of proteins, which are synthesized in the cytoplasm and imported to the 
mitochondria, contain a MTS in the N-terminal region of the protein. The sequence is 
diverse in both length (20 to 60 amino acid residues) and composition. However, the major 
feature appears to be residues with abundant positive charges, very little if any negative 
charges, and frequent hydroxylated residues which can form an amphipathic a-helix 
(Neupert, 1997). A fraction of mitochondrial proteins lacks this targeting sequence, for 
instance, APE1 which has been shown to locate to rat mitochondria (Tell et al., 2001). In 
fact a large number of outer and inner membrane proteins, as well as proteins that reside in 
the intermembrane space, have internal targeting signals and no MTS (Neupert, 1997). The 
conclusion of the re-evaluation of possible targeting signals is, therefore, that MGMT 
seems to lack both MTS and experimentally known nuclear signals. 
Overexpression of the simple glycosylase MPG (AAG) increases sensitivity to alkylating 
agents as a result of accumulation of cytotoxic AP sites (Limp-Foster and Kelley, 2000; 
Coquerelle et al., 1995). This is supported by the finding that overexpression of MPG in the 
human breast carcinoma cells does not alter the activities of the proteins immediately 
downstream in the BER pathway (i.e. APE1) (Kreklau et al., 2001). Increased sensitivity to 
alkylating agents is also observed when MPG is overexpressed in the mitochondria 
                                                          
4 PredictNLS (http://cubic.bioc.columbia.edu/predictNLS) & MitoProt (www.mips.biochem.mpg.de/cgi-
bin/proj/medgen/mitofilter) & PSORT (http://psort.nibb.ac.jp) 
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(personal communication with Dr. Mark R. Kelley, Department of Pediatrics - 
Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA, 
submitted to JBC). It was concluded that overexpression of MPG results in imbalance of 
the proteins involved in BER. MGMT is a direct repair protein and it is unlikely to cause 
imbalance in downstream components of a pathway. However, it has been suggested that 
MGMT binds to O4-MeT DNA lesions, but the repair is slow, resulting in hindrance of 
NER of this lesion (Samson et al., 1997). This could explain the increased sensitivity to 
MNNG treatment in cells overexpressing the mito-MGMT protein in mitochondria (Figure 
6). However; so far no NER activity has been identified in mitochondria. Alternatively, 
MGMT blocks the mitochondrial DNA replication by binding to O4-MeT DNA lesions.  
 
In summary, we have shown that MGMT when fused to GFP does not localize to 
mitochondria but to the nucleus. This nuclear localization is independent of the p53 status 
of the cells. We show that deletion of the first 18 amino acids is sufficient to keep MGMT 
in the cytoplasm and overexpression of MGMT in mitochondria increases sensitivity to the 
alkylating agent MNNG. 
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Legends to figures 
 
Figure 1. Nucleotide sequence of human MGMT cDNA.  Letters in bold indicate the 
sequences deleted in full-length and truncated MGMT expression plasmids.  A highlighted 
box marks the cysteine acceptor residue surrounded by the 3 conserved amino acids.  
 
Figure 2. Subcellular localization of MGMT in MCF12A cells. (A) GFP-control, 
MCF12A transfected with pEGFP-N2 vector. (B) Detection of fixed cells transfected with 
MGMT fused to GFP. (C) Detection of viable cells transfected with MGMT fused to GFP. 
(D) Detection of viable cells transfected ∆MGMT-GFP construct lacking codon 2-18 of the 
N-terminus. 
 
Figure 3. Subcellular localization in HeLa and HTC116 (p53-/-) cells.  (A) Detection of 
HeLa cells transfected with fusion product of MGMT and GFP. (B) Detection of HTC116 
(p53-/-) cells transfected with MGMT-GFP. 
 
Figure 4. Localization of MGMT in MCF12A cells after 20 µM MNNG treatment for 
3 hours. 
 
Figure 5. Survival following methylation. MCF12A cells transfected with Mito-MGMT, 
MGMT-GFP and ∆MGMT-GFP were treated with different doses of MNNG (0, 13.6, 54.4, 
108.8 or 217.6 µM) before the viability of the cells were determined. Each data point 
represents an average number of ten measurements from one representative experiment. 
 
Figure 6. Survival following oxidative damage. MCF12A cells transfected with Mito-
MGMT, MGMT-GFP and ∆MGMT-GFP were treated with different doses of Menadione 
(0, 100, 400 or 1000 µM) before the viability of the cells was determined. Each data point 
represents an average number of ten measurements from one representative experiment. 
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Figure 1 
 
 
 Codons 2-18 are deleted from ∆MGMT-GFP 
ATG GAC AAG GAT TGT GAA ATG AAA CGC ACC ACA CTG GAC AGC CCT TTG GGG AAG CTG GAG CTG  
Met Asp Lys Asp Cys Glu Met Lys Arg Thr Thr Leu Asp Ser Pro Leu Gly Lys Leu Glu Leu  
 1                                  10                                      20 
TCT GGT TGT GAG CAG GGT CTG CAC GAA ATA AAG CTC CTG GGC AAG GGG ACG TCT GCA GCT GAT  
Ser Gly Cys Glu Gln Gly Leu His Glu Ile Lys Leu Leu Gly Lys Gly Thr Ser Ala Ala Asp  
                                30                                      40  
GCC GTG GAG GTC CCA GCC CCC GCT GCG GTT CTC GGA GGT CCG GAG CCC CTG ATG CAG TGC ACA  
Ala Val Glu Val Pro Ala Pro Ala Ala Val Leu Gly Gly Pro Glu Pro Leu Met Gln Cys Thr 
                            50                                      60   
GCC TGG CTG AAT GCC TAT TTC CAC CAG CCC GAG GCT ATC GAA GAG TTC CCC GTG CCG GCT CTT  
Ala Trp Leu Asn Ala Tyr Phe His Gln Pro Glu Ala Ile Glu Glu Phe Pro Val Pro Ala Leu 
                        70                                      80   
CAC CAT CCC GTT TTC CAG CAA GAG TCG TTC ACC AGA CAG GTG TTA TGG AAG CTG CTG AAG GTT  
His His Pro Val Phe Gln Gln Glu Ser Phe Thr Arg Gln Val Leu Trp Lys Leu Leu Lys Val 
                    90                                      100 
GTG AAA TTC GGA GAA GTG ATT TCT TAC CAG CAA TTA GCA GCC CTG GCA GGC AAC CCC AAA GCC  
Val Lys Phe Gly Glu Val Ile Ser Tyr Gln Gln Leu Ala Ala Leu Ala Gly Asn Pro Lys Ala 
                110                                     120 
GCG CGA GCA GTG GGA GGA GCA ATG AGA GGC AAT CCT GTC CCC ATC CTC ATC CCG TGC CAC AGA  
Ala Arg Ala Val Gly Gly Ala Met Arg Gly Asn Pro Val Pro Ile Leu Ile Pro Cys His Arg 
            130                                     140                 145 
GTG GTC TGC AGC AGC GGA GCC GTG GGC AAC TAC TCC GGA GGA CTG GCC GTG AAG GAA TGG CTT  
Val Val Cys Ser Ser Gly Ala Val Gly Asn Tyr Ser Gly Gly Leu Ala Val Lys Glu Trp Leu 
        150                                     160 
CTG GCC CAT GAA GGC CAC CGG TTG GGG AAG CCA GGC TTG GGA GGG AGC TCA GGT CTG GCA GGG  
Leu Ala His Glu Gly His Arg Leu Gly Lys Pro Gly Leu Gly Gly Ser Ser Gly Leu Ala Gly 
    170                                     180 
GCC TGG CTC AAG GGA GCG GGA GCT ACC TCG GGC TCC CCG CCT GCT GGC CGA AAC TGA 
Ala Trp Leu Lys Gly Ala Gly Ala Thr Ser Gly Ser Pro Pro Ala Gly Arg Asn Stop 
190                                                                                          200 
                   Codons 185-207  are deleted from MGMT-GFP and  ∆MGMT-GFP 
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Figure 2  
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Figure 3  
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Figure 5  
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Accumulation of mitochondrial mutations is a consistent phenotype of 
cancer cells (1-2). Another hallmark of cancer cells is the generation of a mutator 
phenotype, which results in a rapid accumulation of mutations that, drives tumor 
development (3). To date, it is not clear how mitochondrial dysfunction impacts 
on the genetic stability of nuclear genome. Using Saccharomyces cerevisiae as a 
model organism we analyzed the consequences of disrupting mitochondrial 
function on genetic stability of the nuclear genome. In strains of yeast lacking 
mitochondrial DNA (rho0), and those with mitochondrial mutations (rho-), we 
tested the instability of the nuclear genome by measuring the frequency of 
canavanine resistant colonies. We demonstrate that mitochondrial dysfunction 
induces mutations in the nuclear genome. We also demonstrate that REV1, REV3 
or REV7 gene products, implicated in error-prone translesion DNA synthesis (TLS) 
(4) mediate the genetic instability of the nuclear genome arising as a result of  
mitochondrial dysfunction. Our results  in the yeast model provide a direct link 
between mitochondrial dysfunction and genomic instability, which has important 
implications in human cancer and aging.    
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Besides generating ATP, mitochondria perform multiple functions that are 
essential to the cell (5). Mitochondrial dysfunction is one of the most common 
and profound phenotypes of many human cancers (6-14). Mitochondrial 
dysfunction is also involved in aging, adaptive mutation, pathogenesis of many 
childhood and adult mitochondrial diseases (7, 16-20).  Aging studies and studies 
conducted in human cancer cells have reported the accumulation of mutations in 
mitochondrial DNA (mtDNA) (2, 5, 11-12, 16-19).  In this paper, we investigated 
the effect of mitochondrial dysfunction on the integrity of the nuclear genome. 
We generated yeast strains that were either impaired in mitochondrial activity 
due to mutations in the mitochondrial genome  (rho-) or strains deficient in 
mitochondrial functions due to the absence of the entire mitochondrial genome 
(rho0) (Figure 1). To these cells, we applied a mutation detection assay that 
measures the stability of the nuclear genome (21). The CAN1 gene of S. 
cerevisiae encodes a transmembrane amino acid transporter that renders the cell 
sensitive to lethal arginine analogue, canavanine. Any inactivating mutation in 
this gene results in a canavanine resistant phenotype (CANR) (15). We calculated 
the frequency of canavanine resistant colonies as a measure of spontaneous 
nuclear mutational events in rho0 and rho- strains. We found that, compared to 
wild type cells, nuclear mutational events were significantly higher in both rho- 
and rho0 strains (Figure 2A).  
Both rho0 and rho- cells lack proper mitochondrial function. Therefore, one 
possible explanation for the increased spontaneous mutation frequencies 
observed in the rho0 and rho- strains is that these cells exhibit defective 
respiratory function. To test if respiratory dysfunction played a role in increased 
rate of mutagenesis in rho- and rho0 cells, we disrupted mitochondrial respiration 
with Oligomycin, Antimycin A, and potassium cyanide, inhibitors of mitochondrial 
function (22). These inhibitors influence different steps in mitochondrial-mediated 
electron transport. Oligomycin binds directly to mitochondrial ATP synthase and 
inhibits both electron transfer and ATP production (complex V). Antimycin A is a 
specific inhibitor of the quinone reduction site, binds to the bc1 complex and 
blocks electron flow at complex III. Potassium cyanide blocks electron flow at 
complex IV (22). Analysis of nuclear mutational events in the strain treated with 
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each of these inhibitors showed that mutation frequency increased in cells 
exposed to the mitochondrial inhibitors (Figure 2B). Of all the mitochondrial 
inhibitors used in this study, Antimycin A had the most profound effect indicating 
that complex III activity is critical for maintaining genomic integrity (Figure 2B). It 
is noteworthy, that of all the mitochondrial inhibitors, only Antimycin A treatment 
induces many of the same genes induced in rho0 cells (23). Together, our results 
provide evidence that mitochondrial dysfunction generates a mutator phenotype 
in the nuclear genome.   
It has been hypothesized that mitochondrial dysfunction could increase the 
level of reactive oxygen species (ROS) (1, 18-19). Elevated level of reactive 
oxygen species could lead to loss of genomic integrity. Therefore, we measured 
superoxide and hydrogen peroxide levels in rho0 and rho- cells. Our results show 
that both complete loss of the mitochondrial genome and mutations in mtDNA 
result in lower levels of superoxide (O2-) and H2O2 (Figure 3 A and B). Thus, ROS 
does not appear to play a major role in the mitochondria-mediated mutagenesis. 
Mitochondria are intimately involved in pyrimidine biosynthesis (24). It is 
conceivable that impairment of nucleotide biosynthesis due to mitochondrial 
dysfunction contributes to mutagenesis of the nuclear genome. 
Yeast cells are known to modulate the expression of nuclear genes in 
response to mitochondrial dysfunction (25). In fact, mitochondria-to-nucleus 
communication has been studied extensively in yeast cells lacking mitochondrial 
function (25-26). Previous studies have demonstrated that up-regulation of 
certain nuclear genes involves activation and nuclear translocation of 
heterodimeric basic helix-loop-helix factors Rtg1 and Rtg3p in response to 
mitochondrial dysfunction. A related protein Rtg2 is also involved in mitochondria-
to-nucleus communication (25). To identify genes, whose expression profiles 
change as a result of impairment of mitochondrial function, we conducted 
microarray analysis (data not shown). We compared gene expression of cells 
lacking mitochondrial function (rho0) with that of wild type cells (rho+). 
Interestingly we found that among other genes, the expression of REV1, which is 
involved in error-prone translesion DNA synthesis (TLS) (27), was upregulated. 
TLS enables cells to repair DNA lesions that escape the vigilance of the generally 
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efficient DNA repair systems (27). TLS occurs when the replication machinery, 
upon encountering a lesion, has, or some how acquires, the ability to copy the 
damaged template directly by incorporating a nucleotide opposite the modified 
base. TLS is potentially mutagenic because it often incorporates incorrect 
nucleotides (27). TLS has significance in tumorigenesis since mutations induced 
during replication of damaged nucleotides are believed  to cause cancer (3).   
In S. cerevisiae, the three proteins, Rev1, Rev3 and Rev7 constitute the 
major components of TLS. The REV1 gene product possesses deoxycytidyl 
transferase activity whereas Rev3 and Rev7 proteins are the subunits of DNA 
polymerase zeta (27). We examined whether these three gene products play a 
role in determining the mitochondria-mediated mutator phenotype. We 
determined mitochondria-mediated mutator phenotype in strains with null 
mutations in REV1, REV3 or REV7 genes. Our results clearly showed that the 
mutator phenotype is eliminated in cells lacking REV1, REV3, or REV7 genes 
(Figure 4). These results strongly suggest that the mitochondria-mediated 
mutator phenotype is dependent on functional Rev1, Rev3 and Rev7 proteins. 
The REV1, REV3 and REV7 genes are conserved between yeast and humans. 
Based on our observations in yeast, it is conceivable that human Rev1p, Rev3p 
and Rev7p proteins are involved in mitochondria-mediated mutagenesis. 
The data presented in this paper supports the following conclusion for the 
role of mitochondrial dysfunction in genetic instability. Mitochondrial dysfunction 
leads to spontaneous nuclear DNA damage. The nature of this spontaneous 
nuclear DNA damage is unknown at this time. In order to avoid cell death due to 
spontaneously damaged nuclear DNA, cells activate the error-prone TLS pathway 
that contributes to cell survival but genetic instability. 
Mitochondrial dysfunction and genetic instability are both characteristic 
features of cancer cells (1-3, 32). Mitochondrial dysfunction due to accumulation 
of mutations in mtDNA is also a key feature of aging (16-19). Our studies using a 
yeast model system suggest that mitochondria contain some intrinsic properties 
that control the mutator phenotype associated with cancer cells. Our study 
provides, for the first time, a link between cancer and aging and mitochondrial 
dysfunction.   
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Methods 
 
Media and Strains.  Growth media were prepared as described in (29). The S. 
cerevisiae strains used in this study are derived from RKY3109 (15) provided by R. 
D. Kolodner (Ludwig Institute for Cancer Research, La Jolla, CA).   
 
Generation of rho- and rho0 strains.  Strains with mitochondrial mutations 
(rho-) or strains lacking mtDNA (rho0) were generated by treatment of strains with 
ethidium bromide (29). The mutants were selected as cells unable to form colonies 
on yeast extract-peptone-glycerol (YPG) plates. In rho0 cells the loss of mtDNA was 
verified by DAPI (4,6-diamidino-2-phenylindole) staining and rho- status was 
verified by genetic crossing with rho0 cells. 
 
Generation of yeast rev null mutants. Mutations in REV1, REV3 and REV7 
genes (rho0rev1, rho0rev3 and rho0rev1) were introduced by one-step gene 
deletion/replacement in YAKR144 (table 1). The plasmids pSF3-REV1∆::URA3, 
pYPG101-REV3∆::URA3 and pYPG102-REV7∆::URA3 used to generate the S. 
cerevisiae REV null mutants. The null plasmids were obtained from Dr. C. 
Lawrence (Department. of Biochemistry and Biophysics, University of Rochester, 
NY).  
 
Determination of spontaneous mutation frequency.  Mutation frequencies 
were determined using the fluctuation test method essentially as described in (30).  
Briefly, for each strain five to seven independent cultures were grown in yeast 
extract-pentose-dextose (5 ml, YPD).  Each experiment was repeated at least 
twice.  Appropriate dilutions were plated on YPD plates to determine the number 
of viable cells. The frequency of forward mutation at the CAN1 gene locus was 
determined from the number of canavanine resistant colonies that grew on 
selective minimal dropout plates (SD/-Arg + 60 µg/ml canavanine). The colonies 
were counted after incubation at 30oC for 3-5 days. The data were analyzed by 
using the method of the median (30). 
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Inhibition of respiratory activity.  Wild type strain (RKY3109) was grown in 
YPD media overnight before plating the cells on YPD plates and SD/-Arg + 
canavanine plates containing either water (control), oligomycin (5 µg/ml), 
Antimycin A (0.02 mM), potassium cyanide (0.5 mM).  After incubation at 30oC for 
3-5 days the colonies were counted and the data were analyzed by the method of 
the median (30). 
 
Flow cytometric analysis of intracellular levels of free radicals.  To 
determine superoxide anion generation, dihydroethidium (DHE, Molecular Probes, 
Eugene, OR) was added to early exponential phase cultures of either wild type 
(RKY3109), rho- (YAKR145) or rho0 (YAKR144). The cultures were grown in YPD 
medium to A600 = 0.4 - 0.5. The cells were washed twice in water and the cells 
were incubated in 1 ml 50 mM Tris pH 7.5 containing 40 µg/ml DHE for 2 hrs 
before they were analyzed by flow cytometry. The H2O2-sensitive dye 5-(and-6)-
chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Molecular 
Probes) was used to measure peroxide production in the cells. CM-H2DCFDA 
staining was conducted by adding the dye (10 µM) to the growth medium (1 ml) 
and incubated for 20 hrs. For sample analysis, an aliquot (100 µl) of the CM-
H2DCFDA-stained yeast cultures were suspended in 900 µl of 50 mM Tris pH 7.5 
before they were analyzed by flow cytometry (31). 
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Table 1 •  S. cerevisiae strains used in this study 
 Strain Genotype 
Wild type 
 
RKY3109 MATa, ura3-52, leu2∆1, trp1∆63, his3∆200, 
lys2∆Bgl,hom3-10, ade8, ade2∆1 
rho- YAKR145 RKY3109 rho-
rho0 YAKR144 RKY3109 rho0
rho0 rev1 YAKR184-188 YAKR144 REV1∆::URA3 
rho0 rev3 YAKR189-193 YAKR144 REV3∆::URA3 
rho0 rev7 YAKR194-198 YAKR144 REV7∆::URA7 
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Figure Legends: 
 
Figure 1: 
Strains with mtDNA mutations (rho-) or strains lacking mtDNA (rho0) were 
generated by treatment of strains with ethidium bromide (29).  The mutants were 
selected as cells unable to form colonies on yeast extract-peptone-glycerol (YPG) 
plates.  Wild type and rho- cells show mtDNA after cells were stained with DAPI 
(4,6-diamidino-2-phenylindole). DAPI stains both the nuclear and mtDNA. The rho0 
cells show nuclear DNA staining but they do not show punctuate staining indicating 
loss of mtDNA. The rho- status was verified by genetic crossing with rho0 cells. 
Fluorescence was examined using a DAPI optimized filter on Zeiss-Axiovert 135 TV 
inverted microscope equipped with a PXl camera (SEBSYS photometrica). 
 
Figure 2 A and B: 
Strains were tested in CAN1R assay as described in Methods. The average 
median frequency in each assay is presented. CAN1S mutation assay detects 
frequency of CAN1S to CAN1R forward mutations. A: Frequency of mutation in 
CAN1 gene in yeast strains defective in mitochondrial function. B: Frequency of 
mutation in CAN1 gene after respiratory inhibition.  Inhibition of respiration was 
carried out as described in material methods.  The data presented are an average 
of at least 10 independent cultures. 
 
Figure 3 A and B:   
Production of reactive oxygen species in yeast strains lacking mitochondrial 
function. A) superoxide and B) hydrogen peroxide.  Free radical production was 
measured as described in Methods. Superoxide was measured by using 
dihydroethidium (DHE) and 5-(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein 
diacetate (CM-H2DCFDA) was used to measure H2O2. 
 
Figure 4: 
Mutation frequency in yeast strain lacking rev1, rev3 or rev7 gene 
expression. Strains were tested in CAN1R assay as described in Methods. The 
average median frequency in each assay is presented. CAN1S mutation assay 
detects frequency of CAN1S to CAN1R forward mutations. The data presented are 
an average of at least 10 independent cultures. 
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Figure 3 B 
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Abstract 
 
Oxidative stress and accumulation of mutation are associated with increased risk of cancer 
and aging. Alterations of oxidative phosphorylation affect intracellular levels of reactive 
oxygen species (ROS) which induce oxidative stress. DNA lesions introduced by ROS are 
potentially cytotoxic and mutagenic. We used Saccharomyces cerevisiae to understand the 
mechanisms of mutagenesis in cells deficient in superoxide dismutases (encoded by the 
SOD1 and SOD2 genes). Our analysis reveals that SOD1 gene inactivation leads to 
mutations in the nuclear genome and that mitochondrial dysfunction suppress this mutator 
phenotype.  We also demonstrate that agents which introduce oxidative damage decrease 
cell survival and increase mutations in cells with mitochondrial dysfunction. 
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Introduction 
 
Mitochondria generate more than 80% of cellular energy in the form of ATP.  In addition, 
these organelles carry out other cellular functions, such as respiration and heme, lipid, 
amino acid and nucleotide biosynthesis (Kang et al., 1998).  Mitochondrial respiration is a 
major endogenous source of reactive oxygen species (ROS), including superoxide radical 
(O2-), hydrogen peroxide (H2O2), and hydroxyl radical (HO•) (Cadenas and Davies, 2000). 
These ROS also arise from external environmental factors such as drugs, radiation, and 
heavy metals (Cadenas, 1989). As a result, ROS cause damage to proteins, lipids, and 
nucleic acids and thereby compromise cell viability.  Both prokaryotic and eukaryotic cells 
have developed defense mechanisms against the lethal and mutagenic effect of ROS. 
Superoxide dismutases (SOD) are enzymes that eliminate O2- and thus protect cells from 
damage induced by free radicals (Halliwell and Gutterridge, 1985; Fridovich, 1995; 
Oberley and Buettner, 1979).  ROS are also reduced by intracellular antioxidant enzymes 
such as glutathione peroxidase (GPx) and catalase (CAT) as well as some antioxidant 
molecules like glutathione (Raha & Robinson, 2001; Jamieson, 1998). Therefore, the 
balance between ROS production and antioxidant defenses determines the degree of 
oxidative stress. 
 
Superoxide is the primary oxygen free radical produced by the mitochondrial respiratory 
chain.  However, O2- is rapidly dismutated to H2O2 by either Sod2 (mitochondria) or Sod1 
(nucleus, cytoplasm, and lysosomes) (Srinivasan et al., 2000). Hydrogen peroxide is 
reduced to water by CAT and GPx (Wallace, 1998). Saccharomyces cerevisiae cells 
deficient in Sod1 activity show a variety of phenotypes such as growth inhibition under 
aerobic conditions, sensitivity to killing by menadione or freeze-thawing, decreased 
viability in stationary phase, auxothropy for the amino acids methionine and lysine as well 
as increased spontaneous mutation rates under aerobic growth conditions. In contrast, 
cells deficient in Sod2 activity have a less dramatic phenotype when grown in glucose 
media but are oxygen-sensitive and grow poorly on carbon sources that require respiration 
for metabolization. The phenotype of the sod1sod2 double mutant strain includes all 
phenotypes of the single mutants (Gralla and Valentine, 1991; Liu et al., 1992; Longo et 
al., 1996; Park et al., 1998). 
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Oxidative phosphorylation generates ROS which suggests a role for mitochondrial 
activity in cell survival and mutagenesis.  Guidot et al. (1993) found that S. cerevisiae 
cells deficient in the mitochondrially-located superoxide dismutase (Sod2) failed to grow 
normally in hyperoxia.  In contrast, strains deficient in both Sod2 and mitochondrial 
activity (rho0) grew normally in hyperoxia.  In addition, the viability was partially 
restored by mutations, which disrupt the electron transport chain.  Lack of respiration also 
prevents viability loss of sod1 and sod1sod2 double mutant strains (Longo et al., 1996).  
These data imply that mitochondrial function and respiration play an important role in 
viability of sod mutant strains.  Studies have shown that rho0 strains as well as strains 
carrying deletions in their mitochondrial DNA (rho-), are more sensitive to killing by O2- 
and H2O2 than wild type cells (Flatter-O'Brien et al., 1993; Jamieson, 1992; Collinson and 
Dawes, 1992; Grant et al., 1997). 
 
Mammalian cells respond to oxidative stress by increasing antioxidant enzymes, which are 
capable of detoxifying reactive oxygen species (Akashi et al., 1995; Brambilla et al., 1997; 
Esposito et al., 1999; de Hann et al., 1998).  However, there exists tissue specificity in the 
cellular response to oxidative stress.  Skeletal muscle dramatically induced SOD2 
expression whereas heart only increased SOD2 expression modestly upon oxidative stress. 
In contrast, expression of GPx1 was induced similarly in both tissues.  In S. cerevisiae, the 
expression of both superoxide dismutases, SOD1 and SOD2, glutathione peroxidase GPX2, 
CTT1 encoding the cytosolic catalase T, and glutathione reductase GLR, which catalyses 
reduction of glutathione disulfide (GSSG) to glutathione (reduced form, GSH) are induced 
in response to oxidative stress (Galiazzo et al., 1987; Gasch et al., 2000; Grant et al., 1996; 
Inoue et al., 1999; Marchler et al., 1993). 
 
In this paper we examined the role of Sod1 and Sod2 in mitochondria-mediated 
mutagenesis in S. cerevisiae.  We show that cells deficient in Sod activity increase 
spontaneous mutation levels in the nuclear genome and that this mutator phenotype is 
suppressed by inactivation of mitochondrial activity.  In order to characterize the role of 
mitochondrial activity in mutagenesis and cell survival we treated wild type and rho0 cells 
with various drugs that affect intracellular levels of ROS.  We show that both H2O2 and 
menadione increase spontaneous mutations in nuclei; but that rho0 cells are 10-20 fold 
more sensitive than wild type cells to mutations introduced by these agents.  Furthermore, 
both H2O2 and menadione decrease survival of rho0 cells indicating that cells deficient in 
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mitochondrial activity are impaired in repair of DNA damage introduced by these agents.  
We used DNA microarray hybridization analysis to further characterize the cellular 
response to oxidative stress.  We compared gene expression patterns in sod1 and sod1rho0 
mutant strains.  We did not detect any increase in the expression of the majority of DNA 
repair genes in sod1rho0 cells compared to sod1 cells.  However, gene expression analysis 
revealed that genes involved in DNA repair are induced in sod1 compared to wild type 
cells. 
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Materials and Methods 
 
Media and strains.  Growth media were prepared as described in Sherman et al., 1994. 
The S. cerevisiae strains used in this study are derived from RKY3109 (Ni et al., 1999) and 
provided by Dr. Richard Kolodner (Ludwig Institute for Cancer Research, La Jolla, CA) or 
strain DL1 (D273-10B) (Paul et al., 1989).  The strains used in this study are listed in Table 
1.  
 
Generation of yeast strains.  Mutations in the superoxide dismutase genes (sod1 and sod2) 
were introduced by one-step gene deletion/replacement in RKY3109. The plasmids pUC-
SOD1∆::URA3-A and pG-SOD2∆::TRP1-A were provided by Dr. Gralla (Department of 
Chemistry and Biochemistry, University of California, Los Angeles, CA). The sod1 mutant 
strain YAKR129 was generated using the SOD1::URA3 deletion/disruption cassette as 
described in (Gralla and Valentine, 1991). The sod2 mutant strain was generated similarly 
using the SOD2::TRP1 deletion/disruption cassette (Marres et al., 1985).  The sod deletion 
derivatives were verified by PCR analysis (data not shown).  
 
Generation of rho- and rho0 strains.  Strains with mitochondrial mutations (rho-) or 
strains lacking mtDNA (rho0) were generated by treatment of wild type, sod1 and sod2 
strains with ethidium bromide (Sherman et al., 1994).  The mutants were selected as cells 
unable to form colonies on extract-pentose-glycerol (YPG) plates. The loss of mtDNA was 
verified by DAPI (4,6-diamidino-2-phenylindole) staining (data not shown). 
 
Determination of spontaneous mutation frequency.  Mutation frequency was determined 
using fluctuation test method described in (von Borstel, 1978). For each strain, five to 
seven independent cultures were grown in 5 ml yeast extract-pentose-dextrose (YPD). 
Appropriate dilutions were plated on YPD agar plates to determine the number of viable 
cell in the cultures. The frequency of forward mutation at the CAN1 gene locus was 
determined from the number of canavanine resistant colonies that grew on selective 
minimal dropout plates (SD/-Arg + 60 mg/liter canavanine). The colonies were counted 
after incubation at 30oC for 3-5 days for wild type and rho0 cells and for 11-14 days for sod 
mutant strains.  The data were analyzed by the method of the median (Lea 1949, von 
Borstel, 1978). Each experiment was repeated at least twice. 
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Drug treatment.  Overnight cultures grown in YPD medium were diluted into fresh 
growth medium at A600 of 0.15 and incubated until cell density reached A600 of 0.4 - 0.5.  
Aliquots of 5 ml were treated with various concentrations of drugs at 30oC with vigorous 
shaking for 1 hr. The concentrations of the drugs were: H2O2 (0, 2 and 4 mM), 4-NQO (4-
Nitroquinole N-oxide) (0, 2 and 4 µg/ml), adriamycin (0, 20 and 40 µg/ml), menadione 
sodium bisulfite (0, 10 and 20 mM), and diamide (0, 25 and 50 mM).  Relative cell survival 
was determined by immediately diluting the samples into sterile H2O and plating on YPD 
plates.  Mutation frequency was determined from the number of canavanine resistant 
colonies by the method of the median (von Borstel, 1978).  The yeast cells were collected 
by centrifugation, washed in water before plating on SD/-Arg + canavanine plates. All 
reagents were obtained from Sigma Chemical Co. (St Louis, MO) with the exception of 
adriamycin (Johns Hopkins Hospital, MD). 
 
Gene array analysis.  Total RNA was isolated from log-phase S. cerevisiae strains 
according to manufactures guide lines using RNeasy (QIAGEN). Total RNA (5 µg) was 
converted into double stranded cDNA by GIBCO BRL's SuperScript Choice system for 
cDNA synthesis (LifeTechnologies) and a T7-(dT)24 oligomer provided by Research 
Genetics (Huntsville, AL). Double stranded cDNA was purified by phenol/chloroform 
extraction and ethanol precipitation. In vitro transcription was performed with T7 RNA 
polymerase following the instructions from BioArray high yield RNA transcript Labeling 
kit from Enzo (distributed by Affymetrix). The Biotin-labeled cRNA was purified on an 
affinity resin (RNeasy mini cleanup, QIAGEN) and the amount of labeled cRNA was 
determined by measuring absorbance at 260 nm and using the convention that 1 OD at 260 
nm corresponds to 40 µg/ml RNA. The Yeast Genome S98 Array (Affymetrix) containing 
approximately 6,400 open reading frames (ORFs) of S. cerevisiae genome was used for 
gene expression analysis. Hybridization, reading and analysis were performed by Research 
Genetics (Huntsville, AL). The classification of genes into functional groups was done as 
described in MIPS database, Munich Information Center for Protein Sequences (Mewes et 
al., 1997; http://mips.gsf.de). 
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Results and Discussion 
 
Mitochondrial dysfunction prevents mutations in the nuclear genome in superoxide 
dismutase deficient cells (Sod1 and Sod2) deficient cells.
Saccharomyces cerevisiae coq3sod1 double mutant deficient in superoxide dismutase 
activity and oxidative phosphorylation show increased viability compared to the superoxide 
deficient sod1 mutant alone (Longo et al., 1996).  This indicates that free radicals generated 
during oxidative phosphorylation in mitochondria are cytotoxic and that superoxide 
dismutases protect the cell from the lethal effect of mitochondrial-mediated damage.  In 
order to characterize the interaction between mitochondrial-mediated mutagenesis and 
repair in more detail we measured spontaneous mutation frequencies.  We applied a 
mutation detection assay that measures the stability of the nuclear genome.  The CAN1 
gene of S. cerevisiae encodes a transmembrane amino acid transporter that renders the cell 
sensitive to the lethal arginine analogue, canavanine.  Any inactivating mutation in this 
gene results in a canavanine resistant phenotype (CANR).  We calculated the frequency of 
canavanine resistant colonies as a measure of spontaneous nuclear mutational events in 
sod1 and sod2 mutant strains (Table 2).  As expected, based on earlier work (Gralla and 
Valentine, 1991; Longo et al., 1997), mutation frequencies are increased in the sod1 mutant 
strain compared to the wild type parental strain (Table 2).  Inactivation of the sod2 gene 
increased mutation frequencies about 2-fold, which is similar to the mutator phenotype 
generated by inhibiting mitochondrial activity (rho0 or rho-) (Rasmussen et al., (III)).  The 
increased mutation frequencies observed in superoxide dismutase deficient cells were 
suppressed by inactivation of mitochondrial activity (sod1rho0 and sod2rho0) (Table 2).  
These data suggest that the mutator phenotype observed in superoxide dismutase deficient 
cells is dependent on mitochondrial activity. 
 
Differential expression of repair genes in superoxide dismutase deficient strains. 
We used genome analysis by DNA microarray hybridization analysis to identify DNA 
repair transcripts differentially expressed as a result of mitochondrial dysfunction and 
superoxide dismutase deficiency (Table 3).  We found that a large number of DNA repair 
genes acting in various DNA repair pathways are induced by the sod1 mutation (Table 3).  
The differentially expressed genes included not only DNA repair genes known to repair 
oxidative DNA damage (NTG2), but also genes involved in repair of other kinds of DNA 
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damage such as base excision repair (MAG1), direct reversal repair (MGT1), nucleotide 
excision repair (RAD10, RAD14, RAD16, RAD26 and RAD28), recombinational repair 
(RAD50, RAD52, RAD59, SGS1, MUS81, and PSO1), mismatch repair (MSH3), and 
meiotic recombination (MSH4).  It has been shown that the transcript of MAG1, encoding a 
3-methyladenine DNA glycosylase, is induced after treatment with the methylating agent 
methylmethane sulfonate (MMS) as well as with the oxidizing agents H2O2 and menadione 
(Jelinsky and Samson, 1999; Gasch et al., 2001).  The induction of DNA repair genes 
observed in the sod1 mutant strain suggests that one or more shared transcription factors 
responsible for expression of DNA repair genes are activated in response to endogenous 
DNA damage in superoxide dismutase deficient cells. 
  
Further analysis of gene expression patterns revealed that several checkpoint genes were 
induced in the sod1 mutant strain (Table 3).  The MEC3 gene is a checkpoint gene that 
together with RAD9, RAD17, RAD24 and DDC1 are required for detection of DNA damage 
and activation of the checkpoint pathways (Elledge, 1996, Zhou and Elledge, 2000).  
Induction of MEC3 and RAD9 suggest that sod1 mutant cells generate DNA damage that is 
detected by the checkpoint pathways. 
 
We show in Table 2 that the mutator phenotype of the sod1 mutant strain is suppressed by 
inactivating mitochondrial activity (sod1rho0).  We compared gene expression patterns of 
the sod1 mutant strain with the sod1rho0 mutant strain in order to identify DNA repair 
genes involved in this suppression.  Interestingly, only seven DNA repair genes were 
differentially expressed (Table 4).  One of these is the OGG1 gene encoding the 8-
oxoguanine DNA glycosylase.  Both purine and pyrimidine residues in DNA are sensitive 
to ROS-mediated DNA damage (Croteau and Bohr, 1997).  However, the most common 
purine DNA lesion is the mutagenic 8-hydroxyguanine (8-oxoG) (Steenken and Jovanovic, 
1997; Burrows and Muller, 1998).  We have recently shown that complete loss of the 
mitochondrial genome (rho0) results in lower levels of ROS (Rasmussen et al., (III)).  
Therefore, it is tempting to speculate that the sod1 mutant strain induces Ogg1 in response 
to high levels of ROS. 
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Cells deficient in mitochondrial activity are sensitive to H2O2 and menadione induced 
DNA damage. 
Studies have shown that rho- and rho0 cells, which are respiratorically deficient, are more 
sensitive to the cytotoxic effect of ROS (Flatter-O'Brien et al., 1993; Jamieson, 1992; 
Collinson and Dawes, 1992; Grant et al., 1997).  We treated exponentially growing wild 
type, rho-, and rho0 cells with various drugs that affect intracellular levels of ROS to 
determine the degree of sensitivity and mutation frequencies for each drug (Figure 1).  
Adriamycin (Doxorubicin) is an anti-tumor drug that can inhibit DNA replication by direct 
intercalation between DNA base pairs (Singal et al., 1997).  Single electron donors such as 
NADPH cytochrome P450 reductase can reduce the quinoid ring in adriamycin to 
semiquinone.  In the presence of molecular oxygen the semiquinone radicals are rapidly 
oxidized to the parent compound in a process, which generate O2- (Olson and Mushlin, 
1990).  NADPH-cytochrome P450 reductase catalyzes the reduction of menadione leading 
to the formation of semiquinones that is readily autooxidized generating O2- (Lind et al., 
1982).  4-nitroquinoline (4-NQO) is metabolized in vivo to the carcinogenic 4-
hydroxyaminoquinoline 1-oxide (4-HAQO), which is oxidized generating H2O2 (Hozumi, 
1969).  However, 4-NQO also undergoes redox cycling to generate superoxide, which can 
be converted to H2O2 and form oxidative DNA damage such as 8-oxoG and DNA strand 
breaks (Nunoshiba and Demple, 1993; Yamamoto et al., 1993).  In addition, acylated 4-
HAQO reacts with DNA to form stable quinoline-purine monoadducts at the N2 of guanine 
and N6 of adenine and 4-NQO is therefore also known as a "UV-mimetic" (Ramotar et al., 
1998).  Finally, diamide induces oxidation of cysteine SH-residues of proteins present in 
mitochondrial membranes and this oxidation also induces formation of O2- (de Souza and 
Geibel, 1999). 
As expected, based on earlier work (Flatter-O'Brien et al., 1993; Jamieson, 1992; Collinson 
and Dawes, 1992; Grant et al., 1997), rho0 cells are more sensitive to killing by H2O2 and 
menadione compared to wild type.  We showed that these agents at the same time increased 
spontaneous mutations in rho0 cells (Figure 1A and 1B, Table 5).  In contrast, 
mitochondrial dysfunction mediated resistance to killing by 4-NQO and adriamycin as well 
as increased 4-NQO-induced mutations (Figure 1D and 1E, Table 5).  A phenotype not only 
observed for yeast as human HeLa rho0 cells have been shown to be more resistant to 
adriamycin than HeLa rho+ cells (Singh et al., 1999).  We did neither detect any difference 
in cell survival nor any difference in spontaneous mutations in rho0 cells after treatment 
with diamide (Figure 1C, Table 5). These results suggest that antioxidant and/or repair 
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defense against damage generated by H2O2 and menadione is impaired in rho0 cells. 
However, the data also indicate that the mutagenic and cytotoxic effect of 4-NQO and 
adriamycin can be separated in rho0 cells. 
The transcript of REV1 is induced in rho0 cells compared to wild type cells (Rasmussen et 
al., III). The Rev1 protein is involved in error-prone translesion synthesis and possesses a 
transferase activity, which incorporate dCMP opposite abasic site in the DNA template 
(Lawrence and Maher, 2001).  The Rev1 protein is also involved in bypass of a T-T (6-4) 
UV photoproduct (Nelson et al., 2000).  Thus, the enzymatic nature of this Rev1p 
function is not yet fully understood.  We are currently testing a Rev1-model to see if Rev1 
can bypass DNA lesions introduced by 4-NQO (UV-mimetic) but not H2O2 and 
menadione. 
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Table 1.  Saccharomyces cerevisiae strains used in this study 
 Strain Genotype 
wild type 
 
RKY3109 MATa, ura3-52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3-10, ade8, 
ade2∆1 
rho- YAKR145 RKY3109 rho-
rho0 YAKR144 RKY3109 rho0
sod1 YAKR129 RKY3109 sod1::URA3 
sod1 rho0 YAKR163-166 RKY3109 rho0
sod2 YAKR133 RKY3109 sod2::TRP1 
sod2 rho0 YAKR135 RKY3109 rho0
sod1 sod2 YAKR137 RKY3109, sod1::URA3, sod2::TRP1 
   
wild type DL1 MATα, met 
rho0 DL1 rho0 DL1 rho0
 
 
 
 
Table 2.  Spontaneous mutation frequencies in 
superoxide deficient strains  
Strain 
 
can1r (x10-8) Fold increase 
Wild type 15.3 ± 3.7 1 
rho- 34.0 ± 5.0 2.2 
rho0 39.9 ± 11.7 2.6 
sod2 30.5± 5.6 2.0 
sod2 rho0 6.4 ± 2.4 0.4 
 can1r (x10-6)  
wild type 1.3 ± 0.3 1 
sod1 165.5 ± 5.1 127.3 
sod1 rho0 8.9 ± 1.8 6.8 
   
Spontaneous mutation frequency in rho-, rho0, sod2, sod2 rho0, 
sod1 and sod1 rho0 is significantly different (P < 0.01) from 
wild type, as determined by t-Test: Two-Sample Assuming 
Equal Variances. 
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Table 3. Functional classification of DNA repair genes induced by       
the SOD1 mutation 
Gene Function Human 
homolog 
Fold 
induction in 
sod1 
MEC3 Checkpoint control and DNA repair  2.8 
RAD9 Checkpoint control and DNA repair hRAD9 3.4 
MSH3 MMR hMSH3 2.9 
MSH4 Meiotic recombination hMSH4 5.1 
NTG2 BER  2 
MAG1 BER AAG 3.2 
MGT1 Direct reversal repair MGMT 6.3 
RAD14 NER XPA 2.4 
RAD16 NER  4.2 
RAD10 NER ERCC1 3.1 
RAD26 NER CSB/ERCC6 2.3 
RAD28 NER CSA 2.6 
RAD50 DSBR hRAD50 3.8 
RAD52 DSBR hRAD52 3.1 
RAD59 DSBR  2.8 
SGS1 DSBR BLM 2.2 
MUS81 DSBR  3.8 
PSO2 DNA repair/recombination  2.2 
RNC1 DNA repair/recombination  2.8 
THI4 Unknown DNA repair function  8.6 
LIF1 DSBR XRCC4 2.6 
ECM32 Unknown DNA repair function  2.5 
TFB3 NER  2.3 
DNA mismatch repair (MMR), Base excision repair (BER), Nucleotide excision repair 
(NER) and Double strand break repair (DSBR)  
 
 
 
 
 
 
Table 4. Functional classification of DNA repair genes induced by       
the SOD1 mutation (sod1 vs sod1rho0) 
Gene Function Human 
homolog 
Fold 
induction in 
sod1 
RAD9 Checkpoint control and DNA repair hRAD9 2.2 
OGG1 BER hOGG1 2.5 
RAD26 NER CSB/ERCC6 2.1 
RAD28 NER CSA 2.2 
MUS81 DSBR  2.7 
CDC2 (POL3) BER, NER  2.1 
FUN30 Unknown DNA repair function  2 
 
Base excision repair (BER), Nucleotide excision repair (NER) and and Double strand 
break repair (DSBR)  
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Table 5.  Spontaneous mutation frequency (x10-8) Spontaneous mutation frequency (x10-7) 
  
H2O2  (mM) 
 
Menadione (mM) 
 
Diamide (mM) 
 
4-NQO (µg/ml) 
 
Adriamycin (µg/ml) 
Conc. 0 2 4 0 10 20 0 25 50 0 2 4 0 20 40 
wt 2.5 6.8 4.0 3.6 1.7 2.4 1.6 4.2 2.2 5.6 34.8 39.2 5.0 6.4 9.7 
rho0 3.8 87.6 85.4 6.1 11.6  4.2 5.9 5.8 27.5 158.1 214.8 71.3 115.1 95.3 
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Figure Legends 
 
Figure 1.  Cell survival of wild type and rho0 cells after drug treatment.  Percent 
survival is expressed relative to the untreated control culture (100%).  Cells were treated 
with various concentrations of (A) H2O2, (B) menadione, (C) diamide, (D) 4-NQO, and (E) 
adriamycin.  Each data point represents an average of duplicate measurements from one 
representative experiment.  Closed symbols: wild type.  Open symbols: rho0. 
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Supplemental materials 
 
Table • Genes repressed in DL1 vs sod1∆ cells 
Probe 
Set Name 
ORF Gene 
name 
A
C 
Fold 
Change 
in DL1 
Descriptions 
DNA Damage Checkpoint  
10048_at YLR288C MEC3 P 2.8 Involved in checkpoint control and DNA repair. 
6274_at YDR217C RAD9 P 3.4 Cell cycle arrest protein. 
 
DNA Mismatch Repair 
 
6787_at YCR092C MSH3 P 2.9 MutS homolog, forms a complex with Msh2p to repair insertion-deletion 
mispairs.  
Meiotic recombination    
5385_at YFL003C MSH4 A 5.1 MutS homolog, localizes to discrete sites on meiotic chromosomes, meiosis 
specific protein. 
 
Base Excision Repair 
 
Oxidative DNA Repair     
8609_at YOL043C NTG2 P 2 Endonuclease III-like glycosylase 2. 
DNA Alkylation Repair    
5582_at YER142C MAG1 A 3.2 3-methyladenine DNA glycosylase. 
 
Direct Repair 
 
6663_at YDL200C MGT1 A 6.3 6-O-methylguanine-DNA methylase. 
 
Nucleotide Excision Repair 
 
9428_at YMR201C RAD14 P 2.4 Human xeroderma pigmentosum group A DNA repair gene homolog. 
7250_at YBR114W RAD16 P 4.2 Radiation repair protein, putative DNA helicase. 
9749_at YML095C RAD10 A 3.1 Endonuclease (with Rad1p) that degrades single-stranded DNA for repair. 
9750_at YML095C RAD10 A 3.2 Questionable ORF 
11009_at YJR035W RAD26 P 2.3 DNA-dependent ATPase, homologous to human Cockayne syndrome B 
gene ERCC6, that is a putative helicase.  
6444_at YDR030C RAD28 P 2.6 Protein involved in the same pathway as Rad26p, has beta-transducin (WD-
40) repeats.  
 
Recombination Repair 
 
9099_at YNL250W RAD50 P 3.8 Protein contains a purine-binding domain, two heptad repeats and a 
hydrophobic tail, Rad50p interacts with Mre11p and Xrs2p in two-hybrid and 
immunoprecipitation analyses\; it co-localizes to spots with Mre11p and 
Xrs2p in a rad50s background.  
9678_at YML032C RAD52 A 3.1 Questionable ORF. 
6539_at YDL059C RAD59 P 2.8 A mutation in this gene results in RADiation sensitivity and recombination 
defects, which are general properties of the RAD52 epistasis group mutants. 
rad59 is epistatic to rad52 for its repair and recombination defects. The 
RAD59 gene product has homology to the Rad52 protein.  
9461_at YMR190C SGS1 P 2.2 Has DNA helicase signature motifs. 
6083_at YDR386W MUS81 A 3.8 MMS and UV Sensitive\; Mus81p and Rad54p are found together in a 
complex from whole-cell extracts. 
9491_at YMR137C PSO2 P 2.2 Interstrand crosslink repair protein. 
 
Other/unknown DNA Repair Function 
 
10528_at YKR056W RNC1 P 2.8 Endo-exonuclease yNucR. 
4844_at YGR144W THI4 A 8.6 Component of the biosynthetic pathway producing the thiazole precursor of 
thiamine. 
5107_at YGL090W LIF1 P 2.6 Ligase Interacting Factor 1\; physically interacts with DNA ligase 4 protein. 
5524_at YER176W ECM32 P 2.5 DNA Helicase I. 
6019_at YDR460W TFB3 P 2.3 TFIIH subunit Tfb3 \; similar to mammalian CAK subunit.  
 
AC = the Absolute Call; The transcript is present (P) or absent (A) for DL1. When the transcript is 
absent is the fold change an approximation and calculated using the noise level. 
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4. Concluding Remarks  
Increased spontaneous mutation frequency is associated with higher risk of cancer. 
However, the relative contribution of spontaneous endogenous mutagenesis to 
carcinogenesis is not yet known. Among the normal cellular metabolic processes that lead 
to elevated spontaneous mutation rates are (Jackson et al., 1998; Rossman & Goncharova, 
1998; Rasmussen et al., III):  
• DNA polymerase errors,  
• Depurination, which gives rise to abasic sites,  
• Deamination of deoxycytidine residues (C → U and 5-methyl-C → T),  
• Methylation of DNA (O6-methylguanine),  
• Damage by oxygen free radicals,  
• and mitochondrial dysfunction. 
 
Thus, both a main repair pathway and one or more backup pathways can generally remove 
these lesions. For example the main repair pathway for eliminating mutations, caused by 
the deoxyguanosine oxidation product 8-oxoG, is BER (hOGG1, hMYH and hMTH). 
However, studies in S. cerevisiae have shown that MSH2-MSH6-dependent MMR is 
involved in repairing 8-oxoG:A mispairs and 8-oxoG:C base pairs. These results suggest 
that MMR is functioning as a backup pathway under high oxidative stress (Ni et al., 1999). 
The MMR pathway is also involved in repair of O6-MeG and O6-MeG-triggered cell death 
when MGMT repair capacity is saturated (see 2.3 Direct Repair: O6-methylguanine-DNA 
methyl-transferase). Furthermore, it has been suggested that the hMLH1 protein, from the 
MMR pathway, has an impact on the apoptosis pathway after oxidative stress. The 
mitochondria were suggested to be involved in this apoptosis pathway because increased 
mitochondrial permeability and cytochrome c release after H2O2 treatment were observed 
preferentially in hMLH proficient cell lines (Hardman et al., 2001). 
Therefore, it seems like inactivation or dysregulation of the DNA protection system are 
important for generating a mutator phenotype. Its importance in human disease is supported 
by the discovery that defects in several kinds of DNA repair are known to raise 
spontaneous mutation frequency i.e. mutations in MMR genes cause hereditary non-
polyposis colon cancer, HNPCC (Hoeijmakers, 2001). 
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In an attempt to identify new MMR genes, we employed the yeast two-hybrid system, using 
the human mismatch repair protein hMSH2 (Rasmussen et al., 2000) or hMLH1 as bait and 
a fetal liver cDNA library as prey. We demonstrated that hMSH2 interacts with 
exonuclease hEXO1 suggesting that hEXO1 plays a role in MMR. Futhermore, we showed 
that hMSH2 and EXO1 are co-expressed at high levels in fetal liver but not in adult liver 
where cell turnover is normally very slow. The hEXO1 protein was highly expressed in 
several liver cancer cell lines as well as in colon and pancreas adenocarcinomas, but not in 
the corresponding non-neoplastic tissue. These results support a role for hEXO1 in cellular 
processes such as MMR, recombination repair or replication, which are expected to be 
active in proliferating cells (Rasmussen et al., 2000). 
 
The mismatch repair protein hMLH1 is known to interact with hPMS1. However, the exact 
biochemical role for the hMLH1-hPMS1 complex has not yet been determined. We showed 
that hMLH1 interacts with hPMS1 in the yeast two-hybrid system using hMLH1 as bait and 
fetal liver cDNA library as prey. Dot-blot analysis of multiple tissue RNA revealed that 
hPMS1 is predominantly expressed in fetal liver, adult liver, pancreas, kidney, testis and 
appendix. Unfortunately, we do not have the corresponding dot-blot analysis for hPMS2. 
However, it is tempting to speculate that hPMS1 is tissue specific and that the hMLH1-
hPMS1 complex plays an important role in DNA repair in liver. Furthermore, it could be 
interesting to compare hPMS1 and hPMS2 expression levels in different cancer cell lines 
with non-neoplastic tissue to investigate if any up or down regulation will occur in the 
cancer cells. 
 
Mutations in MMR genes are known to cause spontaneous mutations. Defects in 
translocation of repair proteins could be a way to inactivate the DNA protection system. We 
present preliminary data showing that hMSH2 and hMLH1 interact with an importin-α 
homolog and importin-α, respectively. Importin-α is part of the translocation system to the 
nucleus. Protein-protein interaction and nuclear localization studies with HNPCC-hMSH2 
mutants or HNPCC-hMLH1 mutants together with importin-α and the importin-α homolog 
could be a way to determine if mutations in MMR mutant genes found in HNPCC patients 
interfere with the translocation system. 
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Another model to inactivate the DNA repair system is oxidative damage. The 
mitochondrial theory of aging postulates that accumulation of oxidative damage in the 
mtDNA leads to mitochondrial dysfunction that results in energy deficiencies in old cells. 
Declined mitochondrial energy capacity could in turn lead to lack in repair (Ames, 1989).  
 
Our results in S. cerevisiae showed that mitochondrial dysfunction caused significantly 
higher spontaneous mutation frequencies in nDNA compared to wild type and this was not 
due to increased levels of ROS in the cells. However, we demonstrated that disruption of 
the respiratory chain function using various mitochondrial inhibitors caused an increase in 
spontaneous mutation frequencies, indicating that increased mitochondrial ROS production 
can diffuse to the nucleus where it causes DNA damage. Furthermore, in rho0 cells we 
found an up-regulation of Rev1 compared to wild type and we showed that mitochondrial-
mediated mutator phenotype of rho0 cells is suppressed by preventing Rev1/Rev3/Rev7-
dependent translesion synthesis (Rasmussen et al., III). Even though we do not know today 
how mitochondrial dysfunction leads to spontaneous nuclear DNA damage, mitochondrial 
dysfunction elevates the spontaneous mutation frequencies.  
 
The nuclear (Sod1) and mitochondrial (Sod2) superoxide dismutases eliminate the 
superoxide anion and thus protect cells from damage induced by free radicals.  We find that 
strains deficient in SOD activity increase spontaneous mutations and that this mutator 
phenotype is suppressed both in sod1∆rho0 and sod2∆rho0 mutant strains. Our results 
suggest that mitochondrial dysfunction either reduces oxidative damage to DNA by 
preventing formation of ROS and/or increases repair of oxidative DNA damage. We 
compared gene expression patterns of the sod1 mutant strain with the sod1rho0 mutant 
strain in order to identify DNA repair genes involved in this suppression. This analysis 
suggested that sod1rho0 cells did not increase repair response compared to sod1 cells. This 
infers that removal of mitochondrial function reduces intracellular levels of ROS and 
consequently decreases mutagenesis caused by oxidative damage to DNA (Rasmussen et 
al., IV).  
 
We found that both H2O2 and menadione treatments reduced cell survival of rho0 cells but 
at the same time increased spontaneous mutations in these cells compared to wild type. 
Gene expression analysis showed that the induced antioxidant enzymes in rho0 cells were 
different from the ones induced in the wild type. Implying that defense against oxidative 
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damage generated by H2O2 and Menadione is different in rho0 cells. These results 
emphasize the significance of mitochondrial activity in controlling cell death as well as 
mutational events following DNA damage.  Proteins involved in such control mechanisms 
have been identified  and include checkpoint proteins such as the human tumor suppressor 
protein p53. It is therefore tempting to consider mitochondria as a new guardian of genomic 
stability. 
 
Given the fact that the integrity of the mtDNA is important it could be beneficial to 
understand the molecular processes and components responsible for mtDNA repair. Most 
DNA glycosylases that have been identified in the nucleus have also been identified in 
mitochondria, which indicates that BER is operating in mitochondria.  
It has not yet been determined if mitochondrial DNA is repaired by MMR. Our two-hybrid 
screenings with hMSH2 or hMLH1 as baits and a fetal liver cDNA library as prey gave no 
answers to this question. However, we found that full-length MGMT, when expressed as a 
GFP fusion protein in human MCF12A (breast) epithelial cells, were localized to the nuclei 
but not to the mitochondria (Rasmussen et al., II). These data suggest that the 
alkyltransferase mechanism, which seems to be operating within the mitochondrion in 
mammalian species, is not MGMT in human breast epithelial cells. 
 
Expression of the mitochondrial genes are required to maintain proper function of the 
organelle, suggesting that even a slight alteration of mitochondrial function may have 
profound effects. Interestingly, one of the profound features of cancer cells is their 
defective mitochondrial function (Warburg, 1956; Polyak et al., 1998; Fliss et al., 2000).  
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